Search Name:	V20130429-05 BS p197-2 wt2/results1
			V20130429-05 BS p197-2 wt2/results1																					
	Uniq Pep	Acc #	UniProt ID	Gene	Num Unique	% Cov	Best Disc Score	Best Expect Val	m/z	z	ppm	DB Peptide	Peptide	Protein Mods	Length	Fraction	RT	Start	End	Score	Expect	P Value	# in DB	Protein MW	Species	Protein Name
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	981.5133	4	4.3	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR		34	V20130429-05_FTMSms2hcd	57.269	237	270	60.4	1.4e-19	3.7e-22	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	635.7852	2	0.89	LGDLYEEEMR	LGDLYEEEM(Oxidation)R	Oxidation@154	10	V20130429-05_FTMSms2hcd	26.163	146	155	33.1	6.8e-18	1.1e-20	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	1101.9834	2	-0.58	EMEENFAVEAANYQDTIGR	EM(Oxidation)EENFAVEAANYQDTIGR	Oxidation@347	19	V20130429-05_FTMSms2hcd	42.992	346	364	55.5	5.8e-16	5.9e-19	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	833.0956	3	6.1	LLQDSVDFSLADAINTEFKNTR	LLQDSVDFSLADAINTEFKNTR		22	V20130429-05_FTMSms2hcd	62.486	79	100	49.0	1.9e-13	2.8e-16	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	918.9037	2	0.35	DGQVINETSQHHDDLE	DGQVINETSQHHDDLE		16	V20130429-05_FTMSms2hcd	22.158	451	466	34.3	3.7e-13	4.7e-16	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	844.9689	4	9.3	ISLPLPNFSSLNLRETNLDSLPLVDTHSKR	ISLPLPNFSSLNLRETNLDSLPLVDTHSKR		30	V20130429-05_FTMSms2hcd	66.260	411	440	50.9	6.8e-13	4.7e-15	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	912.9767	2	0.61	ETNLDSLPLVDTHSKR	ETNLDSLPLVDTHSKR		16	V20130429-05_FTMSms2hcd	35.425	425	440	49.0	2.8e-12	4.1e-15	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	592.9595	3	0.90	FADLSEAANRNNDALR	FADLSEAANRNNDALR		16	V20130429-05_FTMSms2hcd	30.020	295	310	47.0	6.7e-12	7.3e-15	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	859.9168	4	1.6	LQEEMLQREEAENTLQSFRQDVDNASLAR	LQEEM(Oxidation)LQREEAENTLQSFRQDVDNASLAR	Oxidation@193	29	V20130429-05_FTMSms2hcd	51.035	189	217	36.4	2.0e-11	2.2e-14	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	655.3065	2	-0.14	NLQEAEEWYK	NLQEAEEWYK		10	V20130429-05_FTMSms2hcd	35.221	283	292	35.5	5.4e-11	7.4e-14	2	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	1063.5400	2	3.5	LLQDSVDFSLADAINTEFK	LLQDSVDFSLADAINTEFK		19	V20130429-05_FTMSms2hcd	65.577	79	97	43.8	6.3e-11	8.1e-14	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	748.3955	2	-1.7	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-05_FTMSms2hcd	30.027	37	50	37.6	6.4e-11	9.9e-14	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	798.3828	3	0.45	EEAENTLQSFRQDVDNASLAR	EEAENTLQSFRQDVDNASLAR		21	V20130429-05_FTMSms2hcd	46.417	197	217	51.5	1.3e-10	1.3e-13	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	589.6068	3	0.62	LQDEIQNMKEEMAR	LQDEIQNM(Oxidation)KEEM(Oxidation)AR	Oxidation@372;Oxidation@376	14	V20130429-05_FTMSms2hcd	16.118	365	378	36.5	4.6e-10	5.2e-13	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	554.6536	3	-0.60	KVESLQEEIAFLKK	KVESLQEEIAFLKK		14	V20130429-05_FTMSms2hcd	42.399	223	236	42.1	4.7e-10	2.3e-12	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	852.9155	2	0.94	VEVERDNLAEDIMR	VEVERDNLAEDIM(Oxidation)R	Oxidation@183	14	V20130429-05_FTMSms2hcd	30.259	171	184	30.2	4.8e-10	5.3e-13	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	375.8729	3	-0.86	FANYIDKVR	FANYIDKVR		9	V20130429-05_FTMSms2hcd	27.642	114	122	39.9	5.2e-10	9.9e-13	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	504.2413	3	1.8	MFGGPGTASRPSSSR	M(Oxidation)FGGPGTASRPSSSR	Oxidation@14	15	V20130429-05_FTMSms2hcd	14.284	14	28	35.4	9.6e-10	1.3e-12	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	785.9522	2	1.3	ISLPLPNFSSLNLR	ISLPLPNFSSLNLR		14	V20130429-05_FTMSms2hcd	65.277	411	424	43.0	1.7e-9	5.9e-12	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	794.4025	2	0.27	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-05_FTMSms2hcd	26.257	101	113	54.1	1.8e-9	2.2e-12	2	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	547.2664	2	-1.6	FADLSEAANR	FADLSEAANR		10	V20130429-05_FTMSms2hcd	25.154	295	304	41.1	4.0e-8	7.2e-11	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	770.4586	2	-0.35	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-05_FTMSms2hcd	45.154	130	143	51.2	7.2e-8	5.6e-10	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	511.9553	3	-0.61	KVESLQEEIAFLK	KVESLQEEIAFLK		13	V20130429-05_FTMSms2hcd	48.359	223	235	29.9	8.8e-8	2.3e-10	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	509.9475	3	0.095	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-05_FTMSms2hcd	34.561	379	390	29.9	2.6e-7	5.2e-10	4	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	457.7327	2	0.37	SYVTTSTR	SYVTTSTR		8	V20130429-05_FTMSms2hcd	11.365	29	36	35.0	2.6e-7	5.2e-10	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	813.7465	3	4.1	TNEKVELQELNDRFANYIDK	TNEKVELQELNDRFANYIDK		20	V20130429-05_FTMSms2hcd	47.705	101	120	25.1	5.1e-5	6.3e-8	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	512.2587	2	-0.42	QQYESVAAK	QQYESVAAK		9	V20130429-05_FTMSms2hcd	11.430	274	282	20.1	6.3e-5	1.1e-7	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	530.7660	2	-2.1	QVDQLTNDK	QVDQLTNDK		9	V20130429-05_FTMSms2hcd	12.400	160	168	18.8	1.8e-4	2.6e-7	1	53652.1	HUMAN	Vimentin
[1]		P08670	VIME_HUMAN	VIM	29	71.2	10.90	1.4e-19	833.9080	2	0.55	RMFGGPGTASRPSSSR	RM(Oxidation)FGGPGTASRPSSSR	Oxidation@14	16	V20130429-05_FTMSms2hcd	12.160	13	28	14.3	0.0028	3.2e-6	1	53652.1	HUMAN	Vimentin
[1-1]	0	P17661	DESM_HUMAN	DES	2	5.3	5.44	1.8e-9	794.4025	2	0.27	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-05_FTMSms2hcd	26.257	106	118	54.1	1.8e-9	2.2e-12	2	53536.2	HUMAN	Desmin
[1-1]	0	P17661	DESM_HUMAN	DES	2	5.3	5.44	1.8e-9	509.9475	3	0.095	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-05_FTMSms2hcd	34.561	384	395	29.9	2.6e-7	5.2e-10	4	53536.2	HUMAN	Desmin
[1-2]	0	P41219	PERI_HUMAN	PRPH	1	2.1	5.81	5.4e-11	655.3065	2	-0.14	NLQEAEEWYK	NLQEAEEWYK		10	V20130429-05_FTMSms2hcd	35.221	279	288	35.5	5.4e-11	7.4e-14	2	53651.3	HUMAN	Peripherin
[1-3]	0	P07197	NFM_HUMAN	NEFM	1	1.3	3.27	2.6e-7	509.9475	3	0.095	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-05_FTMSms2hcd	34.561	380	391	29.9	2.6e-7	5.2e-10	4	102472.8	HUMAN	Neurofilament medium polypeptide
[1-4]	0	Q16352	AINX_HUMAN	INA	1	2.4	3.27	2.6e-7	509.9475	3	0.095	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-05_FTMSms2hcd	34.561	375	386	29.9	2.6e-7	5.2e-10	4	55391.1	HUMAN	Alpha-internexin
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	871.1244	3	1.5	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-05_FTMSms2hcd	61.519	163	186	54.6	2.9e-19	5.0e-22	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	625.1136	5	-1.8	RVIISAPSADAPMFVMGVNHEKYDNSLK	RVIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEKYDNSLK	Oxidation@130;Oxidation@133	28	V20130429-05_FTMSms2hcd	39.972	118	145	49.0	1.2e-18	1.3e-21	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	756.0632	3	3.0	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-05_FTMSms2hcd	52.264	228	248	53.8	3.2e-18	5.1e-21	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	765.0164	3	0.76	WGDAGAEYVVESTGVFTTMEK	WGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	21	V20130429-05_FTMSms2hcd	53.470	87	107	50.4	3.6e-18	3.7e-21	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	865.7933	3	2.1	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-05_FTMSms2hcd	70.999	163	186	50.9	1.1e-15	2.6e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	989.1541	3	1.5	VIISAPSADAPMFVMGVNHEKYDNSLK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEKYDNSLK	Oxidation@130;Oxidation@133	27	V20130429-05_FTMSms2hcd	42.308	119	145	45.1	5.2e-15	5.4e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	847.4537	3	-0.071	AENGKLVINGNPITIFQERDPSK	AENGKLVINGNPITIFQERDPSK		23	V20130429-05_FTMSms2hcd	47.997	62	84	59.7	1.0e-14	2.3e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	845.4106	3	2.1	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-05_FTMSms2hcd	53.702	85	107	48.6	1.5e-14	1.4e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	681.8237	2	0.68	VVDLMAHMASKE	VVDLM(Oxidation)AHM(Oxidation)ASKE	Oxidation@328;Oxidation@331	12	V20130429-05_FTMSms2hcd	15.708	324	335	43.0	3.8e-14	5.0e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	882.4058	2	1.1	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-05_FTMSms2hcd	49.262	310	323	56.5	3.0e-13	3.4e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	966.8753	5	12	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	Q(Gln->pyro-Glu)ASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	Gln->pyro-Glu@264	46	V20130429-05_FTMSms2hcd	62.617	264	309	46.0	8.6e-13	1.6e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	761.4335	3	-0.33	LVINGNPITIFQERDPSKIK	LVINGNPITIFQERDPSKIK		20	V20130429-05_FTMSms2hcd	50.372	67	86	47.9	8.9e-13	6.0e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	749.0381	3	0.27	VIISAPSADAPMFVMGVNHEK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEK	Oxidation@130;Oxidation@133	21	V20130429-05_FTMSms2hcd	40.844	119	139	36.5	1.1e-12	1.2e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	617.3013	2	-1.0	VVDLMAHMASK	VVDLM(Oxidation)AHM(Oxidation)ASK	Oxidation@328;Oxidation@331	11	V20130429-05_FTMSms2hcd	14.812	324	334	36.5	2.2e-12	3.3e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	1021.0598	2	2.3	LVINGNPITIFQERDPSK	LVINGNPITIFQERDPSK		18	V20130429-05_FTMSms2hcd	51.858	67	84	48.6	1.4e-11	3.9e-14	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	807.4573	2	3.9	LVINGNPITIFQER	LVINGNPITIFQER		14	V20130429-05_FTMSms2hcd	56.799	67	80	51.0	3.8e-10	1.1e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	737.3889	2	-1.7	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-05_FTMSms2hcd	42.918	235	248	51.4	6.7e-10	1.1e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	362.7100	4	1.8	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-05_FTMSms2hcd	13.807	249	260	30.5	5.5e-8	1.7e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	706.3985	2	-0.45	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-05_FTMSms2hcd	38.692	201	215	32.5	2.5e-7	6.9e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	406.2103	2	0.29	LTGMAFR	LTGM(Oxidation)AFR	Oxidation@231	7	V20130429-05_FTMSms2hcd	16.689	228	234	30.8	1.8e-6	3.4e-9	2	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	440.5786	3	0.53	LEKPAKYDDIK	LEKPAKYDDIK		11	V20130429-05_FTMSms2hcd	16.850	249	259	27.1	2.2e-6	4.1e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	435.2584	2	0.49	VIPELNGK	VIPELNGK		8	V20130429-05_FTMSms2hcd	24.315	220	227	28.9	1.2e-5	5.2e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	403.2190	2	-0.98	VGVNGFGR	VGVNGFGR		8	V20130429-05_FTMSms2hcd	21.721	6	13	36.4	1.5e-5	2.8e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	24	69.9	10.73	2.9e-19	808.7267	6	1.1	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK		46	V20130429-05_FTMSms2hcd	58.728	264	309	13.3	0.026	4.2e-5	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2-1]	0	O14556	G3PT_HUMAN	GAPDHS	1	1.7	2.90	1.8e-6	406.2103	2	0.29	LTGMAFR	LTGM(Oxidation)AFR	Oxidation@303	7	V20130429-05_FTMSms2hcd	16.689	300	306	30.8	1.8e-6	3.4e-9	2	44501.6	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	890.8912	2	1.3	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-05_FTMSms2hcd	52.420	1	18	49.0	6.0e-22	7.9e-25	1	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	635.5463	4	-1.2	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@44;Oxidation@47	23	V20130429-05_FTMSms2hcd	17.275	40	62	55.9	5.9e-19	5.5e-22	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	790.9049	2	0.18	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-05_FTMSms2hcd	22.622	313	326	57.3	1.2e-17	1.6e-20	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	1116.0371	2	0.92	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-05_FTMSms2hcd	47.771	292	312	54.6	1.3e-14	1.3e-17	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	787.0585	3	0.47	KDLYANTVLSGGTTMYPGIADR	KDLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	22	V20130429-05_FTMSms2hcd	41.687	291	312	56.0	1.9e-14	2.0e-17	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	977.5359	2	0.061	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-05_FTMSms2hcd	40.325	96	113	50.9	9.2e-14	2.4e-16	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	1067.2090	3	1.0	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-05_FTMSms2hcd	53.115	148	177	34.5	1.6e-13	2.1e-16	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	795.0267	3	0.11	HQGVMVGMGQKDSYVGDEAQSK	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSK	Oxidation@44;Oxidation@47	22	V20130429-05_FTMSms2hcd	18.648	40	61	48.8	8.9e-13	8.8e-16	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	822.9023	2	-0.18	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-05_FTMSms2hcd	18.147	360	373	49.3	1.5e-12	1.7e-15	7	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	239	254	51.5	2.2e-12	2.6e-15	10	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	677.8152	2	-0.17	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-05_FTMSms2hcd	11.498	51	62	42.6	5.4e-12	6.9e-15	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	85	95	36.2	8.1e-12	1.1e-14	9	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	589.3094	2	-1.5	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-05_FTMSms2hcd	24.520	316	326	41.5	1.6e-11	2.4e-14	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	507.7443	2	0.098	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@190	8	V20130429-05_FTMSms2hcd	37.507	184	191	26.4	1.4e-10	2.8e-13	7	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	547.2832	3	-0.57	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@190	14	V20130429-05_FTMSms2hcd	47.320	178	191	35.2	1.8e-10	2.3e-13	7	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	582.8760	2	-1.4	IKIIAPPERK	IKIIAPPERK		10	V20130429-05_FTMSms2hcd	21.410	327	336	33.6	4.6e-10	1.7e-11	7	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-05_FTMSms2hcd	12.932	51	61	40.2	5.7e-10	1.2e-12	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	29	39	43.3	6.0e-10	2.2e-12	9	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	543.2621	3	0.41	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@360	14	V20130429-05_FTMSms2hcd	23.290	360	373	29.1	1.6e-9	1.8e-12	7	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	543.9454	3	-0.90	GYSFTTTAEREIVR	GYSFTTTAEREIVR		14	V20130429-05_FTMSms2hcd	37.117	197	210	33.2	1.6e-7	1.9e-10	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	566.7662	2	-1.6	GYSFTTTAER	GYSFTTTAER		10	V20130429-05_FTMSms2hcd	24.526	197	206	32.6	2.8e-7	4.8e-10	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	22	57.3	12.18	6.0e-22	398.2401	2	0.77	IIAPPER	IIAPPER		7	V20130429-05_FTMSms2hcd	18.622	329	335	28.1	4.5e-7	2.4e-9	7	41737.1	HUMAN	Actin, cytoplasmic 1
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	635.5463	4	-1.2	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@44;Oxidation@47	23	V20130429-05_FTMSms2hcd	17.275	40	62	55.9	5.9e-19	5.5e-22	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	918.9319	2	12	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-05_FTMSms2hcd	60.629	1	18	56.4	1.1e-18	1.1e-21	1	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	790.9049	2	0.18	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-05_FTMSms2hcd	22.622	313	326	57.3	1.2e-17	1.6e-20	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	1116.0371	2	0.92	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-05_FTMSms2hcd	47.771	292	312	54.6	1.3e-14	1.3e-17	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	787.0585	3	0.47	KDLYANTVLSGGTTMYPGIADR	KDLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	22	V20130429-05_FTMSms2hcd	41.687	291	312	56.0	1.9e-14	2.0e-17	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	977.5359	2	0.061	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-05_FTMSms2hcd	40.325	96	113	50.9	9.2e-14	2.4e-16	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	1067.2090	3	1.0	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-05_FTMSms2hcd	53.115	148	177	34.5	1.6e-13	2.1e-16	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	795.0267	3	0.11	HQGVMVGMGQKDSYVGDEAQSK	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSK	Oxidation@44;Oxidation@47	22	V20130429-05_FTMSms2hcd	18.648	40	61	48.8	8.9e-13	8.8e-16	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	822.9023	2	-0.18	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-05_FTMSms2hcd	18.147	360	373	49.3	1.5e-12	1.7e-15	7	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	239	254	51.5	2.2e-12	2.6e-15	10	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	677.8152	2	-0.17	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-05_FTMSms2hcd	11.498	51	62	42.6	5.4e-12	6.9e-15	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	85	95	36.2	8.1e-12	1.1e-14	9	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	589.3094	2	-1.5	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-05_FTMSms2hcd	24.520	316	326	41.5	1.6e-11	2.4e-14	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	507.7443	2	0.098	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@190	8	V20130429-05_FTMSms2hcd	37.507	184	191	26.4	1.4e-10	2.8e-13	7	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	547.2832	3	-0.57	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@190	14	V20130429-05_FTMSms2hcd	47.320	178	191	35.2	1.8e-10	2.3e-13	7	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	582.8760	2	-1.4	IKIIAPPERK	IKIIAPPERK		10	V20130429-05_FTMSms2hcd	21.410	327	336	33.6	4.6e-10	1.7e-11	7	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-05_FTMSms2hcd	12.932	51	61	40.2	5.7e-10	1.2e-12	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	29	39	43.3	6.0e-10	2.2e-12	9	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	543.2621	3	0.41	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@360	14	V20130429-05_FTMSms2hcd	23.290	360	373	29.1	1.6e-9	1.8e-12	7	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	543.9454	3	-0.90	GYSFTTTAEREIVR	GYSFTTTAEREIVR		14	V20130429-05_FTMSms2hcd	37.117	197	210	33.2	1.6e-7	1.9e-10	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	566.7662	2	-1.6	GYSFTTTAER	GYSFTTTAER		10	V20130429-05_FTMSms2hcd	24.526	197	206	32.6	2.8e-7	4.8e-10	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	22	57.3	10.56	5.9e-19	398.2401	2	0.77	IIAPPER	IIAPPER		7	V20130429-05_FTMSms2hcd	18.622	329	335	28.1	4.5e-7	2.4e-9	7	41793.2	HUMAN	Actin, cytoplasmic 2
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	635.5463	4	-1.2	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-05_FTMSms2hcd	17.275	42	64	55.9	5.9e-19	5.5e-22	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	790.9049	2	0.18	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-05_FTMSms2hcd	22.622	315	328	57.3	1.2e-17	1.6e-20	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	795.0267	3	0.11	HQGVMVGMGQKDSYVGDEAQSK	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSK	Oxidation@46;Oxidation@49	22	V20130429-05_FTMSms2hcd	18.648	42	63	48.8	8.9e-13	8.8e-16	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	241	256	51.5	2.2e-12	2.6e-15	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	677.8152	2	-0.17	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-05_FTMSms2hcd	11.498	53	64	42.6	5.4e-12	6.9e-15	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	87	97	36.2	8.1e-12	1.1e-14	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	589.3094	2	-1.5	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-05_FTMSms2hcd	24.520	318	328	41.5	1.6e-11	2.4e-14	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	868.1139	3	1.9	GILTLKYPIEHGIITNWDDMEK	GILTLKYPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	22	V20130429-05_FTMSms2hcd	52.492	65	86	30.1	4.2e-11	5.9e-14	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	507.7443	2	0.098	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-05_FTMSms2hcd	37.507	186	193	26.4	1.4e-10	2.8e-13	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	547.2832	3	-0.57	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-05_FTMSms2hcd	47.320	180	193	35.2	1.8e-10	2.3e-13	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	869.1636	4	-1.3	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-05_FTMSms2hcd	53.546	71	97	34.1	2.1e-10	2.1e-13	2	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	659.6393	3	-1.3	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-05_FTMSms2hcd	38.251	71	86	31.8	4.4e-10	4.5e-13	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	582.8760	2	-1.4	IKIIAPPERK	IKIIAPPERK		10	V20130429-05_FTMSms2hcd	21.410	329	338	33.6	4.6e-10	1.7e-11	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-05_FTMSms2hcd	12.932	53	63	40.2	5.7e-10	1.2e-12	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	31	41	43.3	6.0e-10	2.2e-12	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	398.2401	2	0.77	IIAPPER	IIAPPER		7	V20130429-05_FTMSms2hcd	18.622	331	337	28.1	4.5e-7	2.4e-9	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	4	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.56	5.9e-19	1049.8165	3	-3.9	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=36	28	V20130429-05_FTMSms2hcd	59.002	259	286	17.4	7.2e-7	6.7e-10	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	635.5463	4	-1.2	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-05_FTMSms2hcd	17.275	42	64	55.9	5.9e-19	5.5e-22	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	790.9049	2	0.18	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-05_FTMSms2hcd	22.622	315	328	57.3	1.2e-17	1.6e-20	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	795.0267	3	0.11	HQGVMVGMGQKDSYVGDEAQSK	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSK	Oxidation@46;Oxidation@49	22	V20130429-05_FTMSms2hcd	18.648	42	63	48.8	8.9e-13	8.8e-16	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	241	256	51.5	2.2e-12	2.6e-15	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	677.8152	2	-0.17	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-05_FTMSms2hcd	11.498	53	64	42.6	5.4e-12	6.9e-15	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	87	97	36.2	8.1e-12	1.1e-14	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	589.3094	2	-1.5	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-05_FTMSms2hcd	24.520	318	328	41.5	1.6e-11	2.4e-14	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	868.1139	3	1.9	GILTLKYPIEHGIITNWDDMEK	GILTLKYPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	22	V20130429-05_FTMSms2hcd	52.492	65	86	30.1	4.2e-11	5.9e-14	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	507.7443	2	0.098	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-05_FTMSms2hcd	37.507	186	193	26.4	1.4e-10	2.8e-13	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	547.2832	3	-0.57	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-05_FTMSms2hcd	47.320	180	193	35.2	1.8e-10	2.3e-13	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	869.1636	4	-1.3	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-05_FTMSms2hcd	53.546	71	97	34.1	2.1e-10	2.1e-13	2	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	659.6393	3	-1.3	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-05_FTMSms2hcd	38.251	71	86	31.8	4.4e-10	4.5e-13	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	582.8760	2	-1.4	IKIIAPPERK	IKIIAPPERK		10	V20130429-05_FTMSms2hcd	21.410	329	338	33.6	4.6e-10	1.7e-11	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-05_FTMSms2hcd	12.932	53	63	40.2	5.7e-10	1.2e-12	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	31	41	43.3	6.0e-10	2.2e-12	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	398.2401	2	0.77	IIAPPER	IIAPPER		7	V20130429-05_FTMSms2hcd	18.622	331	337	28.1	4.5e-7	2.4e-9	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	4	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.56	5.9e-19	1049.8165	3	-3.9	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=36	28	V20130429-05_FTMSms2hcd	59.002	259	286	17.4	7.2e-7	6.7e-10	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	635.5463	4	-1.2	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-05_FTMSms2hcd	17.275	42	64	55.9	5.9e-19	5.5e-22	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	790.9049	2	0.18	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-05_FTMSms2hcd	22.622	315	328	57.3	1.2e-17	1.6e-20	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	795.0267	3	0.11	HQGVMVGMGQKDSYVGDEAQSK	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSK	Oxidation@46;Oxidation@49	22	V20130429-05_FTMSms2hcd	18.648	42	63	48.8	8.9e-13	8.8e-16	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	241	256	51.5	2.2e-12	2.6e-15	10	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	677.8152	2	-0.17	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-05_FTMSms2hcd	11.498	53	64	42.6	5.4e-12	6.9e-15	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	589.3094	2	-1.5	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-05_FTMSms2hcd	24.520	318	328	41.5	1.6e-11	2.4e-14	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	868.1139	3	1.9	GILTLKYPIEHGIITNWDDMEK	GILTLKYPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	22	V20130429-05_FTMSms2hcd	52.492	65	86	30.1	4.2e-11	5.9e-14	4	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	507.7443	2	0.098	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-05_FTMSms2hcd	37.507	186	193	26.4	1.4e-10	2.8e-13	7	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	547.2832	3	-0.57	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-05_FTMSms2hcd	47.320	180	193	35.2	1.8e-10	2.3e-13	7	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	659.6393	3	-1.3	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-05_FTMSms2hcd	38.251	71	86	31.8	4.4e-10	4.5e-13	4	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	582.8760	2	-1.4	IKIIAPPERK	IKIIAPPERK		10	V20130429-05_FTMSms2hcd	21.410	329	338	33.6	4.6e-10	1.7e-11	7	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-05_FTMSms2hcd	12.932	53	63	40.2	5.7e-10	1.2e-12	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	31	41	43.3	6.0e-10	2.2e-12	9	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	398.2401	2	0.77	IIAPPER	IIAPPER		7	V20130429-05_FTMSms2hcd	18.622	331	337	28.1	4.5e-7	2.4e-9	7	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	3	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.56	5.9e-19	1049.8165	3	-3.9	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=36	28	V20130429-05_FTMSms2hcd	59.002	259	286	17.4	7.2e-7	6.7e-10	4	42009.4	HUMAN	Actin, aortic smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	635.5463	4	-1.2	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@45;Oxidation@48	23	V20130429-05_FTMSms2hcd	17.275	41	63	55.9	5.9e-19	5.5e-22	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	790.9049	2	0.18	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@314;Oxidation@326	14	V20130429-05_FTMSms2hcd	22.622	314	327	57.3	1.2e-17	1.6e-20	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	795.0267	3	0.11	HQGVMVGMGQKDSYVGDEAQSK	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSK	Oxidation@45;Oxidation@48	22	V20130429-05_FTMSms2hcd	18.648	41	62	48.8	8.9e-13	8.8e-16	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	240	255	51.5	2.2e-12	2.6e-15	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	677.8152	2	-0.17	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-05_FTMSms2hcd	11.498	52	63	42.6	5.4e-12	6.9e-15	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	589.3094	2	-1.5	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-05_FTMSms2hcd	24.520	317	327	41.5	1.6e-11	2.4e-14	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	868.1139	3	1.9	GILTLKYPIEHGIITNWDDMEK	GILTLKYPIEHGIITNWDDM(Oxidation)EK	Oxidation@83	22	V20130429-05_FTMSms2hcd	52.492	64	85	30.1	4.2e-11	5.9e-14	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	507.7443	2	0.098	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@191	8	V20130429-05_FTMSms2hcd	37.507	185	192	26.4	1.4e-10	2.8e-13	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	547.2832	3	-0.57	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@191	14	V20130429-05_FTMSms2hcd	47.320	179	192	35.2	1.8e-10	2.3e-13	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	659.6393	3	-1.3	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@83	16	V20130429-05_FTMSms2hcd	38.251	70	85	31.8	4.4e-10	4.5e-13	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	582.8760	2	-1.4	IKIIAPPERK	IKIIAPPERK		10	V20130429-05_FTMSms2hcd	21.410	328	337	33.6	4.6e-10	1.7e-11	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-05_FTMSms2hcd	12.932	52	62	40.2	5.7e-10	1.2e-12	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	30	40	43.3	6.0e-10	2.2e-12	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	398.2401	2	0.77	IIAPPER	IIAPPER		7	V20130429-05_FTMSms2hcd	18.622	330	336	28.1	4.5e-7	2.4e-9	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	3	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.56	5.9e-19	1049.8165	3	-3.9	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=36	28	V20130429-05_FTMSms2hcd	59.002	258	285	17.4	7.2e-7	6.7e-10	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	5	4.8	7.11	1.5e-12	822.9023	2	-0.18	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-05_FTMSms2hcd	18.147	1060	1073	49.3	1.5e-12	1.7e-15	7	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	5	4.8	7.11	1.5e-12	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	939	954	51.5	2.2e-12	2.6e-15	10	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	5	4.8	7.11	1.5e-12	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	785	795	36.2	8.1e-12	1.1e-14	9	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	5	4.8	7.11	1.5e-12	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	729	739	43.3	6.0e-10	2.2e-12	9	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	5	4.8	7.11	1.5e-12	543.2621	3	0.41	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@1060	14	V20130429-05_FTMSms2hcd	23.290	1060	1073	29.1	1.6e-9	1.8e-12	7	121364.6	HUMAN	POTE ankyrin domain family member E
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	5	4.8	7.11	1.5e-12	822.9023	2	-0.18	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-05_FTMSms2hcd	18.147	1060	1073	49.3	1.5e-12	1.7e-15	7	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	5	4.8	7.11	1.5e-12	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	939	954	51.5	2.2e-12	2.6e-15	10	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	5	4.8	7.11	1.5e-12	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	785	795	36.2	8.1e-12	1.1e-14	9	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	5	4.8	7.11	1.5e-12	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	729	739	43.3	6.0e-10	2.2e-12	9	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	5	4.8	7.11	1.5e-12	543.2621	3	0.41	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@1060	14	V20130429-05_FTMSms2hcd	23.290	1060	1073	29.1	1.6e-9	1.8e-12	7	121445.7	HUMAN	POTE ankyrin domain family member F
[3-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	6	13.8	7.01	2.2e-12	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	240	255	51.5	2.2e-12	2.6e-15	10	42003.6	HUMAN	Beta-actin-like protein 2
[3-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	6	13.8	7.01	2.2e-12	507.7443	2	0.098	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@191	8	V20130429-05_FTMSms2hcd	37.507	185	192	26.4	1.4e-10	2.8e-13	7	42003.6	HUMAN	Beta-actin-like protein 2
[3-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	6	13.8	7.01	2.2e-12	547.2832	3	-0.57	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@191	14	V20130429-05_FTMSms2hcd	47.320	179	192	35.2	1.8e-10	2.3e-13	7	42003.6	HUMAN	Beta-actin-like protein 2
[3-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	6	13.8	7.01	2.2e-12	582.8760	2	-1.4	IKIIAPPERK	IKIIAPPERK		10	V20130429-05_FTMSms2hcd	21.410	328	337	33.6	4.6e-10	1.7e-11	7	42003.6	HUMAN	Beta-actin-like protein 2
[3-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	6	13.8	7.01	2.2e-12	398.2401	2	0.77	IIAPPER	IIAPPER		7	V20130429-05_FTMSms2hcd	18.622	330	336	28.1	4.5e-7	2.4e-9	7	42003.6	HUMAN	Beta-actin-like protein 2
[3-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	6	13.8	7.01	2.2e-12	685.8124	2	12	DCYVGDEAQSKR	DCYVGDEAQSKR		12	V20130429-05_FTMSms2hcd	9.747	52	63	13.6	0.013	1.9e-5	1	42003.6	HUMAN	Beta-actin-like protein 2
[3-9]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	4	10.9	7.11	1.5e-12	822.9023	2	-0.18	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-05_FTMSms2hcd	18.147	360	373	49.3	1.5e-12	1.7e-15	7	42016.6	HUMAN	Putative beta-actin-like protein 3
[3-9]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	4	10.9	7.11	1.5e-12	895.9495	2	-0.11	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-05_FTMSms2hcd	47.493	239	254	51.5	2.2e-12	2.6e-15	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[3-9]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	4	10.9	7.11	1.5e-12	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	85	95	36.2	8.1e-12	1.1e-14	9	42016.6	HUMAN	Putative beta-actin-like protein 3
[3-9]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	4	10.9	7.11	1.5e-12	543.2621	3	0.41	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@360	14	V20130429-05_FTMSms2hcd	23.290	360	373	29.1	1.6e-9	1.8e-12	7	42016.6	HUMAN	Putative beta-actin-like protein 3
[3-10]	0	P0CG38	POTEI_HUMAN	POTEI	4	3.3	7.11	1.5e-12	822.9023	2	-0.18	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-05_FTMSms2hcd	18.147	1060	1073	49.3	1.5e-12	1.7e-15	7	121283.5	HUMAN	POTE ankyrin domain family member I
[3-10]	0	P0CG38	POTEI_HUMAN	POTEI	4	3.3	7.11	1.5e-12	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	785	795	36.2	8.1e-12	1.1e-14	9	121283.5	HUMAN	POTE ankyrin domain family member I
[3-10]	0	P0CG38	POTEI_HUMAN	POTEI	4	3.3	7.11	1.5e-12	400.2398	3	-0.55	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-05_FTMSms2hcd	34.638	729	739	43.3	6.0e-10	2.2e-12	9	121283.5	HUMAN	POTE ankyrin domain family member I
[3-10]	0	P0CG38	POTEI_HUMAN	POTEI	4	3.3	7.11	1.5e-12	543.2621	3	0.41	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@1060	14	V20130429-05_FTMSms2hcd	23.290	1060	1073	29.1	1.6e-9	1.8e-12	7	121283.5	HUMAN	POTE ankyrin domain family member I
[3-11]	1	P0CG39	POTEJ_HUMAN	POTEJ	4	5.1	7.11	1.5e-12	822.9023	2	-0.18	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-05_FTMSms2hcd	18.147	1023	1036	49.3	1.5e-12	1.7e-15	7	117391.0	HUMAN	POTE ankyrin domain family member J
[3-11]	1	P0CG39	POTEJ_HUMAN	POTEJ	4	5.1	7.11	1.5e-12	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-05_FTMSms2hcd	31.453	748	758	36.2	8.1e-12	1.1e-14	9	117391.0	HUMAN	POTE ankyrin domain family member J
[3-11]	1	P0CG39	POTEJ_HUMAN	POTEJ	4	5.1	7.11	1.5e-12	543.2621	3	0.41	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@1023	14	V20130429-05_FTMSms2hcd	23.290	1023	1036	29.1	1.6e-9	1.8e-12	7	117391.0	HUMAN	POTE ankyrin domain family member J
[3-11]	1	P0CG39	POTEJ_HUMAN	POTEJ	4	5.1	7.11	1.5e-12	780.3600	4	1.6	AVFPSIVGCPRQQGMMGGMHQKESYVGK	AVFPSIVGCPRQQGM(Oxidation)MGGMHQKESY(Phospho)VGK	Oxidation@706&Phospho@715|Oxidation@706&Phospho@716|Oxidation@707&Phospho@715|Oxidation@707&Phospho@716|Oxidation@710&Phospho@715|Oxidation@710&Phospho@716	28	V20130429-05_FTMSms2hcd	50.447	692	719	10.2	0.036	3.6e-5	1	117391.0	HUMAN	POTE ankyrin domain family member J
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	755.1578	4	5.0	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-05_FTMSms2hcd	56.185	93	120	54.6	7.0e-19	2.1e-21	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	1088.0660	2	3.1	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-05_FTMSms2hcd	55.125	401	422	56.9	5.8e-15	8.0e-18	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	890.4439	2	2.6	GADFLVTEVENGGSLGSK	GADFLVTEVENGGSLGSK		18	V20130429-05_FTMSms2hcd	49.145	189	206	51.2	6.4e-14	7.6e-17	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	826.4604	3	2.3	KGVNLPGAAVDLPAVSEKDIQDLK	KGVNLPGAAVDLPAVSEKDIQDLK		24	V20130429-05_FTMSms2hcd	51.046	207	230	45.8	1.0e-13	4.7e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	613.3074	3	-2.0	RFDEILEASDGIMVAR	RFDEILEASDGIM(Oxidation)VAR	Oxidation@291	16	V20130429-05_FTMSms2hcd	45.115	279	294	47.2	6.4e-13	7.1e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	668.6733	3	7.9	FGVEQDVDMVFASFIRK	FGVEQDVDM(Oxidation)VFASFIRK	Oxidation@239	17	V20130429-05_FTMSms2hcd	67.689	231	247	39.4	9.4e-13	1.1e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	607.2915	2	-0.98	ITLDNAYMEK	ITLDNAYM(Oxidation)EK	Oxidation@149	10	V20130429-05_FTMSms2hcd	26.594	142	151	43.9	5.5e-12	8.1e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	803.0911	3	1.5	KGDVVIVLTGWRPGSGFTNTMR	KGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	22	V20130429-05_FTMSms2hcd	49.857	505	526	38.4	5.5e-12	1.0e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	696.7018	3	1.7	EAEAAIYHLQLFEELRR	EAEAAIYHLQLFEELRR		17	V20130429-05_FTMSms2hcd	53.077	384	400	57.3	5.0e-11	8.1e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	679.3469	3	-1.6	QKGADFLVTEVENGGSLGSK	QKGADFLVTEVENGGSLGSK		20	V20130429-05_FTMSms2hcd	44.308	187	206	43.7	1.1e-10	1.3e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	783.7609	3	0.91	GVNLPGAAVDLPAVSEKDIQDLK	GVNLPGAAVDLPAVSEKDIQDLK		23	V20130429-05_FTMSms2hcd	55.177	208	230	34.9	1.4e-10	3.7e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	498.2523	2	-0.56	VNFAMNVGK	VNFAM(Oxidation)NVGK	Oxidation@494	9	V20130429-05_FTMSms2hcd	21.945	490	498	40.0	6.0e-10	9.2e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	636.6613	3	-0.81	GADFLVTEVENGGSLGSKK	GADFLVTEVENGGSLGSKK		19	V20130429-05_FTMSms2hcd	45.022	189	207	40.8	6.3e-10	7.8e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	571.3081	2	-0.88	GDLGIEIPAEK	GDLGIEIPAEK		11	V20130429-05_FTMSms2hcd	38.235	295	305	37.2	1.3e-8	2.8e-11	2	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	625.9704	3	1.1	FGVEQDVDMVFASFIR	FGVEQDVDM(Oxidation)VFASFIR	Oxidation@239	16	V20130429-05_FTMSms2hcd	73.714	231	246	26.8	1.4e-8	1.5e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	471.7314	4	0.15	LNFSHGTHEYHAETIK	LNFSHGTHEYHAETIK		16	V20130429-05_FTMSms2hcd	22.000	74	89	26.8	3.2e-8	3.5e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	599.3272	2	-0.21	LDIDSPPITAR	LDIDSPPITAR		11	V20130429-05_FTMSms2hcd	35.412	33	43	37.5	4.8e-8	1.1e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	398.5535	3	1.1	SVETLKEMIK	SVETLKEM(Oxidation)IK	Oxidation@64	10	V20130429-05_FTMSms2hcd	22.697	57	66	31.8	6.5e-8	1.3e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	610.0162	3	6.9	GDLGIEIPAEKVFLAQK	GDLGIEIPAEKVFLAQK		17	V20130429-05_FTMSms2hcd	54.813	295	311	25.2	9.2e-8	3.7e-10	2	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	706.9303	5	-0.73	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-05_FTMSms2hcd	44.936	1	32	30.5	1.3e-7	1.3e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	420.7686	2	-0.29	APIIAVTR	APIIAVTR		8	V20130429-05_FTMSms2hcd	26.250	448	455	39.0	9.6e-7	9.1e-9	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	503.2943	3	-1.3	APIIAVTRNPQTAR	APIIAVTRNPQTAR		14	V20130429-05_FTMSms2hcd	25.204	448	461	23.7	3.2e-6	1.6e-8	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	385.7013	2	1.2	QAHLYR	Q(Gln->pyro-Glu)AHLYR	Gln->pyro-Glu@462	6	V20130429-05_FTMSms2hcd	15.404	462	467	24.1	2.2e-5	6.2e-8	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	353.2188	2	1.3	VFLAQK	VFLAQK		6	V20130429-05_FTMSms2hcd	18.414	306	311	25.0	1.4e-4	8.7e-7	2	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	651.8400	2	-8.2	NTGIICTIGPASR	NTGIICTIGPASR		13	V20130429-05_FTMSms2hcd	36.489	44	56	15.3	0.0023	3.4e-6	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4]		P14618	KPYM_HUMAN	PKM2	26	57.8	10.52	7.0e-19	376.3585	6	-0.59	LNFSHGTHEYHAETIKNVR	LNFSHGTHEYHAETIKNVR		19	V20130429-05_FTMSms2hcd	23.522	74	92	10.1	0.087	9.2e-5	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[4-1]	0	P30613	KPYR_HUMAN	PKLR	3	3.0	4.70	1.3e-8	571.3081	2	-0.88	GDLGIEIPAEK	GDLGIEIPAEK		11	V20130429-05_FTMSms2hcd	38.235	338	348	37.2	1.3e-8	2.8e-11	2	61830.7	HUMAN	Pyruvate kinase isozymes R/L
[4-1]	0	P30613	KPYR_HUMAN	PKLR	3	3.0	4.70	1.3e-8	610.0162	3	6.9	GDLGIEIPAEKVFLAQK	GDLGIEIPAEKVFLAQK		17	V20130429-05_FTMSms2hcd	54.813	338	354	25.2	9.2e-8	3.7e-10	2	61830.7	HUMAN	Pyruvate kinase isozymes R/L
[4-1]	0	P30613	KPYR_HUMAN	PKLR	3	3.0	4.70	1.3e-8	353.2188	2	1.3	VFLAQK	VFLAQK		6	V20130429-05_FTMSms2hcd	18.414	349	354	25.0	1.4e-4	8.7e-7	2	61830.7	HUMAN	Pyruvate kinase isozymes R/L
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	995.8027	3	-0.20	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-05_FTMSms2hcd	65.303	282	306	45.0	4.2e-16	4.1e-19	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	1031.1935	3	2.5	YGKDATNVGDEGGFAPNILENKEGLELLK	YGKDATNVGDEGGFAPNILENKEGLELLK		29	V20130429-05_FTMSms2hcd	54.231	200	228	50.4	8.5e-16	1.1e-18	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	913.9315	2	0.10	SGKYDLDFKSPDDPSR	SGKYDLDFKSPDDPSR		16	V20130429-05_FTMSms2hcd	28.711	254	269	57.2	9.0e-16	1.0e-18	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	634.3256	4	-1.6	AAVPSGASTGIYEALELRDNDKTR	AAVPSGASTGIYEALELRDNDKTR		24	V20130429-05_FTMSms2hcd	42.843	33	56	58.6	4.9e-15	6.4e-18	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	514.5926	3	-0.59	LAQANGWGVMVSHR	LAQANGWGVM(Oxidation)VSHR	Oxidation@368	14	V20130429-05_FTMSms2hcd	27.869	359	372	47.0	3.8e-14	4.6e-17	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	730.3911	3	1.2	FTASAGIQVVGDDLTVTNPKR	FTASAGIQVVGDDLTVTNPKR		21	V20130429-05_FTMSms2hcd	45.482	307	327	45.4	7.1e-14	1.4e-16	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	970.4975	2	5.6	LAMQEFMILPVGAANFR	LAM(Oxidation)QEFM(Oxidation)ILPVGAANFR	Oxidation@165;Oxidation@169	17	V20130429-05_FTMSms2hcd	56.253	163	179	50.0	1.7e-13	2.2e-16	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	915.1400	3	9.8	DATNVGDEGGFAPNILENKEGLELLK	DATNVGDEGGFAPNILENKEGLELLK		26	V20130429-05_FTMSms2hcd	58.194	203	228	49.8	1.1e-12	1.6e-15	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	902.9777	2	2.3	AAVPSGASTGIYEALELR	AAVPSGASTGIYEALELR		18	V20130429-05_FTMSms2hcd	52.251	33	50	45.0	2.0e-12	3.0e-15	3	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	753.6564	4	11	HIADLAGNSEVILPVPAFNVINGGSHAGNK	HIADLAGNSEVILPVPAFNVINGGSHAGNK		30	V20130429-05_FTMSms2hcd	58.201	133	162	53.5	3.4e-12	8.3e-15	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	788.9033	2	-0.39	VNQIGSVTESLQACK	VNQIGSVTESLQACK		15	V20130429-05_FTMSms2hcd	39.020	344	358	41.1	1.9e-11	2.7e-14	2	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	1233.8920	4	3.5	HIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFR	HIADLAGNSEVILPVPAFNVINGGSHAGNKLAM(Oxidation)QEFM(Oxidation)ILPVGAANFR	Oxidation@165;Oxidation@169	47	V20130429-05_FTMSms2hcd	69.428	133	179	50.3	4.1e-11	1.6e-13	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	731.3638	3	3.5	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGM(Oxidation)DVAASEFFR	Oxidation@244	20	V20130429-05_FTMSms2hcd	51.072	234	253	31.6	1.5e-10	1.7e-13	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	718.6957	3	0.56	EIFDSRGNPTVEVDLFTSK	EIFDSRGNPTVEVDLFTSK		19	V20130429-05_FTMSms2hcd	51.482	10	28	41.2	5.0e-10	5.4e-13	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	703.8602	2	-2.2	GNPTVEVDLFTSK	GNPTVEVDLFTSK		13	V20130429-05_FTMSms2hcd	43.856	16	28	37.0	8.2e-10	1.1e-12	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	713.3668	2	0.21	YISPDQLADLYK	YISPDQLADLYK		12	V20130429-05_FTMSms2hcd	48.436	270	281	40.1	1.2e-9	1.6e-12	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	450.2825	2	1.9	TIAPALVSK	TIAPALVSK		9	V20130429-05_FTMSms2hcd	26.211	72	80	30.9	1.3e-6	4.9e-9	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	381.8770	3	0.67	IGAEVYHNLK	IGAEVYHNLK		10	V20130429-05_FTMSms2hcd	22.577	184	193	30.6	6.1e-6	1.0e-8	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	482.2719	3	0.39	KLNVTEQEKIDK	KLNVTEQEKIDK		12	V20130429-05_FTMSms2hcd	16.929	81	92	24.1	1.9e-5	4.5e-8	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	452.7348	2	0.13	IEEELGSK	IEEELGSK		8	V20130429-05_FTMSms2hcd	14.060	413	420	33.5	2.0e-4	3.4e-7	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	352.7081	2	-0.089	GVPLYR	GVPLYR		6	V20130429-05_FTMSms2hcd	21.049	127	132	19.8	9.4e-4	2.5e-6	2	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	383.6904	2	0.69	EIFDSR	EIFDSR		6	V20130429-05_FTMSms2hcd	18.503	10	15	18.8	0.0035	9.0e-6	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	480.2750	2	0.62	NFRNPLAK	NFRNPLAK		8	V20130429-05_FTMSms2hcd	24.125	427	434	21.4	0.0058	1.0e-5	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	24	69.4	9.02	4.2e-16	403.7294	2	-0.48	YNQLLR	YNQLLR		6	V20130429-05_FTMSms2hcd	20.868	407	412	23.4	0.019	4.1e-5	1	47169.4	HUMAN	Alpha-enolase
[5-1]	0	P13929	ENOB_HUMAN	ENO3	3	9.0	7.04	2.0e-12	902.9777	2	2.3	AAVPSGASTGIYEALELR	AAVPSGASTGIYEALELR		18	V20130429-05_FTMSms2hcd	52.251	33	50	45.0	2.0e-12	3.0e-15	3	46932.2	HUMAN	Beta-enolase
[5-1]	0	P13929	ENOB_HUMAN	ENO3	3	9.0	7.04	2.0e-12	788.9033	2	-0.39	VNQIGSVTESIQACK	VNQIGSVTESIQACK		15	V20130429-05_FTMSms2hcd	39.020	344	358	41.1	1.9e-11	2.7e-14	2	46932.2	HUMAN	Beta-enolase
[5-1]	0	P13929	ENOB_HUMAN	ENO3	3	9.0	7.04	2.0e-12	352.7081	2	-0.089	GVPLYR	GVPLYR		6	V20130429-05_FTMSms2hcd	21.049	127	132	19.8	9.4e-4	2.5e-6	2	46932.2	HUMAN	Beta-enolase
[5-2]	0	P09104	ENOG_HUMAN	ENO2	1	4.1	7.04	2.0e-12	902.9777	2	2.3	AAVPSGASTGIYEALELR	AAVPSGASTGIYEALELR		18	V20130429-05_FTMSms2hcd	52.251	33	50	45.0	2.0e-12	3.0e-15	3	47269.0	HUMAN	Gamma-enolase
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	660.2997	2	-1.1	NSLESYAFNMK	NSLESYAFNM(Oxidation)K	Oxidation@549	11	V20130429-05_FTMSms2hcd	33.139	540	550	40.5	4.4e-17	6.2e-20	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	846.3666	2	0.20	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-05_FTMSms2hcd	22.471	221	236	60.2	3.2e-15	4.5e-18	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	661.3386	3	1.7	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-05_FTMSms2hcd	45.826	138	155	38.4	4.6e-14	5.8e-17	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	616.3011	5	1.4	RFDDAVVQSDMKHWPFMVVNDAGRPK	RFDDAVVQSDM(Oxidation)KHWPFM(Oxidation)VVNDAGRPK	Oxidation@87;Oxidation@93	26	V20130429-05_FTMSms2hcd	41.679	77	102	39.3	7.5e-14	7.6e-17	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	833.3986	2	-0.10	NQVAMNPTNTVFDAK	NQVAM(Oxidation)NPTNTVFDAK	Oxidation@61	15	V20130429-05_FTMSms2hcd	30.225	57	71	45.2	2.1e-13	2.4e-16	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	911.4479	2	-1.5	NQVAMNPTNTVFDAKR	NQVAM(Oxidation)NPTNTVFDAKR	Oxidation@61	16	V20130429-05_FTMSms2hcd	26.906	57	72	53.8	2.7e-13	3.1e-16	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	816.8943	2	-0.75	SFYPEEVSSMVLTK	SFYPEEVSSM(Oxidation)VLTK	Oxidation@122	14	V20130429-05_FTMSms2hcd	44.372	113	126	42.5	5.0e-12	5.7e-15	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	894.4993	2	0.64	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-05_FTMSms2hcd	42.616	172	188	45.7	7.5e-12	2.3e-14	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	744.3541	2	-0.23	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-05_FTMSms2hcd	34.321	37	49	40.7	1.1e-11	1.4e-14	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	614.8167	2	-1.6	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-05_FTMSms2hcd	20.331	26	36	48.0	2.5e-10	3.9e-13	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	830.4519	2	0.79	IINEPTAAAIAYGLDK	IINEPTAAAIAYGLDK		16	V20130429-05_FTMSms2hcd	47.051	172	187	34.6	4.2e-10	8.5e-13	4	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	740.8807	2	-0.12	ARFEELNADLFR	ARFEELNADLFR		12	V20130429-05_FTMSms2hcd	44.774	300	311	50.0	3.1e-9	3.7e-12	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	600.3399	2	-1.4	DAGTIAGLNVLR	DAGTIAGLNVLR		12	V20130429-05_FTMSms2hcd	45.190	160	171	39.4	9.3e-9	1.9e-11	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	626.3124	2	-1.2	MVNHFIAEFK	M(Oxidation)VNHFIAEFK	Oxidation@237	10	V20130429-05_FTMSms2hcd	33.367	237	246	25.2	4.0e-8	5.4e-11	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	783.4193	2	-0.57	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-05_FTMSms2hcd	45.259	349	361	30.2	8.9e-8	1.5e-10	3	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	541.2864	2	-2.0	LLQDFFNGK	LLQDFFNGK		9	V20130429-05_FTMSms2hcd	44.801	349	357	36.3	3.6e-7	5.4e-10	3	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	627.3113	2	-0.60	FEELNADLFR	FEELNADLFR		10	V20130429-05_FTMSms2hcd	48.208	302	311	43.0	6.4e-7	7.4e-10	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	494.6072	3	-0.013	SQIHDIVLVGGSTR	SQIHDIVLVGGSTR		14	V20130429-05_FTMSms2hcd	32.570	329	342	23.1	1.4e-6	3.0e-9	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	590.8129	2	-2.0	VQVEYKGETK	VQVEYKGETK		10	V20130429-05_FTMSms2hcd	13.198	103	112	24.4	3.7e-6	5.5e-9	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	423.5564	3	-0.67	MKEIAEAYLGK	M(Oxidation)KEIAEAYLGK	Oxidation@127	11	V20130429-05_FTMSms2hcd	25.256	127	137	24.2	8.8e-6	1.3e-8	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	444.2540	2	-1.3	VCNPIITK	VCNPIITK		8	V20130429-05_FTMSms2hcd	23.482	602	609	15.0	1.9e-4	2.8e-7	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	495.2654	2	-2.7	LSKEDIER	LSKEDIER		8	V20130429-05_FTMSms2hcd	13.380	510	517	32.5	2.8e-4	4.7e-7	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	23	41.3	9.56	4.4e-17	965.6300	5	-4.1	NVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNR	NVLIFDLGGGT(Phospho)FDVSILT(Phospho)IEDGIFEVKS(Phospho)TAGDTHLGGEDFDNR	Phospho@204&208&221|204&208&222|204&208&226|204&211&221|204&211&222|204&211&226|208&211&221|208&211&222|208&211&226	43	V20130429-05_FTMSms2hcd	40.557	194	236	14.3	0.0031	5.8e-6	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	846.3666	2	0.20	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-05_FTMSms2hcd	22.471	224	239	60.2	3.2e-15	4.5e-18	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	894.4993	2	0.64	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-05_FTMSms2hcd	42.616	173	189	45.7	7.5e-12	2.3e-14	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	744.3541	2	-0.23	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-05_FTMSms2hcd	34.321	38	50	40.7	1.1e-11	1.4e-14	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	614.8167	2	-1.6	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-05_FTMSms2hcd	20.331	27	37	48.0	2.5e-10	3.9e-13	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	830.4519	2	0.79	IINEPTAAAIAYGLDK	IINEPTAAAIAYGLDK		16	V20130429-05_FTMSms2hcd	47.051	173	188	34.6	4.2e-10	8.5e-13	4	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	740.8807	2	-0.12	ARFEELNADLFR	ARFEELNADLFR		12	V20130429-05_FTMSms2hcd	44.774	303	314	50.0	3.1e-9	3.7e-12	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	783.4193	2	-0.57	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-05_FTMSms2hcd	45.259	352	364	30.2	8.9e-8	1.5e-10	3	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	541.2864	2	-2.0	LLQDFFNGK	LLQDFFNGK		9	V20130429-05_FTMSms2hcd	44.801	352	360	36.3	3.6e-7	5.4e-10	3	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	627.3113	2	-0.60	FEELNADLFR	FEELNADLFR		10	V20130429-05_FTMSms2hcd	48.208	305	314	43.0	6.4e-7	7.4e-10	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	590.8129	2	-2.0	VQVEYKGETK	VQVEYKGETK		10	V20130429-05_FTMSms2hcd	13.198	104	113	24.4	3.7e-6	5.5e-9	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	11	18.6	8.54	3.2e-15	965.6300	5	-4.1	NVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNR	NVLIFDLGGGT(Phospho)FDVSILT(Phospho)IEDGIFEVKS(Phospho)TAGDTHLGGEDFDNR	Phospho@207&211&224|207&211&225|207&211&229|207&214&224|207&214&225|207&214&229|211&214&224|211&214&225|211&214&229	43	V20130429-05_FTMSms2hcd	40.557	197	239	14.3	0.0031	5.8e-6	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	744.3541	2	-0.23	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-05_FTMSms2hcd	34.321	37	49	40.7	1.1e-11	1.4e-14	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	844.4554	2	1.3	IINEPTAAAIAYGLDR	IINEPTAAAIAYGLDR		16	V20130429-05_FTMSms2hcd	48.006	172	187	44.2	1.6e-10	2.9e-13	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	829.9293	2	1.0	NQVALNPQNTVFDAK	NQVALNPQNTVFDAK		15	V20130429-05_FTMSms2hcd	38.182	57	71	44.4	2.4e-10	3.4e-13	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	614.8167	2	-1.6	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-05_FTMSms2hcd	20.331	26	36	48.0	2.5e-10	3.9e-13	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	652.3040	2	1.5	NALESYAFNMK	NALESYAFNM(Oxidation)K	Oxidation@549	11	V20130429-05_FTMSms2hcd	33.881	540	550	28.9	2.7e-10	3.6e-13	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	711.8545	2	3.2	YKAEDEVQRER	YKAEDEVQRER		11	V20130429-05_FTMSms2hcd	11.404	525	535	42.9	5.7e-9	7.1e-12	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	599.3514	2	0.44	DAGVIAGLNVLR	DAGVIAGLNVLR		12	V20130429-05_FTMSms2hcd	50.041	160	171	38.5	6.3e-8	2.8e-10	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	569.8086	2	-0.30	VQVSYKGETK	VQVSYKGETK		10	V20130429-05_FTMSms2hcd	12.945	103	112	33.6	1.0e-7	2.0e-10	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-2]	7	P08107	HSP71_HUMAN	HSPA1A	9	16.7	6.64	1.1e-11	502.2746	2	0.072	LSKEEIER	LSKEEIER		8	V20130429-05_FTMSms2hcd	12.309	510	517	46.8	8.2e-5	1.3e-7	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-3]	3	P34931	HS71L_HUMAN	HSPA1L	6	11.1	6.64	1.1e-11	744.3541	2	-0.23	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-05_FTMSms2hcd	34.321	39	51	40.7	1.1e-11	1.4e-14	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[6-3]	3	P34931	HS71L_HUMAN	HSPA1L	6	11.1	6.64	1.1e-11	614.8167	2	-1.6	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-05_FTMSms2hcd	20.331	28	38	48.0	2.5e-10	3.9e-13	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[6-3]	3	P34931	HS71L_HUMAN	HSPA1L	6	11.1	6.64	1.1e-11	652.3040	2	1.5	NALESYAFNMK	NALESYAFNM(Oxidation)K	Oxidation@551	11	V20130429-05_FTMSms2hcd	33.881	542	552	28.9	2.7e-10	3.6e-13	2	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[6-3]	3	P34931	HS71L_HUMAN	HSPA1L	6	11.1	6.64	1.1e-11	830.4519	2	0.79	IINEPTAAAIAYGLDK	IINEPTAAAIAYGLDK		16	V20130429-05_FTMSms2hcd	47.051	174	189	34.6	4.2e-10	8.5e-13	4	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[6-3]	3	P34931	HS71L_HUMAN	HSPA1L	6	11.1	6.64	1.1e-11	599.3514	2	0.44	DAGVIAGLNVLR	DAGVIAGLNVLR		12	V20130429-05_FTMSms2hcd	50.041	162	173	38.5	6.3e-8	2.8e-10	2	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[6-3]	3	P34931	HS71L_HUMAN	HSPA1L	6	11.1	6.64	1.1e-11	502.2746	2	0.072	LSKEEIER	LSKEEIER		8	V20130429-05_FTMSms2hcd	12.309	512	519	46.8	8.2e-5	1.3e-7	2	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[6-4]	4	P11021	GRP78_HUMAN	HSPA5	6	13.1	5.90	2.5e-10	614.8167	2	-1.6	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-05_FTMSms2hcd	20.331	50	60	48.0	2.5e-10	3.9e-13	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[6-4]	4	P11021	GRP78_HUMAN	HSPA5	6	13.1	5.90	2.5e-10	830.4519	2	0.79	IINEPTAAAIAYGLDK	IINEPTAAAIAYGLDK		16	V20130429-05_FTMSms2hcd	47.051	198	213	34.6	4.2e-10	8.5e-13	4	72333.5	HUMAN	78 kDa glucose-regulated protein
[6-4]	4	P11021	GRP78_HUMAN	HSPA5	6	13.1	5.90	2.5e-10	830.1101	3	0.67	VLEDSDLKKSDIDEIVLVGGSTR	VLEDSDLKKSDIDEIVLVGGSTR		23	V20130429-05_FTMSms2hcd	45.729	345	367	29.6	3.1e-9	6.5e-12	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[6-4]	4	P11021	GRP78_HUMAN	HSPA5	6	13.1	5.90	2.5e-10	510.2537	3	0.070	AKFEELNMDLFR	AKFEELNM(Oxidation)DLFR	Oxidation@332	12	V20130429-05_FTMSms2hcd	42.439	325	336	32.5	3.2e-9	3.9e-12	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[6-4]	4	P11021	GRP78_HUMAN	HSPA5	6	13.1	5.90	2.5e-10	617.3187	2	3.7	DAGTIAGLNVMR	DAGTIAGLNVM(Oxidation)R	Oxidation@196	12	V20130429-05_FTMSms2hcd	32.187	186	197	27.8	2.4e-8	3.6e-11	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[6-4]	4	P11021	GRP78_HUMAN	HSPA5	6	13.1	5.90	2.5e-10	715.8489	2	-0.36	TWNDPSVQQDIK	TWNDPSVQQDIK		12	V20130429-05_FTMSms2hcd	30.351	102	113	29.7	8.3e-8	9.9e-11	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[6-5]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.64	1.1e-11	744.3541	2	-0.23	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-05_FTMSms2hcd	34.321	39	51	40.7	1.1e-11	1.4e-14	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[6-5]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.64	1.1e-11	844.4554	2	1.3	IINEPTAAAIAYGLDR	IINEPTAAAIAYGLDR		16	V20130429-05_FTMSms2hcd	48.006	174	189	44.2	1.6e-10	2.9e-13	2	71028.7	HUMAN	Heat shock 70 kDa protein 6
[6-5]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.64	1.1e-11	614.8167	2	-1.6	VEILANDQGNR	VEILANDQGNR		11	V20130429-05_FTMSms2hcd	20.331	28	38	48.0	2.5e-10	3.9e-13	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[6-5]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.64	1.1e-11	783.4193	2	-0.57	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-05_FTMSms2hcd	45.259	351	363	30.2	8.9e-8	1.5e-10	3	71028.7	HUMAN	Heat shock 70 kDa protein 6
[6-5]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.64	1.1e-11	541.2864	2	-2.0	LLQDFFNGK	LLQDFFNGK		9	V20130429-05_FTMSms2hcd	44.801	351	359	36.3	3.6e-7	5.4e-10	3	71028.7	HUMAN	Heat shock 70 kDa protein 6
[6-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.64	1.1e-11	744.3541	2	-0.23	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-05_FTMSms2hcd	34.321	39	51	40.7	1.1e-11	1.4e-14	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[6-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.64	1.1e-11	614.8167	2	-1.6	VEILANDQGNR	VEILANDQGNR		11	V20130429-05_FTMSms2hcd	20.331	28	38	48.0	2.5e-10	3.9e-13	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	681.3647	3	2.8	MAVTFIGNSTAIQELFKR	M(Oxidation)AVTFIGNSTAIQELFKR	Oxidation@363	18	V20130429-05_FTMSms2hcd	58.639	363	380	58.5	1.1e-15	2.2e-18	1	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	776.3567	4	-0.83	FWEVISDEHGIDPTGTYHGDSDLQLDR	FWEVISDEHGIDPTGTYHGDSDLQLDR		27	V20130429-05_FTMSms2hcd	50.403	20	46	39.7	3.4e-14	3.2e-17	1	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	1044.0432	2	1.1	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-05_FTMSms2hcd	57.881	104	122	53.8	1.8e-13	2.5e-16	5	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	933.4618	3	9.8	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-05_FTMSms2hcd	60.974	78	103	47.1	3.2e-13	3.4e-16	5	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-05_FTMSms2hcd	51.248	263	276	38.2	3.4e-13	4.3e-16	9	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	848.9208	2	0.81	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-05_FTMSms2hcd	53.692	337	350	33.9	7.4e-13	8.5e-16	7	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	553.9700	3	0.14	ALTVPELTQQVFDAK	ALTVPELTQQVFDAK		15	V20130429-05_FTMSms2hcd	56.629	283	297	44.1	2.3e-11	4.7e-14	1	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	668.3525	2	0.018	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-05_FTMSms2hcd	35.892	163	174	42.2	4.2e-11	6.7e-14	4	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	979.9777	2	-17	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-05_FTMSms2hcd	61.936	104	121	39.2	7.4e-11	8.2e-14	5	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	782.2032	5	0.72	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-05_FTMSms2hcd	68.885	217	252	41.5	1.7e-10	3.6e-13	5	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	651.3211	2	-1.8	ISVYYNEATGGK	ISVYYNEATGGK		12	V20130429-05_FTMSms2hcd	26.697	47	58	42.8	2.1e-10	3.0e-13	1	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	731.8477	2	2.7	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-05_FTMSms2hcd	20.719	325	336	29.1	2.9e-9	3.4e-12	4	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	520.3003	2	-0.16	YLTVAAVFR	YLTVAAVFR		9	V20130429-05_FTMSms2hcd	47.804	310	318	38.9	8.5e-9	3.6e-11	3	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	657.9651	3	-0.65	MSMKEVDEQMLNVQNK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNK	Oxidation@321;Oxidation@323;Oxidation@330	16	V20130429-05_FTMSms2hcd	19.225	321	336	29.8	3.0e-8	3.7e-11	4	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	606.3129	3	0.73	ISVYYNEATGGKYVPR	ISVYYNEATGGKYVPR		16	V20130429-05_FTMSms2hcd	33.287	47	62	37.0	3.7e-7	4.8e-10	1	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	589.3050	3	-0.53	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-05_FTMSms2hcd	29.434	3	19	31.1	4.0e-7	5.4e-10	6	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	359.8490	3	0.091	IREEYPDR	IREEYPDR		8	V20130429-05_FTMSms2hcd	12.087	155	162	30.4	1.0e-6	1.8e-9	8	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	943.4922	2	2.3	MAVTFIGNSTAIQELFK	M(Oxidation)AVTFIGNSTAIQELFK	Oxidation@363	17	V20130429-05_FTMSms2hcd	63.701	363	379	21.4	3.4e-6	4.9e-9	1	49671.3	HUMAN	Tubulin beta chain
[7]		P07437	TBB5_HUMAN	TUBB	21	57.9	8.79	1.1e-15	798.7430	3	0.94	IREEYPDRIMNTFSVVPSPK	IREEYPDRIM(Oxidation)NTFSVVPSPK	Oxidation@164	20	V20130429-05_FTMSms2hcd	39.643	155	174	28.5	4.3e-6	5.7e-9	2	49671.3	HUMAN	Tubulin beta chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	854.4351	2	0.42	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-05_FTMSms2hcd	45.493	283	297	42.4	8.8e-14	1.1e-16	3	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	1044.0432	2	1.1	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-05_FTMSms2hcd	57.881	104	122	53.8	1.8e-13	2.5e-16	5	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	933.4618	3	9.8	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-05_FTMSms2hcd	60.974	78	103	47.1	3.2e-13	3.4e-16	5	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-05_FTMSms2hcd	51.248	263	276	38.2	3.4e-13	4.3e-16	9	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	848.9208	2	0.81	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-05_FTMSms2hcd	53.692	337	350	33.9	7.4e-13	8.5e-16	7	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	809.4124	2	1.4	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-05_FTMSms2hcd	40.410	63	77	39.8	2.6e-12	3.2e-15	3	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	668.3525	2	0.018	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-05_FTMSms2hcd	35.892	163	174	42.2	4.2e-11	6.7e-14	4	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	979.9777	2	-17	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-05_FTMSms2hcd	61.936	104	121	39.2	7.4e-11	8.2e-14	5	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	782.2032	5	0.72	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-05_FTMSms2hcd	68.885	217	252	41.5	1.7e-10	3.6e-13	5	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	731.8477	2	2.7	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-05_FTMSms2hcd	20.719	325	336	29.1	2.9e-9	3.4e-12	4	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	520.3003	2	-0.16	YLTVAAVFR	YLTVAAVFR		9	V20130429-05_FTMSms2hcd	47.804	310	318	38.9	8.5e-9	3.6e-11	3	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	657.9651	3	-0.65	MSMKEVDEQMLNVQNK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNK	Oxidation@321;Oxidation@323;Oxidation@330	16	V20130429-05_FTMSms2hcd	19.225	321	336	29.8	3.0e-8	3.7e-11	4	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	589.3050	3	-0.53	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-05_FTMSms2hcd	29.434	3	19	31.1	4.0e-7	5.4e-10	6	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	359.8490	3	0.091	IREEYPDR	IREEYPDR		8	V20130429-05_FTMSms2hcd	12.087	155	162	30.4	1.0e-6	1.8e-9	8	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	846.4396	2	2.7	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-05_FTMSms2hcd	57.560	283	297	20.8	2.9e-6	3.9e-9	3	49831.5	HUMAN	Tubulin beta-4B chain
[7-1]	3	P68371	TBB4B_HUMAN	TUBB4B	18	47.4	7.77	8.8e-14	798.7430	3	0.94	IREEYPDRIMNTFSVVPSPK	IREEYPDRIM(Oxidation)NTFSVVPSPK	Oxidation@164	20	V20130429-05_FTMSms2hcd	39.643	155	174	28.5	4.3e-6	5.7e-9	2	49831.5	HUMAN	Tubulin beta-4B chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	854.4351	2	0.42	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-05_FTMSms2hcd	45.493	283	297	42.4	8.8e-14	1.1e-16	3	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	933.4618	3	9.8	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-05_FTMSms2hcd	60.974	78	103	47.1	3.2e-13	3.4e-16	5	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-05_FTMSms2hcd	51.248	263	276	38.2	3.4e-13	4.3e-16	9	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	848.9208	2	0.81	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-05_FTMSms2hcd	53.692	337	350	33.9	7.4e-13	8.5e-16	7	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	809.4124	2	1.4	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-05_FTMSms2hcd	40.410	63	77	39.8	2.6e-12	3.2e-15	3	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	668.3525	2	0.018	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-05_FTMSms2hcd	35.892	163	174	42.2	4.2e-11	6.7e-14	4	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	782.2032	5	0.72	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-05_FTMSms2hcd	68.885	217	252	41.5	1.7e-10	3.6e-13	5	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	520.3003	2	-0.16	YLTVAAVFR	YLTVAAVFR		9	V20130429-05_FTMSms2hcd	47.804	310	318	38.9	8.5e-9	3.6e-11	3	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	589.3050	3	-0.53	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-05_FTMSms2hcd	29.434	3	19	31.1	4.0e-7	5.4e-10	6	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	49586.2	HUMAN	Tubulin beta-4A chain
[7-2]	3	P04350	TBB4A_HUMAN	TUBB4A	12	37.8	7.77	8.8e-14	846.4396	2	2.7	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-05_FTMSms2hcd	57.560	283	297	20.8	2.9e-6	3.9e-9	3	49586.2	HUMAN	Tubulin beta-4A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	1044.0432	2	1.1	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-05_FTMSms2hcd	57.881	104	122	53.8	1.8e-13	2.5e-16	5	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	933.4618	3	9.8	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-05_FTMSms2hcd	60.974	78	103	47.1	3.2e-13	3.4e-16	5	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-05_FTMSms2hcd	51.248	263	276	38.2	3.4e-13	4.3e-16	9	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	848.9208	2	0.81	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-05_FTMSms2hcd	53.692	337	350	33.9	7.4e-13	8.5e-16	7	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	979.9777	2	-17	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-05_FTMSms2hcd	61.936	104	121	39.2	7.4e-11	8.2e-14	5	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	782.2032	5	0.72	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-05_FTMSms2hcd	68.885	217	252	41.5	1.7e-10	3.6e-13	5	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	731.8477	2	2.7	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-05_FTMSms2hcd	20.719	325	336	29.1	2.9e-9	3.4e-12	4	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	657.9651	3	-0.65	MSMKEVDEQMLNVQNK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNK	Oxidation@321;Oxidation@323;Oxidation@330	16	V20130429-05_FTMSms2hcd	19.225	321	336	29.8	3.0e-8	3.7e-11	4	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	589.3050	3	-0.53	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-05_FTMSms2hcd	29.434	3	19	31.1	4.0e-7	5.4e-10	6	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	49907.4	HUMAN	Tubulin beta-2A chain
[7-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	12	36.0	7.61	1.8e-13	359.8490	3	0.091	IREEYPDR	IREEYPDR		8	V20130429-05_FTMSms2hcd	12.087	155	162	30.4	1.0e-6	1.8e-9	8	49907.4	HUMAN	Tubulin beta-2A chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	1044.0432	2	1.1	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-05_FTMSms2hcd	57.881	104	122	53.8	1.8e-13	2.5e-16	5	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	933.4618	3	9.8	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-05_FTMSms2hcd	60.974	78	103	47.1	3.2e-13	3.4e-16	5	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-05_FTMSms2hcd	51.248	263	276	38.2	3.4e-13	4.3e-16	9	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	848.9208	2	0.81	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-05_FTMSms2hcd	53.692	337	350	33.9	7.4e-13	8.5e-16	7	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	979.9777	2	-17	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-05_FTMSms2hcd	61.936	104	121	39.2	7.4e-11	8.2e-14	5	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	782.2032	5	0.72	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-05_FTMSms2hcd	68.885	217	252	41.5	1.7e-10	3.6e-13	5	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	731.8477	2	2.7	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-05_FTMSms2hcd	20.719	325	336	29.1	2.9e-9	3.4e-12	4	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	657.9651	3	-0.65	MSMKEVDEQMLNVQNK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNK	Oxidation@321;Oxidation@323;Oxidation@330	16	V20130429-05_FTMSms2hcd	19.225	321	336	29.8	3.0e-8	3.7e-11	4	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	589.3050	3	-0.53	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-05_FTMSms2hcd	29.434	3	19	31.1	4.0e-7	5.4e-10	6	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	49953.5	HUMAN	Tubulin beta-2B chain
[7-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	12	36.0	7.61	1.8e-13	359.8490	3	0.091	IREEYPDR	IREEYPDR		8	V20130429-05_FTMSms2hcd	12.087	155	162	30.4	1.0e-6	1.8e-9	8	49953.5	HUMAN	Tubulin beta-2B chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	854.4351	2	0.42	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-05_FTMSms2hcd	45.493	283	297	42.4	8.8e-14	1.1e-16	3	50433.2	HUMAN	Tubulin beta-3 chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	1044.0432	2	1.1	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-05_FTMSms2hcd	57.881	104	122	53.8	1.8e-13	2.5e-16	5	50433.2	HUMAN	Tubulin beta-3 chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	848.9208	2	0.81	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-05_FTMSms2hcd	53.692	337	350	33.9	7.4e-13	8.5e-16	7	50433.2	HUMAN	Tubulin beta-3 chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	668.3525	2	0.018	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-05_FTMSms2hcd	35.892	163	174	42.2	4.2e-11	6.7e-14	4	50433.2	HUMAN	Tubulin beta-3 chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	979.9777	2	-17	GHYTEGAELVDSVLDVVR	GHYTEGAELVDSVLDVVR		18	V20130429-05_FTMSms2hcd	61.936	104	121	39.2	7.4e-11	8.2e-14	5	50433.2	HUMAN	Tubulin beta-3 chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	50433.2	HUMAN	Tubulin beta-3 chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	589.3050	3	-0.53	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-05_FTMSms2hcd	29.434	3	19	31.1	4.0e-7	5.4e-10	6	50433.2	HUMAN	Tubulin beta-3 chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	50433.2	HUMAN	Tubulin beta-3 chain
[7-5]	2	Q13509	TBB3_HUMAN	TUBB3	9	19.6	7.77	8.8e-14	846.4396	2	2.7	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-05_FTMSms2hcd	57.560	283	297	20.8	2.9e-6	3.9e-9	3	50433.2	HUMAN	Tubulin beta-3 chain
[7-6]	2	Q3ZCM7	TBB8_HUMAN	TUBB8	6	16.7	7.45	3.4e-13	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-05_FTMSms2hcd	51.248	263	276	38.2	3.4e-13	4.3e-16	9	49776.5	HUMAN	Tubulin beta-8 chain
[7-6]	2	Q3ZCM7	TBB8_HUMAN	TUBB8	6	16.7	7.45	3.4e-13	809.4124	2	1.4	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-05_FTMSms2hcd	40.410	63	77	39.8	2.6e-12	3.2e-15	3	49776.5	HUMAN	Tubulin beta-8 chain
[7-6]	2	Q3ZCM7	TBB8_HUMAN	TUBB8	6	16.7	7.45	3.4e-13	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	49776.5	HUMAN	Tubulin beta-8 chain
[7-6]	2	Q3ZCM7	TBB8_HUMAN	TUBB8	6	16.7	7.45	3.4e-13	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	49776.5	HUMAN	Tubulin beta-8 chain
[7-6]	2	Q3ZCM7	TBB8_HUMAN	TUBB8	6	16.7	7.45	3.4e-13	359.8490	3	0.091	IREEYPDR	IREEYPDR		8	V20130429-05_FTMSms2hcd	12.087	155	162	30.4	1.0e-6	1.8e-9	8	49776.5	HUMAN	Tubulin beta-8 chain
[7-6]	2	Q3ZCM7	TBB8_HUMAN	TUBB8	6	16.7	7.45	3.4e-13	938.7861	3	8.2	SGPFGQVFRPDNFIFGQCGAGNNWAK	SGPFGQVFRPDNFIFGQCGAGNNWAK		26	V20130429-05_FTMSms2hcd	59.382	78	103	22.4	7.4e-6	7.2e-9	1	49776.5	HUMAN	Tubulin beta-8 chain
[7-7]	0	Q9BUF5	TBB6_HUMAN	TUBB6	4	8.7	7.45	3.4e-13	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-05_FTMSms2hcd	51.248	263	276	38.2	3.4e-13	4.3e-16	9	49857.6	HUMAN	Tubulin beta-6 chain
[7-7]	0	Q9BUF5	TBB6_HUMAN	TUBB6	4	8.7	7.45	3.4e-13	848.9208	2	0.81	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-05_FTMSms2hcd	53.692	337	350	33.9	7.4e-13	8.5e-16	7	49857.6	HUMAN	Tubulin beta-6 chain
[7-7]	0	Q9BUF5	TBB6_HUMAN	TUBB6	4	8.7	7.45	3.4e-13	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	49857.6	HUMAN	Tubulin beta-6 chain
[7-7]	0	Q9BUF5	TBB6_HUMAN	TUBB6	4	8.7	7.45	3.4e-13	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	49857.6	HUMAN	Tubulin beta-6 chain
[7-8]	0	A6NKZ8	YI016_HUMAN		4	8.9	7.45	3.4e-13	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@195	14	V20130429-05_FTMSms2hcd	51.248	191	204	38.2	3.4e-13	4.3e-16	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[7-8]	0	A6NKZ8	YI016_HUMAN		4	8.9	7.45	3.4e-13	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@185	10	V20130429-05_FTMSms2hcd	40.068	181	190	43.9	6.7e-10	1.0e-12	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[7-8]	0	A6NKZ8	YI016_HUMAN		4	8.9	7.45	3.4e-13	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@185	11	V20130429-05_FTMSms2hcd	35.343	180	190	21.6	5.9e-7	1.4e-9	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[7-8]	0	A6NKZ8	YI016_HUMAN		4	8.9	7.45	3.4e-13	359.8490	3	0.091	IREEYPDR	IREEYPDR		8	V20130429-05_FTMSms2hcd	12.087	83	90	30.4	1.0e-6	1.8e-9	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[7-9]	0	A6NNZ2	TBB8B_HUMAN		4	7.4	7.45	3.4e-13	546.2831	3	2.6	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-05_FTMSms2hcd	51.248	263	276	38.2	3.4e-13	4.3e-16	9	49573.1	HUMAN	Tubulin beta-8 chain B
[7-9]	0	A6NNZ2	TBB8B_HUMAN		4	7.4	7.45	3.4e-13	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	49573.1	HUMAN	Tubulin beta-8 chain B
[7-9]	0	A6NNZ2	TBB8B_HUMAN		4	7.4	7.45	3.4e-13	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	49573.1	HUMAN	Tubulin beta-8 chain B
[7-9]	0	A6NNZ2	TBB8B_HUMAN		4	7.4	7.45	3.4e-13	359.8490	3	0.091	IREEYPDR	IREEYPDR		8	V20130429-05_FTMSms2hcd	12.087	155	162	30.4	1.0e-6	1.8e-9	8	49573.1	HUMAN	Tubulin beta-8 chain B
[7-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	3	4.2	5.67	6.7e-10	580.3180	2	-0.43	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-05_FTMSms2hcd	40.068	253	262	43.9	6.7e-10	1.0e-12	11	50327.4	HUMAN	Tubulin beta-1 chain
[7-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	3	4.2	5.67	6.7e-10	429.9125	3	-0.96	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-05_FTMSms2hcd	35.343	252	262	21.6	5.9e-7	1.4e-9	11	50327.4	HUMAN	Tubulin beta-1 chain
[7-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	3	4.2	5.67	6.7e-10	359.8490	3	0.091	IREEYPDR	IREEYPDR		8	V20130429-05_FTMSms2hcd	12.087	155	162	30.4	1.0e-6	1.8e-9	8	50327.4	HUMAN	Tubulin beta-1 chain
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	732.3604	4	4.5	RAEDGSVIDYELIDQDARDLYDAGVK	RAEDGSVIDYELIDQDARDLYDAGVK		26	V20130429-05_FTMSms2hcd	57.075	179	204	58.1	8.2e-15	8.7e-18	1	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	924.1149	3	8.9	AEDGSVIDYELIDQDARDLYDAGVK	AEDGSVIDYELIDQDARDLYDAGVK		25	V20130429-05_FTMSms2hcd	60.259	180	204	48.3	1.6e-14	1.6e-17	1	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	714.3942	4	-0.38	SALSGHLETVILGLLKTPAQYDASELK	SALSGHLETVILGLLKTPAQYDASELK		27	V20130429-05_FTMSms2hcd	71.287	89	115	48.1	2.8e-14	1.2e-16	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	954.9444	2	-0.32	AEDGSVIDYELIDQDAR	AEDGSVIDYELIDQDAR		17	V20130429-05_FTMSms2hcd	45.624	180	196	51.3	1.1e-13	1.2e-16	1	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	922.9564	2	1.6	LSLEGDHSTPPSAYGSVK	LSLEGDHSTPPSAYGSVK		18	V20130429-05_FTMSms2hcd	29.839	11	28	46.3	2.2e-13	2.5e-16	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	825.9951	2	2.4	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-05_FTMSms2hcd	69.686	89	104	54.6	2.4e-13	3.9e-15	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	647.3242	3	-1.4	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-05_FTMSms2hcd	40.335	153	169	47.3	8.3e-13	9.9e-16	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	828.4001	2	-0.96	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-05_FTMSms2hcd	21.010	105	119	43.6	1.7e-12	1.9e-15	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	771.9316	2	4.7	GVDEVTIVNILTNR	GVDEVTIVNILTNR		14	V20130429-05_FTMSms2hcd	59.449	50	63	52.5	7.8e-11	1.9e-13	1	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	688.9997	3	0.63	RAEDGSVIDYELIDQDAR	RAEDGSVIDYELIDQDAR		18	V20130429-05_FTMSms2hcd	41.818	179	196	33.2	1.5e-10	1.6e-13	1	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	536.2783	2	-0.92	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-05_FTMSms2hcd	33.714	1	10	35.8	6.8e-10	1.3e-12	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	535.5920	3	-0.65	SYSPYDMLESIRK	SYSPYDM(Oxidation)LESIRK	Oxidation@240	13	V20130429-05_FTMSms2hcd	35.990	234	246	25.4	4.9e-8	5.9e-11	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	719.0272	3	0.21	AYTNFDAERDALNIETAIK	AYTNFDAERDALNIETAIK		19	V20130429-05_FTMSms2hcd	49.702	29	47	29.2	8.1e-8	8.9e-11	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	556.2798	2	-0.68	QDIAFAYQR	QDIAFAYQR		9	V20130429-05_FTMSms2hcd	30.159	69	77	31.9	4.6e-7	6.7e-10	1	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	381.2329	2	-0.59	LMVALAK	LM(Oxidation)VALAK	Oxidation@171	7	V20130429-05_FTMSms2hcd	24.723	170	176	28.6	9.6e-6	3.4e-8	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	526.2649	2	-1.5	WISIMTER	WISIM(Oxidation)TER	Oxidation@217	8	V20130429-05_FTMSms2hcd	33.275	213	220	26.4	1.8e-5	3.1e-8	2	38604.4	HUMAN	Annexin A2
[8]		P07355	ANXA2_HUMAN	ANXA2	17	51.0	8.33	8.2e-15	518.7755	2	1.5	DLYDAGVKR	DLYDAGVKR		9	V20130429-05_FTMSms2hcd	19.098	197	205	28.6	0.0018	3.3e-6	1	38604.4	HUMAN	Annexin A2
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	714.3942	4	-0.38	SALSGHLETVILGLLKTPAQYDASELK	SALSGHLETVILGLLKTPAQYDASELK		27	V20130429-05_FTMSms2hcd	71.287	89	115	48.1	2.8e-14	1.2e-16	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	922.9564	2	1.6	LSLEGDHSTPPSAYGSVK	LSLEGDHSTPPSAYGSVK		18	V20130429-05_FTMSms2hcd	29.839	11	28	46.3	2.2e-13	2.5e-16	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	825.9951	2	2.4	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-05_FTMSms2hcd	69.686	89	104	54.6	2.4e-13	3.9e-15	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	647.3242	3	-1.4	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-05_FTMSms2hcd	40.335	153	169	47.3	8.3e-13	9.9e-16	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	828.4001	2	-0.96	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-05_FTMSms2hcd	21.010	105	119	43.6	1.7e-12	1.9e-15	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	536.2783	2	-0.92	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-05_FTMSms2hcd	33.714	1	10	35.8	6.8e-10	1.3e-12	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	535.5920	3	-0.65	SYSPYDMLESIRK	SYSPYDM(Oxidation)LESIRK	Oxidation@240	13	V20130429-05_FTMSms2hcd	35.990	234	246	25.4	4.9e-8	5.9e-11	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	719.0272	3	0.21	AYTNFDAERDALNIETAIK	AYTNFDAERDALNIETAIK		19	V20130429-05_FTMSms2hcd	49.702	29	47	29.2	8.1e-8	8.9e-11	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	381.2329	2	-0.59	LMVALAK	LM(Oxidation)VALAK	Oxidation@171	7	V20130429-05_FTMSms2hcd	24.723	170	176	28.6	9.6e-6	3.4e-8	2	38659.3	HUMAN	Putative annexin A2-like protein
[8-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	10	36.3	8.04	2.8e-14	526.2649	2	-1.5	WISIMTER	WISIM(Oxidation)TER	Oxidation@217	8	V20130429-05_FTMSms2hcd	33.275	213	220	26.4	1.8e-5	3.1e-8	2	38659.3	HUMAN	Putative annexin A2-like protein
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	973.3989	2	-0.25	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=62	17	V20130429-05_FTMSms2hcd	12.024	250	266	54.5	3.0e-20	4.9e-23	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	683.3690	2	0.97	TLTLVDTGIGMTK	TLTLVDTGIGM(Oxidation)TK	Oxidation@93	13	V20130429-05_FTMSms2hcd	38.981	83	95	47.0	4.5e-15	7.3e-18	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	594.9881	3	0.022	HLEINPDHPIVETLR	HLEINPDHPIVETLR		15	V20130429-05_FTMSms2hcd	37.833	625	639	51.9	2.4e-14	4.2e-17	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	956.0261	2	0.13	KHLEINPDHPIVETLR	KHLEINPDHPIVETLR		16	V20130429-05_FTMSms2hcd	33.218	624	639	44.6	5.9e-14	1.7e-16	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	698.7061	3	0.90	HSQFIGYPITLYLEKER	HSQFIGYPITLYLEKER		17	V20130429-05_FTMSms2hcd	51.625	205	221	48.2	1.5e-13	2.6e-16	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	757.3966	2	0.17	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-05_FTMSms2hcd	44.084	379	392	50.9	3.9e-11	5.8e-14	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	571.2831	2	-0.62	LGIHEDSTNR	LGIHEDSTNR		10	V20130429-05_FTMSms2hcd	12.709	439	448	53.0	9.5e-10	1.5e-12	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	580.7946	2	-1.3	SIYYITGESK	SIYYITGESK		10	V20130429-05_FTMSms2hcd	29.462	482	491	32.1	1.8e-9	2.7e-12	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	612.6085	3	1.4	AQALRDNSTMGYMMAK	AQALRDNSTM(Oxidation)GYM(Oxidation)M(Oxidation)AK	Oxidation@617;Oxidation@620;Oxidation@621	16	V20130429-05_FTMSms2hcd	14.867	608	623	30.5	1.1e-8	1.3e-11	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	515.6141	3	-0.074	ELISNASDALDKIR	ELISNASDALDKIR		14	V20130429-05_FTMSms2hcd	41.168	42	55	53.0	1.2e-8	2.2e-11	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	597.8287	2	2.0	IDIIPNPQER	IDIIPNPQER		10	V20130429-05_FTMSms2hcd	35.806	73	82	25.6	2.2e-7	4.3e-10	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	625.3116	2	-0.97	EQVANSAFVER	EQVANSAFVER		11	V20130429-05_FTMSms2hcd	23.548	492	502	39.8	2.6e-7	3.7e-10	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	576.2819	2	-1.2	YIDQEELNK	YIDQEELNK		9	V20130429-05_FTMSms2hcd	20.350	276	284	26.0	6.4e-7	9.6e-10	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	603.6581	3	0.88	HSQFIGYPITLYLEK	HSQFIGYPITLYLEK		15	V20130429-05_FTMSms2hcd	55.815	205	219	29.3	6.6e-7	1.1e-9	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	621.8546	2	-2.7	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-05_FTMSms2hcd	43.355	96	107	34.4	6.6e-7	1.4e-9	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	415.2679	2	-1.1	ALLFIPR	ALLFIPR		7	V20130429-05_FTMSms2hcd	45.598	331	337	29.1	3.2e-5	1.2e-7	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9]		P08238	HS90B_HUMAN	HSP90AB1	17	26.1	11.26	3.0e-20	509.9194	3	-0.099	SLTNDWEDHLAVK	SLTNDWEDHLAVK		13	V20130429-05_FTMSms2hcd	39.578	307	319	11.2	0.027	3.5e-5	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	683.3690	2	0.97	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@98	13	V20130429-05_FTMSms2hcd	38.981	88	100	47.0	4.5e-15	7.3e-18	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	688.7063	3	6.3	HSQFIGYPITLFVEKER	HSQFIGYPITLFVEKER		17	V20130429-05_FTMSms2hcd	54.423	210	226	47.9	2.8e-12	5.6e-15	1	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	596.3205	3	1.3	HLEINPDHSIIETLR	HLEINPDHSIIETLR		15	V20130429-05_FTMSms2hcd	41.782	633	647	45.6	3.1e-12	5.3e-15	1	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	757.3966	2	0.17	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-05_FTMSms2hcd	44.084	387	400	50.9	3.9e-11	5.8e-14	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	479.5159	4	1.1	KHLEINPDHSIIETLR	KHLEINPDHSIIETLR		16	V20130429-05_FTMSms2hcd	37.083	632	647	40.8	6.4e-11	1.7e-13	1	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	618.3024	2	-3.2	DQVANSAFVER	DQVANSAFVER		11	V20130429-05_FTMSms2hcd	24.387	500	510	31.3	2.7e-7	4.4e-10	1	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	576.2819	2	-1.2	YIDQEELNK	YIDQEELNK		9	V20130429-05_FTMSms2hcd	20.350	284	292	26.0	6.4e-7	9.6e-10	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	621.8546	2	-2.7	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-05_FTMSms2hcd	43.355	101	112	34.4	6.6e-7	1.4e-9	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-1]	4	P07900	HS90A_HUMAN	HSP90AA1	9	14.3	8.47	4.5e-15	509.9194	3	-0.099	SLTNDWEDHLAVK	SLTNDWEDHLAVK		13	V20130429-05_FTMSms2hcd	39.578	315	327	11.2	0.027	3.5e-5	2	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[9-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	11.26	3.0e-20	973.3989	2	-0.25	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=62	17	V20130429-05_FTMSms2hcd	12.024	172	188	54.5	3.0e-20	4.9e-23	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	11.26	3.0e-20	698.7061	3	0.90	HSQFLGYPITLYLEKER	HSQFLGYPITLYLEKER		17	V20130429-05_FTMSms2hcd	51.625	127	143	48.2	1.5e-13	2.6e-16	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	11.26	3.0e-20	580.7946	2	-1.3	SIYYITGESK	SIYYITGESK		10	V20130429-05_FTMSms2hcd	29.462	258	267	32.1	1.8e-9	2.7e-12	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	11.26	3.0e-20	576.2819	2	-1.2	YIDQEELNK	YIDQEELNK		9	V20130429-05_FTMSms2hcd	20.350	198	206	26.0	6.4e-7	9.6e-10	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	11.26	3.0e-20	603.6581	3	0.88	HSQFLGYPITLYLEK	HSQFLGYPITLYLEK		15	V20130429-05_FTMSms2hcd	55.815	127	141	29.3	6.6e-7	1.1e-9	3	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	11.26	3.0e-20	621.8546	2	-2.7	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-05_FTMSms2hcd	43.355	96	107	34.4	6.6e-7	1.4e-9	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	4	8.7	4.99	1.1e-8	612.6085	3	1.4	AQALRDNSTMGYMMAK	AQALRDNSTM(Oxidation)GYM(Oxidation)M(Oxidation)AK	Oxidation@490;Oxidation@493;Oxidation@494	16	V20130429-05_FTMSms2hcd	14.867	481	496	30.5	1.1e-8	1.3e-11	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[9-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	4	8.7	4.99	1.1e-8	597.8287	2	2.0	IDIIPNPQER	IDIIPNPQER		10	V20130429-05_FTMSms2hcd	35.806	73	82	25.6	2.2e-7	4.3e-10	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[9-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	4	8.7	4.99	1.1e-8	625.3116	2	-0.97	EQVANSAFVER	EQVANSAFVER		11	V20130429-05_FTMSms2hcd	23.548	365	375	39.8	2.6e-7	3.7e-10	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[9-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	4	8.7	4.99	1.1e-8	603.6581	3	0.88	HSQFIGYPITLYLEK	HSQFIGYPITLYLEK		15	V20130429-05_FTMSms2hcd	55.815	184	198	29.3	6.6e-7	1.1e-9	3	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[9-4]	0	Q58FG1	HS904_HUMAN	HSP90AA4P	1	3.1	8.47	4.5e-15	683.3690	2	0.97	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@38	13	V20130429-05_FTMSms2hcd	38.981	28	40	47.0	4.5e-15	7.3e-18	3	47712.3	HUMAN	Putative heat shock protein HSP 90-alpha A4
[9-5]	1	P14625	ENPL_HUMAN	HSP90B1	2	2.7	4.99	1.2e-8	515.6141	3	-0.074	ELISNASDALDKIR	ELISNASDALDKIR		14	V20130429-05_FTMSms2hcd	41.168	103	116	53.0	1.2e-8	2.2e-11	2	92469.6	HUMAN	Endoplasmin
[9-5]	1	P14625	ENPL_HUMAN	HSP90B1	2	2.7	4.99	1.2e-8	482.2972	2	-0.23	LIINSLYK	LIINSLYK		8	V20130429-05_FTMSms2hcd	39.395	88	95	24.7	2.8e-5	2.7e-7	1	92469.6	HUMAN	Endoplasmin
[9-6]	0	Q14568	HS902_HUMAN	HSP90AA2	2	6.1	3.51	6.4e-7	576.2819	2	-1.2	YIDQEELNK	YIDQEELNK		9	V20130429-05_FTMSms2hcd	20.350	283	291	26.0	6.4e-7	9.6e-10	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[9-6]	0	Q14568	HS902_HUMAN	HSP90AA2	2	6.1	3.51	6.4e-7	621.8546	2	-2.7	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-05_FTMSms2hcd	43.355	101	112	34.4	6.6e-7	1.4e-9	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[9-7]	0	Q12931	TRAP1_HUMAN	TRAP1	1	2.0	6.34	3.9e-11	757.3966	2	0.17	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR		14	V20130429-05_FTMSms2hcd	44.084	389	402	50.9	3.9e-11	5.8e-14	3	80110.7	HUMAN	Heat shock protein 75 kDa, mitochondrial
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	794.9441	2	0.22	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-05_FTMSms2hcd	33.894	6	20	46.2	1.6e-15	3.7e-18	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	813.9056	2	-0.26	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-05_FTMSms2hcd	21.265	38	51	50.8	4.4e-14	5.1e-17	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	1243.2590	3	1.7	KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK	KIGYNPDTVAFVPISGWNGDNM(Oxidation)LEPSANM(Oxidation)PWFK	Oxidation@201;Oxidation@208	33	V20130429-05_FTMSms2hcd	63.795	180	212	40.2	7.6e-13	8.1e-16	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	844.4689	3	5.2	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-05_FTMSms2hcd	50.821	267	290	43.3	6.0e-11	2.7e-13	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	981.0361	4	11	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-05_FTMSms2hcd	74.132	220	255	34.3	7.4e-11	4.3e-13	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	1200.5695	3	9.2	IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK	IGYNPDTVAFVPISGWNGDNM(Oxidation)LEPSANM(Oxidation)PWFK	Oxidation@201;Oxidation@208	32	V20130429-05_FTMSms2hcd	67.957	181	212	33.2	2.0e-10	2.2e-13	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	839.1447	3	14	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGMVVTFAPVNVTTEVK		24	V20130429-05_FTMSms2hcd	55.362	267	290	37.4	1.8e-9	1.8e-11	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	560.8026	2	-1.6	STTTGHLIYK	STTTGHLIYK		10	V20130429-05_FTMSms2hcd	17.454	21	30	36.6	2.4e-8	4.1e-11	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	885.2512	4	3.3	IGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVK	IGGIGTVPVGRVETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	35	V20130429-05_FTMSms2hcd	57.295	256	290	29.0	2.8e-8	3.5e-10	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	538.8981	5	-0.38	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-05_FTMSms2hcd	37.551	6	30	24.4	2.3e-7	9.1e-10	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	513.3086	2	-0.27	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-05_FTMSms2hcd	30.756	256	266	46.5	2.6e-7	1.9e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	432.9907	4	-0.50	YEEIVKEVSTYIKK	YEEIVKEVSTYIKK		14	V20130429-05_FTMSms2hcd	41.774	167	180	23.2	9.8e-7	2.3e-9	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[10]		P68104	EF1A1_HUMAN	EEF1A1	13	35.7	8.71	1.6e-15	457.7870	2	-0.24	QTVAVGVIK	QTVAVGVIK		9	V20130429-05_FTMSms2hcd	26.050	431	439	32.5	8.5e-6	2.5e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	794.9441	2	0.22	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-05_FTMSms2hcd	33.894	6	20	46.2	1.6e-15	3.7e-18	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	813.9056	2	-0.26	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-05_FTMSms2hcd	21.265	38	51	50.8	4.4e-14	5.1e-17	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	1243.2590	3	1.7	KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK	KIGYNPDTVAFVPISGWNGDNM(Oxidation)LEPSANM(Oxidation)PWFK	Oxidation@201;Oxidation@208	33	V20130429-05_FTMSms2hcd	63.795	180	212	40.2	7.6e-13	8.1e-16	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	844.4689	3	5.2	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-05_FTMSms2hcd	50.821	267	290	43.3	6.0e-11	2.7e-13	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	981.0361	4	11	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-05_FTMSms2hcd	74.132	220	255	34.3	7.4e-11	4.3e-13	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	1200.5695	3	9.2	IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK	IGYNPDTVAFVPISGWNGDNM(Oxidation)LEPSANM(Oxidation)PWFK	Oxidation@201;Oxidation@208	32	V20130429-05_FTMSms2hcd	67.957	181	212	33.2	2.0e-10	2.2e-13	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	839.1447	3	14	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGMVVTFAPVNVTTEVK		24	V20130429-05_FTMSms2hcd	55.362	267	290	37.4	1.8e-9	1.8e-11	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	560.8026	2	-1.6	STTTGHLIYK	STTTGHLIYK		10	V20130429-05_FTMSms2hcd	17.454	21	30	36.6	2.4e-8	4.1e-11	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	885.2512	4	3.3	IGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVK	IGGIGTVPVGRVETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	35	V20130429-05_FTMSms2hcd	57.295	256	290	29.0	2.8e-8	3.5e-10	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	538.8981	5	-0.38	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-05_FTMSms2hcd	37.551	6	30	24.4	2.3e-7	9.1e-10	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	513.3086	2	-0.27	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-05_FTMSms2hcd	30.756	256	266	46.5	2.6e-7	1.9e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	432.9907	4	-0.50	YEEIVKEVSTYIKK	YEEIVKEVSTYIKK		14	V20130429-05_FTMSms2hcd	41.774	167	180	23.2	9.8e-7	2.3e-9	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	13	35.7	8.71	1.6e-15	457.7870	2	-0.24	QTVAVGVIK	QTVAVGVIK		9	V20130429-05_FTMSms2hcd	26.050	431	439	32.5	8.5e-6	2.5e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[10-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	17.9	8.71	1.6e-15	794.9441	2	0.22	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-05_FTMSms2hcd	33.894	6	20	46.2	1.6e-15	3.7e-18	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[10-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	17.9	8.71	1.6e-15	813.9056	2	-0.26	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-05_FTMSms2hcd	21.265	38	51	50.8	4.4e-14	5.1e-17	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[10-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	17.9	8.71	1.6e-15	863.1469	3	3.8	VETGILRPGMVVTFAPVNITTEVK	VETGILRPGM(Oxidation)VVTFAPVNITTEVK	Oxidation@276	24	V20130429-05_FTMSms2hcd	56.227	267	290	45.8	9.7e-12	5.0e-14	1	50470.6	HUMAN	Elongation factor 1-alpha 2
[10-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	17.9	8.71	1.6e-15	560.8026	2	-1.6	STTTGHLIYK	STTTGHLIYK		10	V20130429-05_FTMSms2hcd	17.454	21	30	36.6	2.4e-8	4.1e-11	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[10-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	17.9	8.71	1.6e-15	538.8981	5	-0.38	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-05_FTMSms2hcd	37.551	6	30	24.4	2.3e-7	9.1e-10	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[10-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	17.9	8.71	1.6e-15	513.3086	2	-0.27	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-05_FTMSms2hcd	30.756	256	266	46.5	2.6e-7	1.9e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[10-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	17.9	8.71	1.6e-15	457.7870	2	-0.24	QTVAVGVIK	QTVAVGVIK		9	V20130429-05_FTMSms2hcd	26.050	431	439	32.5	8.5e-6	2.5e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	604.5566	4	-0.24	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-05_FTMSms2hcd	40.358	85	105	56.2	7.8e-15	8.7e-18	6	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	1004.4517	2	1.5	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-05_FTMSms2hcd	50.933	41	60	46.5	1.1e-13	1.2e-16	5	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	1199.5951	2	1.8	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-05_FTMSms2hcd	48.701	85	105	58.4	2.7e-13	2.9e-16	6	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	760.7368	3	3.9	AVFVDLEPTVIDEVRTGTYR	AVFVDLEPTVIDEVRTGTYR		20	V20130429-05_FTMSms2hcd	56.760	65	84	49.1	2.0e-12	3.7e-15	3	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	851.4614	2	5.7	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-05_FTMSms2hcd	57.060	65	79	51.2	8.5e-12	1.6e-14	3	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	586.3263	3	0.63	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-05_FTMSms2hcd	51.804	265	280	34.4	2.9e-11	7.2e-14	6	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	744.4432	2	-0.031	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-05_FTMSms2hcd	67.543	230	243	51.9	2.4e-9	1.4e-11	5	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	388.9539	4	-0.19	LDHKFDLMYAKR	LDHKFDLM(Oxidation)YAKR	Oxidation@398	12	V20130429-05_FTMSms2hcd	24.468	391	402	27.1	2.0e-8	2.7e-11	7	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	859.9447	2	0.059	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-05_FTMSms2hcd	33.677	216	229	45.8	4.5e-8	5.8e-11	7	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	508.2925	2	-0.50	DVNAAIATIK	DVNAAIATIK		10	V20130429-05_FTMSms2hcd	32.324	327	336	32.5	2.0e-7	3.8e-10	5	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	466.2353	3	-1.1	LDHKFDLMYAK	LDHKFDLM(Oxidation)YAK	Oxidation@398	11	V20130429-05_FTMSms2hcd	27.582	391	401	26.2	4.8e-7	5.7e-10	7	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	455.2556	2	-0.094	LSVDYGKK	LSVDYGKK		8	V20130429-05_FTMSms2hcd	14.988	157	164	24.6	5.8e-6	1.3e-8	5	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	13	33.9	8.34	7.8e-15	912.9962	2	-0.17	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-05_FTMSms2hcd	44.172	353	370	13.3	3.1e-4	6.6e-7	7	50152.1	HUMAN	Tubulin alpha-1B chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	604.5566	4	-0.24	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-05_FTMSms2hcd	40.358	85	105	56.2	7.8e-15	8.7e-18	6	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	1004.4517	2	1.5	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-05_FTMSms2hcd	50.933	41	60	46.5	1.1e-13	1.2e-16	5	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	1199.5951	2	1.8	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-05_FTMSms2hcd	48.701	85	105	58.4	2.7e-13	2.9e-16	6	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	760.7368	3	3.9	AVFVDLEPTVIDEVRTGTYR	AVFVDLEPTVIDEVRTGTYR		20	V20130429-05_FTMSms2hcd	56.760	65	84	49.1	2.0e-12	3.7e-15	3	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	851.4614	2	5.7	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-05_FTMSms2hcd	57.060	65	79	51.2	8.5e-12	1.6e-14	3	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	586.3263	3	0.63	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-05_FTMSms2hcd	51.804	265	280	34.4	2.9e-11	7.2e-14	6	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	744.4432	2	-0.031	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-05_FTMSms2hcd	67.543	230	243	51.9	2.4e-9	1.4e-11	5	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	388.9539	4	-0.19	LDHKFDLMYAKR	LDHKFDLM(Oxidation)YAKR	Oxidation@398	12	V20130429-05_FTMSms2hcd	24.468	391	402	27.1	2.0e-8	2.7e-11	7	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	859.9447	2	0.059	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-05_FTMSms2hcd	33.677	216	229	45.8	4.5e-8	5.8e-11	7	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	508.2925	2	-0.50	DVNAAIATIK	DVNAAIATIK		10	V20130429-05_FTMSms2hcd	32.324	327	336	32.5	2.0e-7	3.8e-10	5	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	466.2353	3	-1.1	LDHKFDLMYAK	LDHKFDLM(Oxidation)YAK	Oxidation@398	11	V20130429-05_FTMSms2hcd	27.582	391	401	26.2	4.8e-7	5.7e-10	7	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	455.2556	2	-0.094	LSVDYGKK	LSVDYGKK		8	V20130429-05_FTMSms2hcd	14.988	157	164	24.6	5.8e-6	1.3e-8	5	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	13	34.1	8.34	7.8e-15	912.9962	2	-0.17	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-05_FTMSms2hcd	44.172	353	370	13.3	3.1e-4	6.6e-7	7	49895.8	HUMAN	Tubulin alpha-1C chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	604.5566	4	-0.24	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-05_FTMSms2hcd	40.358	85	105	56.2	7.8e-15	8.7e-18	6	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	1004.4517	2	1.5	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-05_FTMSms2hcd	50.933	41	60	46.5	1.1e-13	1.2e-16	5	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	1199.5951	2	1.8	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-05_FTMSms2hcd	48.701	85	105	58.4	2.7e-13	2.9e-16	6	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	760.7368	3	3.9	AVFVDLEPTVIDEVRTGTYR	AVFVDLEPTVIDEVRTGTYR		20	V20130429-05_FTMSms2hcd	56.760	65	84	49.1	2.0e-12	3.7e-15	3	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	851.4614	2	5.7	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-05_FTMSms2hcd	57.060	65	79	51.2	8.5e-12	1.6e-14	3	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	586.3263	3	0.63	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-05_FTMSms2hcd	51.804	265	280	34.4	2.9e-11	7.2e-14	6	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	388.9539	4	-0.19	LDHKFDLMYAKR	LDHKFDLM(Oxidation)YAKR	Oxidation@398	12	V20130429-05_FTMSms2hcd	24.468	391	402	27.1	2.0e-8	2.7e-11	7	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	859.9447	2	0.059	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-05_FTMSms2hcd	33.677	216	229	45.8	4.5e-8	5.8e-11	7	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	508.2925	2	-0.50	DVNAAIATIK	DVNAAIATIK		10	V20130429-05_FTMSms2hcd	32.324	327	336	32.5	2.0e-7	3.8e-10	5	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	466.2353	3	-1.1	LDHKFDLMYAK	LDHKFDLM(Oxidation)YAK	Oxidation@398	11	V20130429-05_FTMSms2hcd	27.582	391	401	26.2	4.8e-7	5.7e-10	7	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	455.2556	2	-0.094	LSVDYGKK	LSVDYGKK		8	V20130429-05_FTMSms2hcd	14.988	157	164	24.6	5.8e-6	1.3e-8	5	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	12	30.8	8.34	7.8e-15	912.9962	2	-0.17	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-05_FTMSms2hcd	44.172	353	370	13.3	3.1e-4	6.6e-7	7	50136.1	HUMAN	Tubulin alpha-1A chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	604.5566	4	-0.24	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-05_FTMSms2hcd	40.358	85	105	56.2	7.8e-15	8.7e-18	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	1004.4517	2	1.5	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-05_FTMSms2hcd	50.933	41	60	46.5	1.1e-13	1.2e-16	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	1199.5951	2	1.8	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-05_FTMSms2hcd	48.701	85	105	58.4	2.7e-13	2.9e-16	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	844.4486	2	-0.12	AVFVDLEPTVVDEVR	AVFVDLEPTVVDEVR		15	V20130429-05_FTMSms2hcd	54.197	65	79	38.7	2.1e-11	3.5e-14	2	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	586.3263	3	0.63	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-05_FTMSms2hcd	51.804	265	280	34.4	2.9e-11	7.2e-14	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	388.9539	4	-0.19	LDHKFDLMYAKR	LDHKFDLM(Oxidation)YAKR	Oxidation@398	12	V20130429-05_FTMSms2hcd	24.468	391	402	27.1	2.0e-8	2.7e-11	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	859.9447	2	0.059	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-05_FTMSms2hcd	33.677	216	229	45.8	4.5e-8	5.8e-11	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	508.2925	2	-0.50	DVNAAIATIK	DVNAAIATIK		10	V20130429-05_FTMSms2hcd	32.324	327	336	32.5	2.0e-7	3.8e-10	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	466.2353	3	-1.1	LDHKFDLMYAK	LDHKFDLM(Oxidation)YAK	Oxidation@398	11	V20130429-05_FTMSms2hcd	27.582	391	401	26.2	4.8e-7	5.7e-10	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	455.2556	2	-0.094	LSVDYGKK	LSVDYGKK		8	V20130429-05_FTMSms2hcd	14.988	157	164	24.6	5.8e-6	1.3e-8	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	1	Q13748	TBA3C_HUMAN	TUBA3C	11	29.8	8.34	7.8e-15	912.9962	2	-0.17	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-05_FTMSms2hcd	44.172	353	370	13.3	3.1e-4	6.6e-7	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	604.5566	4	-0.24	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-05_FTMSms2hcd	40.358	85	105	56.2	7.8e-15	8.7e-18	6	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	1199.5951	2	1.8	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-05_FTMSms2hcd	48.701	85	105	58.4	2.7e-13	2.9e-16	6	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	586.3263	3	0.63	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-05_FTMSms2hcd	51.804	265	280	34.4	2.9e-11	7.2e-14	6	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	744.4432	2	-0.031	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-05_FTMSms2hcd	67.543	230	243	51.9	2.4e-9	1.4e-11	5	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	388.9539	4	-0.19	LDHKFDLMYAKR	LDHKFDLM(Oxidation)YAKR	Oxidation@398	12	V20130429-05_FTMSms2hcd	24.468	391	402	27.1	2.0e-8	2.7e-11	7	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	859.9447	2	0.059	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-05_FTMSms2hcd	33.677	216	229	45.8	4.5e-8	5.8e-11	7	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	466.2353	3	-1.1	LDHKFDLMYAK	LDHKFDLM(Oxidation)YAK	Oxidation@398	11	V20130429-05_FTMSms2hcd	27.582	391	401	26.2	4.8e-7	5.7e-10	7	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	455.2556	2	-0.094	LSVDYGKK	LSVDYGKK		8	V20130429-05_FTMSms2hcd	14.988	157	164	24.6	5.8e-6	1.3e-8	5	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	9	23.0	8.34	7.8e-15	912.9962	2	-0.17	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-05_FTMSms2hcd	44.172	353	370	13.3	3.1e-4	6.6e-7	7	49924.9	HUMAN	Tubulin alpha-4A chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	7	17.6	8.34	7.8e-15	604.5566	4	-0.24	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-05_FTMSms2hcd	40.358	85	105	56.2	7.8e-15	8.7e-18	6	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	7	17.6	8.34	7.8e-15	1199.5951	2	1.8	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-05_FTMSms2hcd	48.701	85	105	58.4	2.7e-13	2.9e-16	6	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	7	17.6	8.34	7.8e-15	744.4432	2	-0.031	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-05_FTMSms2hcd	67.543	230	243	51.9	2.4e-9	1.4e-11	5	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	7	17.6	8.34	7.8e-15	388.9539	4	-0.19	LDHKFDLMYAKR	LDHKFDLM(Oxidation)YAKR	Oxidation@398	12	V20130429-05_FTMSms2hcd	24.468	391	402	27.1	2.0e-8	2.7e-11	7	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	7	17.6	8.34	7.8e-15	859.9447	2	0.059	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-05_FTMSms2hcd	33.677	216	229	45.8	4.5e-8	5.8e-11	7	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	7	17.6	8.34	7.8e-15	466.2353	3	-1.1	LDHKFDLMYAK	LDHKFDLM(Oxidation)YAK	Oxidation@398	11	V20130429-05_FTMSms2hcd	27.582	391	401	26.2	4.8e-7	5.7e-10	7	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	7	17.6	8.34	7.8e-15	912.9962	2	-0.17	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-05_FTMSms2hcd	44.172	353	370	13.3	3.1e-4	6.6e-7	7	50094.0	HUMAN	Tubulin alpha-8 chain
[11-6]	1	Q6PEY2	TBA3E_HUMAN	TUBA3E	6	20.7	7.72	1.1e-13	1004.4517	2	1.5	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-05_FTMSms2hcd	50.933	41	60	46.5	1.1e-13	1.2e-16	5	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	1	Q6PEY2	TBA3E_HUMAN	TUBA3E	6	20.7	7.72	1.1e-13	844.4486	2	-0.12	AVFVDLEPTVVDEVR	AVFVDLEPTVVDEVR		15	V20130429-05_FTMSms2hcd	54.197	65	79	38.7	2.1e-11	3.5e-14	2	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	1	Q6PEY2	TBA3E_HUMAN	TUBA3E	6	20.7	7.72	1.1e-13	586.3263	3	0.63	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-05_FTMSms2hcd	51.804	265	280	34.4	2.9e-11	7.2e-14	6	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	1	Q6PEY2	TBA3E_HUMAN	TUBA3E	6	20.7	7.72	1.1e-13	859.9447	2	0.059	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-05_FTMSms2hcd	33.677	216	229	45.8	4.5e-8	5.8e-11	7	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	1	Q6PEY2	TBA3E_HUMAN	TUBA3E	6	20.7	7.72	1.1e-13	508.2925	2	-0.50	DVNAAIATIK	DVNAAIATIK		10	V20130429-05_FTMSms2hcd	32.324	327	336	32.5	2.0e-7	3.8e-10	5	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	1	Q6PEY2	TBA3E_HUMAN	TUBA3E	6	20.7	7.72	1.1e-13	912.9962	2	-0.17	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-05_FTMSms2hcd	44.172	353	370	13.3	3.1e-4	6.6e-7	7	49859.0	HUMAN	Tubulin alpha-3E chain
[11-7]	0	A6NHL2	TBAL3_HUMAN	TUBAL3	2	2.7	3.58	2.0e-8	388.9539	4	-0.19	LDHKFDLMYAKR	LDHKFDLM(Oxidation)YAKR	Oxidation@405	12	V20130429-05_FTMSms2hcd	24.468	398	409	27.1	2.0e-8	2.7e-11	7	49909.2	HUMAN	Tubulin alpha chain-like 3
[11-7]	0	A6NHL2	TBAL3_HUMAN	TUBAL3	2	2.7	3.58	2.0e-8	466.2353	3	-1.1	LDHKFDLMYAK	LDHKFDLM(Oxidation)YAK	Oxidation@405	11	V20130429-05_FTMSms2hcd	27.582	398	408	26.2	4.8e-7	5.7e-10	7	49909.2	HUMAN	Tubulin alpha chain-like 3
[11-8]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	5.37	2.4e-9	744.4432	2	-0.031	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-05_FTMSms2hcd	67.543	169	182	51.9	2.4e-9	1.4e-11	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	795.0040	3	1.7	KGAGDGSDEEVDGKADGAEAKPAE	KGAGDGS(Phospho)DEEVDGKADGAEAKPAE	Phospho@1943	24	V20130429-05_FTMSms2hcd	15.434	1937	1960	45.9	3.2e-19	3.9e-22	1	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	862.9144	2	0.99	NAEQYKDQADKASTR	NAEQYKDQADKASTR		15	V20130429-05_FTMSms2hcd	11.798	1857	1871	53.5	1.4e-12	1.5e-15	1	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	666.0081	3	0.17	HSQAVEELAEQLEQTKR	HSQAVEELAEQLEQTKR		17	V20130429-05_FTMSms2hcd	39.806	1194	1210	42.4	1.9e-12	2.4e-15	1	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	855.4726	2	9.3	QLLQANPILEAFGNAK	Q(Gln->pyro-Glu)LLQANPILEAFGNAK	Gln->pyro-Glu@210	16	V20130429-05_FTMSms2hcd	73.498	210	225	36.0	5.8e-12	1.5e-14	3	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	824.7289	3	-0.60	IAQLEEELEEEQGNTELINDR	IAQLEEELEEEQGNTELINDR		21	V20130429-05_FTMSms2hcd	48.229	1731	1751	41.8	3.2e-11	3.2e-14	1	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	1070.2084	3	1.4	MAQQAADKYLYVDKNFINNPLAQADWAAK	M(Met-loss+Acetyl)AQQAADKYLYVDKNFINNPLAQADWAAK	Met-loss+Acetyl@1	29	V20130429-05_FTMSms2hcd	59.856	1	29	35.2	4.8e-11	6.9e-14	1	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	863.9850	2	8.2	QLLQANPILEAFGNAK	QLLQANPILEAFGNAK		16	V20130429-05_FTMSms2hcd	61.487	210	225	48.6	1.9e-9	5.9e-12	3	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	839.8896	2	1.1	EMEAELEDERKQR	EM(Oxidation)EAELEDERKQR	Oxidation@1594	13	V20130429-05_FTMSms2hcd	11.456	1593	1605	30.9	1.1e-8	1.2e-11	1	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	539.0027	3	-0.37	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-05_FTMSms2hcd	57.699	342	356	34.6	4.3e-8	1.2e-9	1	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	524.6232	3	0.66	VSHLLGINVTDFTR	VSHLLGINVTDFTR		14	V20130429-05_FTMSms2hcd	49.210	374	387	34.0	1.1e-7	2.2e-10	1	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	783.3709	2	2.7	YAEERDRAEAEAR	YAEERDRAEAEAR		13	V20130429-05_FTMSms2hcd	10.199	1460	1472	34.1	7.9e-7	9.5e-10	2	226534.2	HUMAN	Myosin-9
[12]		P35579	MYH9_HUMAN	MYH9	12	9.7	10.71	3.2e-19	493.6049	3	-0.030	VIQYLAYVASSHK	VIQYLAYVASSHK		13	V20130429-05_FTMSms2hcd	39.565	187	199	25.9	5.7e-6	1.1e-8	1	226534.2	HUMAN	Myosin-9
[12-1]	0	P35749	MYH11_HUMAN	MYH11	2	0.8	6.79	5.8e-12	855.4726	2	9.3	QLLQANPILEAFGNAK	Q(Gln->pyro-Glu)LLQANPILEAFGNAK	Gln->pyro-Glu@217	16	V20130429-05_FTMSms2hcd	73.498	217	232	36.0	5.8e-12	1.5e-14	3	227341.1	HUMAN	Myosin-11
[12-1]	0	P35749	MYH11_HUMAN	MYH11	2	0.8	6.79	5.8e-12	863.9850	2	8.2	QLLQANPILEAFGNAK	QLLQANPILEAFGNAK		16	V20130429-05_FTMSms2hcd	61.487	217	232	48.6	1.9e-9	5.9e-12	3	227341.1	HUMAN	Myosin-11
[12-2]	0	Q7Z406	MYH14_HUMAN	MYH14	2	0.8	6.79	5.8e-12	855.4726	2	9.3	QLLQANPILEAFGNAK	Q(Gln->pyro-Glu)LLQANPILEAFGNAK	Gln->pyro-Glu@237	16	V20130429-05_FTMSms2hcd	73.498	237	252	36.0	5.8e-12	1.5e-14	3	227872.4	HUMAN	Myosin-14
[12-2]	0	Q7Z406	MYH14_HUMAN	MYH14	2	0.8	6.79	5.8e-12	863.9850	2	8.2	QLLQANPILEAFGNAK	QLLQANPILEAFGNAK		16	V20130429-05_FTMSms2hcd	61.487	237	252	48.6	1.9e-9	5.9e-12	3	227872.4	HUMAN	Myosin-14
[12-3]	0	P35580	MYH10_HUMAN	MYH10	1	0.7	3.43	7.9e-7	783.3709	2	2.7	YAEERDRAEAEAR	YAEERDRAEAEAR		13	V20130429-05_FTMSms2hcd	10.199	1467	1479	34.1	7.9e-7	9.5e-10	2	229001.0	HUMAN	Myosin-10
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	741.9031	2	0.30	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-05_FTMSms2hcd	40.211	81	93	55.9	6.5e-12	1.4e-14	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	566.0569	4	0.92	VFLENVIRDAVTYTEHAKR	VFLENVIRDAVTYTEHAKR		19	V20130429-05_FTMSms2hcd	59.237	61	79	44.5	1.2e-11	2.4e-14	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	565.3391	3	-2.6	VLRDNIQGITKPAIR	VLRDNIQGITKPAIR		15	V20130429-05_FTMSms2hcd	30.717	22	36	30.7	1.4e-10	1.7e-12	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	663.8509	2	-2.1	TVTAMDVVYALK	TVTAM(Oxidation)DVVYALK	Oxidation@85	12	V20130429-05_FTMSms2hcd	43.394	81	92	35.9	1.5e-10	2.6e-13	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	489.6063	3	0.54	TVTAMDVVYALKR	TVTAMDVVYALKR		13	V20130429-05_FTMSms2hcd	48.571	81	93	27.4	2.2e-10	5.2e-13	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	527.0370	4	11	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-05_FTMSms2hcd	62.578	61	78	36.8	8.7e-10	1.7e-12	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	567.7748	2	-0.23	DAVTYTEHAK	DAVTYTEHAK		10	V20130429-05_FTMSms2hcd	12.201	69	78	38.2	9.2e-9	1.5e-11	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	741.4312	2	0.30	DNIQGITKPAIRR	DNIQGITKPAIRR		13	V20130429-05_FTMSms2hcd	23.238	25	37	43.8	1.5e-8	7.7e-11	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	663.3804	2	-0.039	DNIQGITKPAIR	DNIQGITKPAIR		12	V20130429-05_FTMSms2hcd	27.082	25	36	38.4	2.2e-8	7.9e-11	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	526.6340	3	-1.4	ISGLIYEETRGVLK	ISGLIYEETRGVLK		14	V20130429-05_FTMSms2hcd	43.136	47	60	42.2	5.7e-8	1.8e-10	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	590.8140	2	-0.090	ISGLIYEETR	ISGLIYEETR		10	V20130429-05_FTMSms2hcd	32.693	47	56	43.8	7.1e-8	1.1e-10	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	495.2929	2	0.69	VFLENVIR	VFLENVIR		8	V20130429-05_FTMSms2hcd	43.167	61	68	34.5	2.2e-7	6.7e-10	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	13	60.2	6.76	6.5e-12	463.2813	4	-2.7	VLRDNIQGITKPAIRR	VLRDNIQGITKPAIRR		16	V20130429-05_FTMSms2hcd	27.448	22	37	19.6	2.3e-6	3.5e-8	1	11367.4	HUMAN	Histone H4
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	1073.0690	2	0.62	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-05_FTMSms2hcd	70.323	38	58	64.0	4.6e-20	8.1e-23	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	740.7897	5	2.3	QSKPVTTPEEIAQVATISANGDKEIGNIISDAMKK	QSKPVTTPEEIAQVATISANGDKEIGNIISDAM(Oxidation)KK	Oxidation@190	35	V20130429-05_FTMSms2hcd	58.689	158	192	57.0	1.8e-16	4.4e-19	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	524.9789	3	12	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-05_FTMSms2hcd	59.057	143	157	37.2	9.8e-12	7.4e-14	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	646.9876	3	0.27	TLNDELEIIEGMKFDR	TLNDELEIIEGM(Oxidation)KFDR	Oxidation@217	16	V20130429-05_FTMSms2hcd	50.149	206	221	44.5	2.2e-11	2.3e-14	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	549.6391	3	-0.36	VGEVIVTKDDAMLLK	VGEVIVTKDDAM(Oxidation)LLK	Oxidation@356	15	V20130429-05_FTMSms2hcd	37.012	345	359	41.0	2.6e-11	5.6e-14	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	544.9445	3	0.12	VGGTSDVEVNEKKDR	VGGTSDVEVNEKKDR		15	V20130429-05_FTMSms2hcd	11.280	406	420	60.4	9.8e-10	1.2e-12	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	672.8643	2	4.1	TVIIEQSWGSPK	TVIIEQSWGSPK		12	V20130429-05_FTMSms2hcd	36.416	61	72	35.4	3.8e-9	6.4e-12	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	401.5773	3	-0.30	TLKIPAMTIAK	TLKIPAM(Oxidation)TIAK	Oxidation@477	11	V20130429-05_FTMSms2hcd	28.338	471	481	36.0	9.8e-9	4.9e-11	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	480.7592	2	0.25	VTDALNATR	VTDALNATR		9	V20130429-05_FTMSms2hcd	15.774	421	429	39.8	4.9e-6	7.5e-9	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	1151.8129	4	17	TALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	TALLDAAGVAS(Phospho)LLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	Phospho@537|540|541|547	47	V20130429-05_FTMSms2hcd	77.466	527	573	17.5	4.5e-5	7.0e-8	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[14]		P10809	CH60_HUMAN	HSPD1	11	35.8	11.16	4.6e-20	506.2878	2	-1.1	GANPVEIRR	GANPVEIRR		9	V20130429-05_FTMSms2hcd	15.252	134	142	28.1	1.8e-4	5.7e-7	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	779.3622	2	-1.1	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-05_FTMSms2hcd	42.666	56	69	48.5	9.9e-20	1.2e-22	2	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	916.4577	2	-1.7	SIYGEKFEDENFILK	SIYGEKFEDENFILK		15	V20130429-05_FTMSms2hcd	46.135	77	91	37.5	2.9e-16	3.4e-19	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	917.4373	3	-1.9	HTGPGILSMANAGPNTNGSQFFICTAK	HTGPGILSM(Oxidation)ANAGPNTNGSQFFICTAK	Oxidation@100	27	V20130429-05_FTMSms2hcd	47.692	92	118	56.9	2.5e-15	2.4e-18	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	973.5108	2	6.4	MVNPTVFFDIAVDGEPLGR	M(Met-loss)VNPTVFFDIAVDGEPLGR	Met-loss@1	19	V20130429-05_FTMSms2hcd	66.717	1	19	48.5	4.1e-15	6.3e-18	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	769.3707	2	-0.50	VKEGMNIVEAMER	VKEGM(Oxidation)NIVEAM(Oxidation)ER	Oxidation@136;Oxidation@142	13	V20130429-05_FTMSms2hcd	17.585	132	144	40.9	6.1e-11	7.6e-14	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	655.7899	2	0.77	EGMNIVEAMER	EGM(Oxidation)NIVEAM(Oxidation)ER	Oxidation@136;Oxidation@142	11	V20130429-05_FTMSms2hcd	18.755	134	144	33.9	2.3e-10	3.9e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	758.4007	2	-0.87	TEWLDGKHVVFGK	TEWLDGKHVVFGK		13	V20130429-05_FTMSms2hcd	36.296	119	131	37.1	3.4e-10	5.3e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	577.7897	2	-0.60	FEDENFILK	FEDENFILK		9	V20130429-05_FTMSms2hcd	41.330	83	91	25.4	4.6e-7	6.3e-10	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15]		P62937	PPIA_HUMAN	PPIA	9	68.5	10.98	9.9e-20	690.3829	2	1.2	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-05_FTMSms2hcd	47.104	20	31	27.3	4.7e-5	1.1e-7	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[15-1]	0	Q9Y536	PAL4A_HUMAN	PPIAL4A	1	8.5	10.98	9.9e-20	779.3622	2	-1.1	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-05_FTMSms2hcd	42.666	56	69	48.5	9.9e-20	1.2e-22	2	18182.0	HUMAN	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	900.4557	2	4.4	AYLPVNESFGFTADLR	AYLPVNESFGFTADLR		16	V20130429-05_FTMSms2hcd	56.875	786	801	38.4	1.2e-13	1.4e-16	1	95339.0	HUMAN	Elongation factor 2
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	785.0785	3	0.97	GVQYLNEIKDSVVAGFQWATK	GVQYLNEIKDSVVAGFQWATK		21	V20130429-05_FTMSms2hcd	68.387	668	688	46.7	6.9e-12	1.1e-14	1	95339.0	HUMAN	Elongation factor 2
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	715.0302	3	-0.83	ARPFPDGLAEDIDKGEVSAR	ARPFPDGLAEDIDKGEVSAR		20	V20130429-05_FTMSms2hcd	40.765	606	625	44.9	8.7e-12	9.9e-15	1	95339.0	HUMAN	Elongation factor 2
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	872.8146	3	2.8	WLPAGDALLQMITIHLPSPVTAQK	WLPAGDALLQM(Oxidation)ITIHLPSPVTAQK	Oxidation@353	24	V20130429-05_FTMSms2hcd	71.260	343	366	35.5	5.1e-11	1.9e-13	1	95339.0	HUMAN	Elongation factor 2
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	901.4812	3	6.7	YVEPIEDVPCGNIVGLVGVDQFLVK	YVEPIEDVPCGNIVGLVGVDQFLVK		25	V20130429-05_FTMSms2hcd	75.054	457	481	24.0	1.1e-9	2.2e-12	1	95339.0	HUMAN	Elongation factor 2
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	554.3240	2	-0.10	VFSGLVSTGLK	VFSGLVSTGLK		11	V20130429-05_FTMSms2hcd	39.741	416	426	39.8	4.2e-9	1.7e-11	1	95339.0	HUMAN	Elongation factor 2
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	546.2956	2	-0.42	MVNFTVDQIR	M(Met-loss)VNFTVDQIR	Met-loss@1	10	V20130429-05_FTMSms2hcd	35.188	1	10	33.8	2.1e-8	3.6e-11	1	95339.0	HUMAN	Elongation factor 2
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	485.2776	2	0.33	GGGQIIPTAR	GGGQIIPTAR		10	V20130429-05_FTMSms2hcd	22.497	717	726	24.8	3.2e-7	1.0e-9	2	95339.0	HUMAN	Elongation factor 2
[16]		P13639	EF2_HUMAN	EEF2	9	17.5	7.69	1.2e-13	722.8882	2	0.62	EGIPALDNFLDKL	EGIPALDNFLDKL		13	V20130429-05_FTMSms2hcd	71.718	846	858	33.8	7.3e-6	1.3e-8	1	95339.0	HUMAN	Elongation factor 2
[16-1]	0	Q15029	U5S1_HUMAN	EFTUD2	1	1.0	2.71	3.2e-7	485.2776	2	0.33	GGGQIIPTAR	GGGQIIPTAR		10	V20130429-05_FTMSms2hcd	22.497	804	813	24.8	3.2e-7	1.0e-9	2	109436.7	HUMAN	116 kDa U5 small nuclear ribonucleoprotein component
[17]		P09651	ROA1_HUMAN	HNRNPA1	7	32.5	13.23	6.9e-24	847.8532	2	-0.57	NQGGYGGSSSSSSYGSGR	NQGGYGGSSSSSSYGSGR		18	V20130429-05_FTMSms2hcd	11.851	353	370	57.5	6.9e-24	1.0e-26	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	7	32.5	13.23	6.9e-24	814.8952	2	0.95	SSGPYGGGGQYFAKPR	SSGPYGGGGQYFAKPR		16	V20130429-05_FTMSms2hcd	25.029	337	352	61.5	2.4e-14	2.7e-17	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	7	32.5	13.23	6.9e-24	892.9621	2	5.8	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-05_FTMSms2hcd	57.921	16	31	49.9	2.6e-13	3.6e-16	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	7	32.5	13.23	6.9e-24	591.4916	5	0.94	GFGFVTYATVEEVDAAMNARPHKVDGR	GFGFVTYATVEEVDAAM(Oxidation)NARPHKVDGR	Oxidation@72	27	V20130429-05_FTMSms2hcd	48.662	56	82	35.2	7.8e-11	7.8e-14	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	7	32.5	13.23	6.9e-24	761.0559	3	1.4	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-05_FTMSms2hcd	52.277	147	166	28.1	1.4e-9	1.9e-12	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	7	32.5	13.23	6.9e-24	650.3304	2	-0.31	SESPKEPEQLR	SESPKEPEQLR		11	V20130429-05_FTMSms2hcd	15.053	4	14	34.3	1.9e-6	2.7e-9	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	7	32.5	13.23	6.9e-24	479.9191	3	-1.2	EDSQRPGAHLTVK	EDSQRPGAHLTVK		13	V20130429-05_FTMSms2hcd	14.154	93	105	25.1	8.2e-6	1.1e-8	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	3	15.3	7.52	2.6e-13	892.9621	2	5.8	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-05_FTMSms2hcd	57.921	16	31	49.9	2.6e-13	3.6e-16	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[17-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	3	15.3	7.52	2.6e-13	761.0559	3	1.4	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-05_FTMSms2hcd	52.277	147	166	28.1	1.4e-9	1.9e-12	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[17-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	3	15.3	7.52	2.6e-13	479.9191	3	-1.2	EDSQRPGAHLTVK	EDSQRPGAHLTVK		13	V20130429-05_FTMSms2hcd	14.154	93	105	25.1	8.2e-6	1.1e-8	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	1050.5195	2	1.6	YGINTTDIFQTVDLWEGK	YGINTTDIFQTVDLWEGK		18	V20130429-05_FTMSms2hcd	69.152	103	120	47.1	9.6e-12	9.9e-15	1	22391.7	HUMAN	Transgelin-2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	847.9122	2	0.28	QMEQISQFLQAAER	QM(Oxidation)EQISQFLQAAER	Oxidation@90	14	V20130429-05_FTMSms2hcd	46.942	89	102	49.0	1.3e-11	1.4e-14	1	22391.7	HUMAN	Transgelin-2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	708.3065	2	1.1	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-05_FTMSms2hcd	11.985	183	196	38.5	6.7e-10	1.2e-12	2	22391.7	HUMAN	Transgelin-2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	640.2988	2	-0.78	NFSDNQLQEGK	NFSDNQLQEGK		11	V20130429-05_FTMSms2hcd	20.462	161	171	40.6	1.4e-9	2.2e-12	1	22391.7	HUMAN	Transgelin-2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	616.3447	2	-0.48	TLMNLGGLAVAR	TLM(Oxidation)NLGGLAVAR	Oxidation@130	12	V20130429-05_FTMSms2hcd	38.130	128	139	40.5	1.1e-8	2.3e-11	1	22391.7	HUMAN	Transgelin-2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	602.3140	2	-1.8	MANRGPAYGLSR	M(Met-loss+Acetyl)ANRGPAYGLSR	Met-loss+Acetyl@1	12	V20130429-05_FTMSms2hcd	22.342	1	12	50.0	7.7e-8	1.1e-10	1	22391.7	HUMAN	Transgelin-2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	609.8170	2	0.65	NVIGLQMGTNR	NVIGLQM(Oxidation)GTNR	Oxidation@178	11	V20130429-05_FTMSms2hcd	23.903	172	182	27.3	4.2e-7	5.5e-10	1	22391.7	HUMAN	Transgelin-2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	506.7592	2	-2.0	IQASTMAFK	IQASTM(Oxidation)AFK	Oxidation@85	9	V20130429-05_FTMSms2hcd	20.019	80	88	35.7	1.4e-6	2.6e-9	1	22391.7	HUMAN	Transgelin-2
[18]		P37802	TAGL2_HUMAN	TAGLN2	9	58.3	6.67	9.6e-12	574.9428	3	0.95	DDGLFSGDPNWFPKK	DDGLFSGDPNWFPKK		15	V20130429-05_FTMSms2hcd	50.296	140	154	17.8	3.6e-6	4.0e-9	1	22391.7	HUMAN	Transgelin-2
[18-1]	0	Q9UI15	TAGL3_HUMAN	TAGLN3	1	7.0	5.53	6.7e-10	708.3065	2	1.1	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-05_FTMSms2hcd	11.985	183	196	38.5	6.7e-10	1.2e-12	2	22472.9	HUMAN	Transgelin-3
[19]		P23528	COF1_HUMAN	CFL1	8	55.4	8.73	1.5e-15	947.9850	2	2.6	MASGVAVSDGVIKVFNDMK	M(Met-loss+Acetyl)ASGVAVSDGVIKVFNDM(Oxidation)K	Met-loss+Acetyl@1;Oxidation@18	19	V20130429-05_FTMSms2hcd	51.277	1	19	48.4	1.5e-15	1.8e-18	1	18502.7	HUMAN	Cofilin-1
[19]		P23528	COF1_HUMAN	CFL1	8	55.4	8.73	1.5e-15	1021.5458	3	9.7	NIILEEGKEILVGDVGQTVDDPYATFVK	NIILEEGKEILVGDVGQTVDDPYATFVK		28	V20130429-05_FTMSms2hcd	64.345	46	73	48.8	3.1e-13	8.4e-16	1	18502.7	HUMAN	Cofilin-1
[19]		P23528	COF1_HUMAN	CFL1	8	55.4	8.73	1.5e-15	670.8918	2	-1.5	LGGSAVISLEGKPL	LGGSAVISLEGKPL		14	V20130429-05_FTMSms2hcd	45.944	153	166	34.4	5.3e-9	2.1e-11	1	18502.7	HUMAN	Cofilin-1
[19]		P23528	COF1_HUMAN	CFL1	8	55.4	8.73	1.5e-15	584.3162	4	2.1	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-05_FTMSms2hcd	61.277	93	112	31.6	1.1e-7	2.3e-10	2	18502.7	HUMAN	Cofilin-1
[19]		P23528	COF1_HUMAN	CFL1	8	55.4	8.73	1.5e-15	612.7967	2	-0.85	MASGVAVSDGVIK	M(Met-loss+Acetyl)AS(Phospho)GVAVSDGVIK	Met-loss+Acetyl@1;Phospho@3=76	13	V20130429-05_FTMSms2hcd	39.033	1	13	19.3	1.9e-7	2.6e-10	1	18502.7	HUMAN	Cofilin-1
[19]		P23528	COF1_HUMAN	CFL1	8	55.4	8.73	1.5e-15	572.8140	2	-0.093	MASGVAVSDGVIK	M(Met-loss+Acetyl)ASGVAVSDGVIK	Met-loss+Acetyl@1	13	V20130429-05_FTMSms2hcd	35.274	1	13	38.6	2.8e-7	4.8e-10	1	18502.7	HUMAN	Cofilin-1
[19]		P23528	COF1_HUMAN	CFL1	8	55.4	8.73	1.5e-15	664.0289	3	1.9	KEDLVFIFWAPESAPLK	KEDLVFIFWAPESAPLK		17	V20130429-05_FTMSms2hcd	65.564	96	112	27.9	3.8e-7	8.7e-10	2	18502.7	HUMAN	Cofilin-1
[19]		P23528	COF1_HUMAN	CFL1	8	55.4	8.73	1.5e-15	621.8236	2	0.059	MIYASSKDAIK	M(Oxidation)IYASSKDAIK	Oxidation@115	11	V20130429-05_FTMSms2hcd	16.538	115	125	32.5	8.1e-7	1.3e-9	3	18502.7	HUMAN	Cofilin-1
[19-1]	0	Q9Y281	COF2_HUMAN	CFL2	3	18.7	3.73	1.1e-7	584.3162	4	2.1	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-05_FTMSms2hcd	61.277	93	112	31.6	1.1e-7	2.3e-10	2	18736.8	HUMAN	Cofilin-2
[19-1]	0	Q9Y281	COF2_HUMAN	CFL2	3	18.7	3.73	1.1e-7	664.0289	3	1.9	KEDLVFIFWAPESAPLK	KEDLVFIFWAPESAPLK		17	V20130429-05_FTMSms2hcd	65.564	96	112	27.9	3.8e-7	8.7e-10	2	18736.8	HUMAN	Cofilin-2
[19-1]	0	Q9Y281	COF2_HUMAN	CFL2	3	18.7	3.73	1.1e-7	621.8236	2	0.059	MIYASSKDAIK	M(Oxidation)IYASSKDAIK	Oxidation@115	11	V20130429-05_FTMSms2hcd	16.538	115	125	32.5	8.1e-7	1.3e-9	3	18736.8	HUMAN	Cofilin-2
[19-2]	0	P60981	DEST_HUMAN	DSTN	1	6.7	3.26	8.1e-7	621.8236	2	0.059	MIYASSKDAIK	M(Oxidation)IYASSKDAIK	Oxidation@115	11	V20130429-05_FTMSms2hcd	16.538	115	125	32.5	8.1e-7	1.3e-9	3	18505.9	HUMAN	Destrin
[20]		P62158	CALM_HUMAN	CALM1	6	66.4	10.65	4.0e-19	1130.5476	3	0.34	MADQLTEEQIAEFKEAFSLFDKDGDGTITTK	M(Met-loss+Acetyl)ADQLTEEQIAEFKEAFSLFDKDGDGTITTK	Met-loss+Acetyl@1	31	V20130429-05_FTMSms2hcd	72.804	1	31	58.6	4.0e-19	4.3e-22	1	16837.7	HUMAN	Calmodulin
[20]		P62158	CALM_HUMAN	CALM1	6	66.4	10.65	4.0e-19	877.9395	2	0.53	VFDKDGNGYISAAELR	VFDKDGNGYISAAELR		16	V20130429-05_FTMSms2hcd	36.347	92	107	61.7	1.9e-15	2.1e-18	1	16837.7	HUMAN	Calmodulin
[20]		P62158	CALM_HUMAN	CALM1	6	66.4	10.65	4.0e-19	1030.2191	4	5.7	SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR	SLGQNPTEAELQDM(Oxidation)INEVDADGNGTIDFPEFLTM(Oxidation)M(Oxidation)AR	Oxidation@52;Oxidation@72;Oxidation@73	37	V20130429-05_FTMSms2hcd	67.797	39	75	50.1	2.4e-15	2.9e-18	1	16837.7	HUMAN	Calmodulin
[20]		P62158	CALM_HUMAN	CALM1	6	66.4	10.65	4.0e-19	782.3801	2	-0.49	MADQLTEEQIAEFK	M(Met-loss+Acetyl)ADQLTEEQIAEFK	Met-loss+Acetyl@1	14	V20130429-05_FTMSms2hcd	48.217	1	14	45.7	2.2e-11	2.6e-14	1	16837.7	HUMAN	Calmodulin
[20]		P62158	CALM_HUMAN	CALM1	6	66.4	10.65	4.0e-19	615.6360	3	1.2	EAFSLFDKDGDGTITTK	EAFSLFDKDGDGTITTK		17	V20130429-05_FTMSms2hcd	42.365	15	31	36.8	1.1e-10	1.2e-13	1	16837.7	HUMAN	Calmodulin
[20]		P62158	CALM_HUMAN	CALM1	6	66.4	10.65	4.0e-19	624.6193	3	-0.34	MKDTDSEEEIREAFR	M(Oxidation)KDTDSEEEIREAFR	Oxidation@77	15	V20130429-05_FTMSms2hcd	29.891	77	91	12.2	0.0044	4.9e-6	1	16837.7	HUMAN	Calmodulin
[21]		O60814	H2B1K_HUMAN	HIST1H2BK	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13890.3	HUMAN	Histone H2B type 1-K
[21]		O60814	H2B1K_HUMAN	HIST1H2BK	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13890.3	HUMAN	Histone H2B type 1-K
[21]		O60814	H2B1K_HUMAN	HIST1H2BK	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13890.3	HUMAN	Histone H2B type 1-K
[21]		O60814	H2B1K_HUMAN	HIST1H2BK	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13890.3	HUMAN	Histone H2B type 1-K
[21]		O60814	H2B1K_HUMAN	HIST1H2BK	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13890.3	HUMAN	Histone H2B type 1-K
[21]		O60814	H2B1K_HUMAN	HIST1H2BK	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13890.3	HUMAN	Histone H2B type 1-K
[21]		O60814	H2B1K_HUMAN	HIST1H2BK	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13890.3	HUMAN	Histone H2B type 1-K
[21]		O60814	H2B1K_HUMAN	HIST1H2BK	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13890.3	HUMAN	Histone H2B type 1-K
[21-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13944.3	HUMAN	Histone H2B type F-S
[21-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13944.3	HUMAN	Histone H2B type F-S
[21-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13944.3	HUMAN	Histone H2B type F-S
[21-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13944.3	HUMAN	Histone H2B type F-S
[21-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13944.3	HUMAN	Histone H2B type F-S
[21-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13944.3	HUMAN	Histone H2B type F-S
[21-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13944.3	HUMAN	Histone H2B type F-S
[21-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13944.3	HUMAN	Histone H2B type F-S
[21-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13936.3	HUMAN	Histone H2B type 1-D
[21-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13936.3	HUMAN	Histone H2B type 1-D
[21-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13936.3	HUMAN	Histone H2B type 1-D
[21-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13936.3	HUMAN	Histone H2B type 1-D
[21-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13936.3	HUMAN	Histone H2B type 1-D
[21-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13936.3	HUMAN	Histone H2B type 1-D
[21-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13936.3	HUMAN	Histone H2B type 1-D
[21-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13936.3	HUMAN	Histone H2B type 1-D
[21-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[21-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[21-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[21-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[21-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[21-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[21-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[21-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[21-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13920.3	HUMAN	Histone H2B type 2-F
[21-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13920.3	HUMAN	Histone H2B type 2-F
[21-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13920.3	HUMAN	Histone H2B type 2-F
[21-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13920.3	HUMAN	Histone H2B type 2-F
[21-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13920.3	HUMAN	Histone H2B type 2-F
[21-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13920.3	HUMAN	Histone H2B type 2-F
[21-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13920.3	HUMAN	Histone H2B type 2-F
[21-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13920.3	HUMAN	Histone H2B type 2-F
[21-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13892.2	HUMAN	Histone H2B type 1-H
[21-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13892.2	HUMAN	Histone H2B type 1-H
[21-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13892.2	HUMAN	Histone H2B type 1-H
[21-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13892.2	HUMAN	Histone H2B type 1-H
[21-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13892.2	HUMAN	Histone H2B type 1-H
[21-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13892.2	HUMAN	Histone H2B type 1-H
[21-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13892.2	HUMAN	Histone H2B type 1-H
[21-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13892.2	HUMAN	Histone H2B type 1-H
[21-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13922.3	HUMAN	Histone H2B type 1-N
[21-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13922.3	HUMAN	Histone H2B type 1-N
[21-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13922.3	HUMAN	Histone H2B type 1-N
[21-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13922.3	HUMAN	Histone H2B type 1-N
[21-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13922.3	HUMAN	Histone H2B type 1-N
[21-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13922.3	HUMAN	Histone H2B type 1-N
[21-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13922.3	HUMAN	Histone H2B type 1-N
[21-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13922.3	HUMAN	Histone H2B type 1-N
[21-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13989.4	HUMAN	Histone H2B type 1-M
[21-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13989.4	HUMAN	Histone H2B type 1-M
[21-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13989.4	HUMAN	Histone H2B type 1-M
[21-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13989.4	HUMAN	Histone H2B type 1-M
[21-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13989.4	HUMAN	Histone H2B type 1-M
[21-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13989.4	HUMAN	Histone H2B type 1-M
[21-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13989.4	HUMAN	Histone H2B type 1-M
[21-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13989.4	HUMAN	Histone H2B type 1-M
[21-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13952.3	HUMAN	Histone H2B type 1-L
[21-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13952.3	HUMAN	Histone H2B type 1-L
[21-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13952.3	HUMAN	Histone H2B type 1-L
[21-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	39.7	7.76	9.2e-14	569.2762	2	-1.0	ESYSVYVYK	ESYSVYVYK		9	V20130429-05_FTMSms2hcd	30.131	36	44	19.6	4.7e-8	7.4e-11	9	13952.3	HUMAN	Histone H2B type 1-L
[21-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	39.7	7.76	9.2e-14	503.5962	3	-0.21	SRKESYSVYVYK	SRKESYSVYVYK		12	V20130429-05_FTMSms2hcd	21.805	33	44	34.0	2.8e-7	3.6e-10	9	13952.3	HUMAN	Histone H2B type 1-L
[21-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13952.3	HUMAN	Histone H2B type 1-L
[21-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13952.3	HUMAN	Histone H2B type 1-L
[21-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	39.7	7.76	9.2e-14	633.3243	2	0.073	KESYSVYVYK	KESYSVYVYK		10	V20130429-05_FTMSms2hcd	25.191	35	44	27.8	6.9e-6	8.2e-9	9	13952.3	HUMAN	Histone H2B type 1-L
[21-9]	3	P06899	H2B1J_HUMAN	HIST1H2BJ	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13904.3	HUMAN	Histone H2B type 1-J
[21-9]	3	P06899	H2B1J_HUMAN	HIST1H2BJ	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13904.3	HUMAN	Histone H2B type 1-J
[21-9]	3	P06899	H2B1J_HUMAN	HIST1H2BJ	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13904.3	HUMAN	Histone H2B type 1-J
[21-9]	3	P06899	H2B1J_HUMAN	HIST1H2BJ	8	39.7	7.76	9.2e-14	640.3312	2	-1.4	KESYSIYVYK	KESYSIYVYK		10	V20130429-05_FTMSms2hcd	28.656	35	44	28.1	2.9e-8	4.1e-11	7	13904.3	HUMAN	Histone H2B type 1-J
[21-9]	3	P06899	H2B1J_HUMAN	HIST1H2BJ	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13904.3	HUMAN	Histone H2B type 1-J
[21-9]	3	P06899	H2B1J_HUMAN	HIST1H2BJ	8	39.7	7.76	9.2e-14	508.2674	3	-1.6	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-05_FTMSms2hcd	25.167	33	44	18.8	1.6e-6	2.1e-9	6	13904.3	HUMAN	Histone H2B type 1-J
[21-9]	3	P06899	H2B1J_HUMAN	HIST1H2BJ	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13904.3	HUMAN	Histone H2B type 1-J
[21-9]	3	P06899	H2B1J_HUMAN	HIST1H2BJ	8	39.7	7.76	9.2e-14	576.2852	2	1.0	ESYSIYVYK	ESYSIYVYK		9	V20130429-05_FTMSms2hcd	34.030	36	44	17.4	3.4e-6	4.9e-9	7	13904.3	HUMAN	Histone H2B type 1-J
[21-10]	3	P23527	H2B1O_HUMAN	HIST1H2BO	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13906.3	HUMAN	Histone H2B type 1-O
[21-10]	3	P23527	H2B1O_HUMAN	HIST1H2BO	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13906.3	HUMAN	Histone H2B type 1-O
[21-10]	3	P23527	H2B1O_HUMAN	HIST1H2BO	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13906.3	HUMAN	Histone H2B type 1-O
[21-10]	3	P23527	H2B1O_HUMAN	HIST1H2BO	8	39.7	7.76	9.2e-14	640.3312	2	-1.4	KESYSIYVYK	KESYSIYVYK		10	V20130429-05_FTMSms2hcd	28.656	35	44	28.1	2.9e-8	4.1e-11	7	13906.3	HUMAN	Histone H2B type 1-O
[21-10]	3	P23527	H2B1O_HUMAN	HIST1H2BO	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13906.3	HUMAN	Histone H2B type 1-O
[21-10]	3	P23527	H2B1O_HUMAN	HIST1H2BO	8	39.7	7.76	9.2e-14	508.2674	3	-1.6	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-05_FTMSms2hcd	25.167	33	44	18.8	1.6e-6	2.1e-9	6	13906.3	HUMAN	Histone H2B type 1-O
[21-10]	3	P23527	H2B1O_HUMAN	HIST1H2BO	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13906.3	HUMAN	Histone H2B type 1-O
[21-10]	3	P23527	H2B1O_HUMAN	HIST1H2BO	8	39.7	7.76	9.2e-14	576.2852	2	1.0	ESYSIYVYK	ESYSIYVYK		9	V20130429-05_FTMSms2hcd	34.030	36	44	17.4	3.4e-6	4.9e-9	7	13906.3	HUMAN	Histone H2B type 1-O
[21-11]	3	P33778	H2B1B_HUMAN	HIST1H2BB	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13950.3	HUMAN	Histone H2B type 1-B
[21-11]	3	P33778	H2B1B_HUMAN	HIST1H2BB	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13950.3	HUMAN	Histone H2B type 1-B
[21-11]	3	P33778	H2B1B_HUMAN	HIST1H2BB	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13950.3	HUMAN	Histone H2B type 1-B
[21-11]	3	P33778	H2B1B_HUMAN	HIST1H2BB	8	39.7	7.76	9.2e-14	640.3312	2	-1.4	KESYSIYVYK	KESYSIYVYK		10	V20130429-05_FTMSms2hcd	28.656	35	44	28.1	2.9e-8	4.1e-11	7	13950.3	HUMAN	Histone H2B type 1-B
[21-11]	3	P33778	H2B1B_HUMAN	HIST1H2BB	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13950.3	HUMAN	Histone H2B type 1-B
[21-11]	3	P33778	H2B1B_HUMAN	HIST1H2BB	8	39.7	7.76	9.2e-14	508.2674	3	-1.6	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-05_FTMSms2hcd	25.167	33	44	18.8	1.6e-6	2.1e-9	6	13950.3	HUMAN	Histone H2B type 1-B
[21-11]	3	P33778	H2B1B_HUMAN	HIST1H2BB	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13950.3	HUMAN	Histone H2B type 1-B
[21-11]	3	P33778	H2B1B_HUMAN	HIST1H2BB	8	39.7	7.76	9.2e-14	576.2852	2	1.0	ESYSIYVYK	ESYSIYVYK		9	V20130429-05_FTMSms2hcd	34.030	36	44	17.4	3.4e-6	4.9e-9	7	13950.3	HUMAN	Histone H2B type 1-B
[21-12]	3	Q16778	H2B2E_HUMAN	HIST2H2BE	8	39.7	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13920.3	HUMAN	Histone H2B type 2-E
[21-12]	3	Q16778	H2B2E_HUMAN	HIST2H2BE	8	39.7	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13920.3	HUMAN	Histone H2B type 2-E
[21-12]	3	Q16778	H2B2E_HUMAN	HIST2H2BE	8	39.7	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13920.3	HUMAN	Histone H2B type 2-E
[21-12]	3	Q16778	H2B2E_HUMAN	HIST2H2BE	8	39.7	7.76	9.2e-14	640.3312	2	-1.4	KESYSIYVYK	KESYSIYVYK		10	V20130429-05_FTMSms2hcd	28.656	35	44	28.1	2.9e-8	4.1e-11	7	13920.3	HUMAN	Histone H2B type 2-E
[21-12]	3	Q16778	H2B2E_HUMAN	HIST2H2BE	8	39.7	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13920.3	HUMAN	Histone H2B type 2-E
[21-12]	3	Q16778	H2B2E_HUMAN	HIST2H2BE	8	39.7	7.76	9.2e-14	508.2674	3	-1.6	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-05_FTMSms2hcd	25.167	33	44	18.8	1.6e-6	2.1e-9	6	13920.3	HUMAN	Histone H2B type 2-E
[21-12]	3	Q16778	H2B2E_HUMAN	HIST2H2BE	8	39.7	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13920.3	HUMAN	Histone H2B type 2-E
[21-12]	3	Q16778	H2B2E_HUMAN	HIST2H2BE	8	39.7	7.76	9.2e-14	576.2852	2	1.0	ESYSIYVYK	ESYSIYVYK		9	V20130429-05_FTMSms2hcd	34.030	36	44	17.4	3.4e-6	4.9e-9	7	13920.3	HUMAN	Histone H2B type 2-E
[21-13]	2	Q8N257	H2B3B_HUMAN	HIST3H2BB	7	38.1	7.76	9.2e-14	880.4170	2	7.1	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=65	15	V20130429-05_FTMSms2hcd	64.407	59	73	44.3	9.2e-14	9.9e-17	14	13908.2	HUMAN	Histone H2B type 3-B
[21-13]	2	Q8N257	H2B3B_HUMAN	HIST3H2BB	7	38.1	7.76	9.2e-14	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	45	58	47.2	3.6e-12	1.0e-14	15	13908.2	HUMAN	Histone H2B type 3-B
[21-13]	2	Q8N257	H2B3B_HUMAN	HIST3H2BB	7	38.1	7.76	9.2e-14	888.4124	2	4.7	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-05_FTMSms2hcd	54.984	59	73	46.7	5.9e-12	6.0e-15	14	13908.2	HUMAN	Histone H2B type 3-B
[21-13]	2	Q8N257	H2B3B_HUMAN	HIST3H2BB	7	38.1	7.76	9.2e-14	640.3312	2	-1.4	KESYSIYVYK	KESYSIYVYK		10	V20130429-05_FTMSms2hcd	28.656	35	44	28.1	2.9e-8	4.1e-11	7	13908.2	HUMAN	Histone H2B type 3-B
[21-13]	2	Q8N257	H2B3B_HUMAN	HIST3H2BB	7	38.1	7.76	9.2e-14	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-05_FTMSms2hcd	18.403	48	58	37.2	3.8e-7	5.4e-10	15	13908.2	HUMAN	Histone H2B type 3-B
[21-13]	2	Q8N257	H2B3B_HUMAN	HIST3H2BB	7	38.1	7.76	9.2e-14	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	101	109	34.1	2.2e-6	2.6e-8	15	13908.2	HUMAN	Histone H2B type 3-B
[21-13]	2	Q8N257	H2B3B_HUMAN	HIST3H2BB	7	38.1	7.76	9.2e-14	576.2852	2	1.0	ESYSIYVYK	ESYSIYVYK		9	V20130429-05_FTMSms2hcd	34.030	36	44	17.4	3.4e-6	4.9e-9	7	13908.2	HUMAN	Histone H2B type 3-B
[21-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	18.1	6.90	3.6e-12	754.9242	2	-1.3	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-05_FTMSms2hcd	17.286	46	59	47.2	3.6e-12	1.0e-14	15	14167.6	HUMAN	Histone H2B type 1-A
[21-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	18.1	6.90	3.6e-12	576.2895	2	2.3	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@49	11	V20130429-05_FTMSms2hcd	18.403	49	59	37.2	3.8e-7	5.4e-10	15	14167.6	HUMAN	Histone H2B type 1-A
[21-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	18.1	6.90	3.6e-12	477.3053	2	0.35	LLLPGELAK	LLLPGELAK		9	V20130429-05_FTMSms2hcd	40.928	102	110	34.1	2.2e-6	2.6e-8	15	14167.6	HUMAN	Histone H2B type 1-A
[22]		P06748	NPM_HUMAN	NPM1	8	29.9	9.33	1.2e-16	748.4157	3	9.9	MSVQPTVSLGGFEITPPVVLR	M(Oxidation)SVQPTVSLGGFEITPPVVLR	Oxidation@81	21	V20130429-05_FTMSms2hcd	64.843	81	101	42.9	1.2e-16	4.1e-19	1	32575.3	HUMAN	Nucleophosmin
[22]		P06748	NPM_HUMAN	NPM1	8	29.9	9.33	1.2e-16	918.4254	2	2.9	MTDQEAIQDLWQWR	M(Oxidation)TDQEAIQDLWQWR	Oxidation@278	14	V20130429-05_FTMSms2hcd	57.587	278	291	49.1	1.3e-12	1.4e-15	1	32575.3	HUMAN	Nucleophosmin
[22]		P06748	NPM_HUMAN	NPM1	8	29.9	9.33	1.2e-16	735.1941	5	5.8	TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIKVTLATLK	Oxidation@65	35	V20130429-05_FTMSms2hcd	62.525	46	80	33.8	2.0e-9	6.3e-12	1	32575.3	HUMAN	Nucleophosmin
[22]		P06748	NPM_HUMAN	NPM1	8	29.9	9.33	1.2e-16	565.8070	2	1.4	GPSSVEDIKAK	GPSSVEDIKAK		11	V20130429-05_FTMSms2hcd	14.691	240	250	34.5	2.7e-8	4.5e-11	1	32575.3	HUMAN	Nucleophosmin
[22]		P06748	NPM_HUMAN	NPM1	8	29.9	9.33	1.2e-16	737.1195	4	0.031	TVSLGAGAKDELHIVEAEAMNYEGSPIK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIK	Oxidation@65	28	V20130429-05_FTMSms2hcd	53.286	46	73	39.3	3.8e-8	4.3e-11	1	32575.3	HUMAN	Nucleophosmin
[22]		P06748	NPM_HUMAN	NPM1	8	29.9	9.33	1.2e-16	655.3170	3	1.7	MTDQEAIQDLWQWRK	M(Oxidation)TDQEAIQDLWQWRK	Oxidation@278	15	V20130429-05_FTMSms2hcd	49.808	278	292	41.1	9.0e-8	9.6e-11	1	32575.3	HUMAN	Nucleophosmin
[22]		P06748	NPM_HUMAN	NPM1	8	29.9	9.33	1.2e-16	466.2407	2	1.1	GPSSVEDIK	GPSSVEDIK		9	V20130429-05_FTMSms2hcd	16.766	240	248	15.2	1.2e-4	2.2e-7	1	32575.3	HUMAN	Nucleophosmin
[22]		P06748	NPM_HUMAN	NPM1	8	29.9	9.33	1.2e-16	392.2236	2	-0.036	FINYVK	FINYVK		6	V20130429-05_FTMSms2hcd	24.341	268	273	19.7	1.5e-4	6.3e-7	1	32575.3	HUMAN	Nucleophosmin
[23]		P78371	TCPB_HUMAN	CCT2	7	21.9	9.43	7.4e-17	1144.5886	2	3.6	VQDDEVGDGTTSVTVLAAELLR	VQDDEVGDGTTSVTVLAAELLR		22	V20130429-05_FTMSms2hcd	68.407	90	111	52.3	7.4e-17	9.8e-20	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[23]		P78371	TCPB_HUMAN	CCT2	7	21.9	9.43	7.4e-17	773.8492	2	-0.21	AAHSEGNTTAGLDMR	AAHSEGNTTAGLDM(Oxidation)R	Oxidation@480	15	V20130429-05_FTMSms2hcd	11.664	467	481	44.6	2.7e-16	3.6e-19	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[23]		P78371	TCPB_HUMAN	CCT2	7	21.9	9.43	7.4e-17	759.4503	2	-0.29	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-05_FTMSms2hcd	67.556	26	40	39.7	8.8e-13	6.5e-15	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[23]		P78371	TCPB_HUMAN	CCT2	7	21.9	9.43	7.4e-17	681.0283	3	11	LGGSLADSYLDEGFLLDKK	LGGSLADSYLDEGFLLDKK		19	V20130429-05_FTMSms2hcd	54.621	205	223	50.5	5.5e-12	8.8e-15	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[23]		P78371	TCPB_HUMAN	CCT2	7	21.9	9.43	7.4e-17	651.3777	2	1.4	MASLSLAPVNIFK	M(Met-loss+Acetyl)ASLSLAPVNIFK	Met-loss+Acetyl@1	13	V20130429-05_FTMSms2hcd	65.619	1	13	30.9	2.3e-8	6.8e-11	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[23]		P78371	TCPB_HUMAN	CCT2	7	21.9	9.43	7.4e-17	435.7738	2	-0.47	LAVEAVLR	LAVEAVLR		8	V20130429-05_FTMSms2hcd	36.069	182	189	30.2	0.0011	5.7e-6	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[23]		P78371	TCPB_HUMAN	CCT2	7	21.9	9.43	7.4e-17	923.1399	3	7.3	ALRMLPTIIADNAGYDSADLVAQLR	ALRMLPT(Phospho)IIADNAGYDSADLVAQLR	Phospho@448=18	25	V20130429-05_FTMSms2hcd	64.664	442	466	10.4	0.037	5.1e-5	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[24]		P60174	TPIS_HUMAN	TPI1	8	33.9	7.44	3.6e-13	801.9587	2	13	VVLAYEPVWAIGTGK	VVLAYEPVWAIGTGK		15	V20130429-05_FTMSms2hcd	55.460	198	212	43.6	3.6e-13	1.3e-15	1	30791.3	HUMAN	Triosephosphate isomerase
[24]		P60174	TPIS_HUMAN	TPI1	8	33.9	7.44	3.6e-13	733.8657	2	0.50	TATPQQAQEVHEK	TATPQQAQEVHEK		13	V20130429-05_FTMSms2hcd	10.708	213	225	37.0	9.2e-12	1.1e-14	1	30791.3	HUMAN	Triosephosphate isomerase
[24]		P60174	TPIS_HUMAN	TPI1	8	33.9	7.44	3.6e-13	425.5625	3	-0.77	VIADNVKDWSK	VIADNVKDWSK		11	V20130429-05_FTMSms2hcd	26.582	187	197	51.0	8.9e-10	1.3e-12	1	30791.3	HUMAN	Triosephosphate isomerase
[24]		P60174	TPIS_HUMAN	TPI1	8	33.9	7.44	3.6e-13	617.8052	2	0.73	SNVSDAVAQSTR	SNVSDAVAQSTR		12	V20130429-05_FTMSms2hcd	18.427	232	243	42.0	1.1e-8	1.5e-11	1	30791.3	HUMAN	Triosephosphate isomerase
[24]		P60174	TPIS_HUMAN	TPI1	8	33.9	7.44	3.6e-13	486.9124	3	0.21	HVFGESDELIGQK	HVFGESDELIGQK		13	V20130429-05_FTMSms2hcd	31.040	138	150	25.4	1.7e-8	2.2e-11	1	30791.3	HUMAN	Triosephosphate isomerase
[24]		P60174	TPIS_HUMAN	TPI1	8	33.9	7.44	3.6e-13	707.9080	2	13	QSLGELIGTLNAAK	QSLGELIGTLNAAK		14	V20130429-05_FTMSms2hcd	52.707	57	70	41.6	5.2e-8	1.7e-10	1	30791.3	HUMAN	Triosephosphate isomerase
[24]		P60174	TPIS_HUMAN	TPI1	8	33.9	7.44	3.6e-13	477.7455	2	0.53	FFVGGNWK	FFVGGNWK		8	V20130429-05_FTMSms2hcd	39.488	44	51	30.8	1.2e-7	1.7e-10	1	30791.3	HUMAN	Triosephosphate isomerase
[24]		P60174	TPIS_HUMAN	TPI1	8	33.9	7.44	3.6e-13	630.8252	2	0.081	LDEREAGITEK	LDEREAGITEK		11	V20130429-05_FTMSms2hcd	16.701	169	179	36.2	7.4e-4	1.1e-6	1	30791.3	HUMAN	Triosephosphate isomerase
[25]		P22626	ROA2_HUMAN	HNRNPA2B1	8	28.3	6.63	9.3e-12	565.9300	3	6.2	GFGFVTFDDHDPVDK	GFGFVTFDDHDPVDK		15	V20130429-05_FTMSms2hcd	46.712	154	168	31.4	9.3e-12	1.1e-14	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[25]		P22626	ROA2_HUMAN	HNRNPA2B1	8	28.3	6.63	9.3e-12	470.9007	3	0.18	YHTINGHNAEVR	YHTINGHNAEVR		12	V20130429-05_FTMSms2hcd	12.240	174	185	35.2	1.9e-10	2.3e-13	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[25]		P22626	ROA2_HUMAN	HNRNPA2B1	8	28.3	6.63	9.3e-12	956.4693	3	1.6	LFIGGLSFETTEESLRNYYEQWGK	LFIGGLSFETTEESLRNYYEQWGK		24	V20130429-05_FTMSms2hcd	69.644	23	46	35.2	5.5e-9	6.0e-12	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[25]		P22626	ROA2_HUMAN	HNRNPA2B1	8	28.3	6.63	9.3e-12	689.3179	2	-0.66	GGGGNFGPGPGSNFR	GGGGNFGPGPGSNFR		15	V20130429-05_FTMSms2hcd	26.762	214	228	39.5	8.4e-9	1.2e-11	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[25]		P22626	ROA2_HUMAN	HNRNPA2B1	8	28.3	6.63	9.3e-12	507.2249	2	-1.00	GGNFGFGDSR	GGNFGFGDSR		10	V20130429-05_FTMSms2hcd	25.244	204	213	25.1	2.9e-8	6.7e-11	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[25]		P22626	ROA2_HUMAN	HNRNPA2B1	8	28.3	6.63	9.3e-12	610.7646	2	0.60	QEMQEVQSSR	Q(Gln->pyro-Glu)EM(Oxidation)QEVQSSR	Gln->pyro-Glu@191;Oxidation@193	10	V20130429-05_FTMSms2hcd	10.790	191	200	27.8	7.5e-8	1.3e-10	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[25]		P22626	ROA2_HUMAN	HNRNPA2B1	8	28.3	6.63	9.3e-12	529.2979	2	-0.26	TLETVPLER	TLETVPLER		9	V20130429-05_FTMSms2hcd	29.935	4	12	33.9	4.7e-7	1.0e-9	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[25]		P22626	ROA2_HUMAN	HNRNPA2B1	8	28.3	6.63	9.3e-12	759.7249	3	2.3	GFGFVTFDDHDPVDKIVLQK	GFGFVTFDDHDPVDKIVLQK		20	V20130429-05_FTMSms2hcd	55.293	154	173	27.1	1.3e-6	1.7e-9	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	23.3	6.93	3.1e-12	615.0311	3	0.049	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-05_FTMSms2hcd	71.120	87	103	39.0	3.1e-12	3.5e-14	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	23.3	6.93	3.1e-12	506.9832	3	-1.0	LLIHQSLAGGIIGVK	LLIHQSLAGGIIGVK		15	V20130429-05_FTMSms2hcd	45.246	149	163	44.5	5.6e-12	1.7e-13	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	23.3	6.93	3.1e-12	518.6478	3	1.8	IILDLISESPIKGR	IILDLISESPIKGR		14	V20130429-05_FTMSms2hcd	51.367	208	221	45.3	6.5e-10	5.5e-12	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	23.3	6.93	3.1e-12	959.0228	2	2.9	GSYGDLGGPIITTQVTIPK	GSYGDLGGPIITTQVTIPK		19	V20130429-05_FTMSms2hcd	50.744	378	396	33.0	7.7e-10	1.9e-12	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	23.3	6.93	3.1e-12	863.8085	3	8.8	IITITGTQDQIQNAQYLLQNSVK	IITITGTQDQIQNAQYLLQNSVK		23	V20130429-05_FTMSms2hcd	59.356	434	456	31.2	1.8e-8	6.7e-11	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	23.3	6.93	3.1e-12	670.9059	2	0.73	IILDLISESPIK	IILDLISESPIK		12	V20130429-05_FTMSms2hcd	58.420	208	219	44.3	5.5e-7	2.9e-9	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	23.3	6.93	3.1e-12	707.6788	3	0.54	ALRTDYNASVSVPDSSGPER	ALRTDYNASVSVPDSSGPER		20	V20130429-05_FTMSms2hcd	29.903	67	86	17.6	9.9e-5	1.0e-7	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[27]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	8.73	1.5e-15	955.8033	3	0.65	TLGLYGKDQQEAALVDMVNDGVEDLR	TLGLYGKDQQEAALVDM(Oxidation)VNDGVEDLR	Oxidation@92	26	V20130429-05_FTMSms2hcd	53.137	76	101	54.2	1.5e-15	1.5e-18	1	23356.0	HUMAN	Glutathione S-transferase P
[27]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	8.73	1.5e-15	669.3674	2	1.7	MPPYTVVYFPVR	M(Met-loss)PPYTVVYFPVR	Met-loss@1	12	V20130429-05_FTMSms2hcd	48.949	1	12	51.0	4.4e-13	9.3e-16	1	23356.0	HUMAN	Glutathione S-transferase P
[27]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	8.73	1.5e-15	942.4799	2	1.5	FQDGDLTLYQSNTILR	FQDGDLTLYQSNTILR		16	V20130429-05_FTMSms2hcd	49.080	56	71	46.6	4.5e-12	5.9e-15	1	23356.0	HUMAN	Glutathione S-transferase P
[27]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	8.73	1.5e-15	709.3894	3	-3.2	ALPGQLKPFETLLSQNQGGK	ALPGQLKPFETLLSQNQGGK		20	V20130429-05_FTMSms2hcd	53.340	122	141	48.6	2.1e-11	6.1e-14	1	23356.0	HUMAN	Glutathione S-transferase P
[27]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	8.73	1.5e-15	1016.5308	2	2.2	AFLASPEYVNLPINGNGKQ	AFLASPEYVNLPINGNGKQ		19	V20130429-05_FTMSms2hcd	51.158	192	210	44.7	4.0e-11	5.9e-14	1	23356.0	HUMAN	Glutathione S-transferase P
[28]		P12814	ACTN1_HUMAN	ACTN1	6	8.9	8.08	2.4e-14	675.3213	3	-4.4	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-05_FTMSms2hcd	53.365	237	254	38.6	2.4e-14	2.4e-17	2	103058.4	HUMAN	Alpha-actinin-1
[28]		P12814	ACTN1_HUMAN	ACTN1	6	8.9	8.08	2.4e-14	431.9219	3	-1.1	LAILGIHNEVSK	LAILGIHNEVSK		12	V20130429-05_FTMSms2hcd	36.219	566	577	43.1	6.9e-11	3.2e-13	1	103058.4	HUMAN	Alpha-actinin-1
[28]		P12814	ACTN1_HUMAN	ACTN1	6	8.9	8.08	2.4e-14	693.8915	2	1.3	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-05_FTMSms2hcd	65.499	715	726	48.0	1.8e-10	3.7e-13	2	103058.4	HUMAN	Alpha-actinin-1
[28]		P12814	ACTN1_HUMAN	ACTN1	6	8.9	8.08	2.4e-14	623.3503	3	11	LLETIDQLYLEYAKR	LLETIDQLYLEYAKR		15	V20130429-05_FTMSms2hcd	57.987	503	517	39.6	3.0e-10	1.0e-12	1	103058.4	HUMAN	Alpha-actinin-1
[28]		P12814	ACTN1_HUMAN	ACTN1	6	8.9	8.08	2.4e-14	558.2870	2	-2.2	ATLPDADKER	ATLPDADKER		10	V20130429-05_FTMSms2hcd	13.452	556	565	34.5	3.2e-9	6.0e-12	1	103058.4	HUMAN	Alpha-actinin-1
[28]		P12814	ACTN1_HUMAN	ACTN1	6	8.9	8.08	2.4e-14	715.3859	2	-0.0070	TINEVENQILTR	TINEVENQILTR		12	V20130429-05_FTMSms2hcd	38.476	727	738	22.2	2.5e-5	4.3e-8	2	103058.4	HUMAN	Alpha-actinin-1
[28-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	4.6	8.08	2.4e-14	675.3213	3	-4.4	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-05_FTMSms2hcd	53.365	256	273	38.6	2.4e-14	2.4e-17	2	104854.9	HUMAN	Alpha-actinin-4
[28-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	4.6	8.08	2.4e-14	693.8915	2	1.3	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-05_FTMSms2hcd	65.499	734	745	48.0	1.8e-10	3.7e-13	2	104854.9	HUMAN	Alpha-actinin-4
[28-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	4.6	8.08	2.4e-14	715.3859	2	-0.0070	TINEVENQILTR	TINEVENQILTR		12	V20130429-05_FTMSms2hcd	38.476	746	757	22.2	2.5e-5	4.3e-8	2	104854.9	HUMAN	Alpha-actinin-4
[29]		P04083	ANXA1_HUMAN	ANXA1	6	25.1	6.68	9.0e-12	772.4404	2	2.9	GVDEATIIDILTKR	GVDEATIIDILTKR		14	V20130429-05_FTMSms2hcd	58.459	59	72	52.9	9.0e-12	2.8e-14	1	38714.6	HUMAN	Annexin A1
[29]		P04083	ANXA1_HUMAN	ANXA1	6	25.1	6.68	9.0e-12	786.0573	3	0.23	GGPGSAVSPYPTFNPSSDVAALHK	GGPGSAVSPYPTFNPSSDVAALHK		24	V20130429-05_FTMSms2hcd	44.031	30	53	35.4	2.0e-11	2.0e-14	1	38714.6	HUMAN	Annexin A1
[29]		P04083	ANXA1_HUMAN	ANXA1	6	25.1	6.68	9.0e-12	775.9230	2	14	GTDVNVFNTILTTR	GTDVNVFNTILTTR		14	V20130429-05_FTMSms2hcd	55.375	215	228	45.4	4.8e-11	9.8e-14	1	38714.6	HUMAN	Annexin A1
[29]		P04083	ANXA1_HUMAN	ANXA1	6	25.1	6.68	9.0e-12	535.9902	3	-0.85	ALTGHLEEVVLALLK	ALTGHLEEVVLALLK		15	V20130429-05_FTMSms2hcd	72.080	99	113	38.4	1.2e-9	1.7e-11	1	38714.6	HUMAN	Annexin A1
[29]		P04083	ANXA1_HUMAN	ANXA1	6	25.1	6.68	9.0e-12	631.8030	2	-1.9	TPAQFDADELR	TPAQFDADELR		11	V20130429-05_FTMSms2hcd	31.195	114	124	37.0	3.3e-9	4.7e-12	1	38714.6	HUMAN	Annexin A1
[29]		P04083	ANXA1_HUMAN	ANXA1	6	25.1	6.68	9.0e-12	491.7490	2	-0.68	MAMVSEFLK	M(Met-loss+Acetyl)AM(Oxidation)VSEFLK	Met-loss+Acetyl@1;Oxidation@3	9	V20130429-05_FTMSms2hcd	46.738	1	9	26.2	2.6e-6	3.6e-9	1	38714.6	HUMAN	Annexin A1
[30]		P07910	HNRPC_HUMAN	HNRNPC	7	22.5	7.16	1.2e-12	482.3008	3	-0.53	VFIGNLNTLVVKK	VFIGNLNTLVVKK		13	V20130429-05_FTMSms2hcd	44.676	18	30	42.1	1.2e-12	2.0e-14	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	7	22.5	7.16	1.2e-12	658.9011	2	0.97	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-05_FTMSms2hcd	51.455	18	29	36.7	8.8e-10	8.5e-12	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	7	22.5	7.16	1.2e-12	665.3323	2	-0.97	GFAFVQYVNER	GFAFVQYVNER		11	V20130429-05_FTMSms2hcd	46.224	51	61	40.6	1.5e-8	2.1e-11	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	7	22.5	7.16	1.2e-12	410.2465	3	-0.83	LKGDDLQAIKK	LKGDDLQAIKK		11	V20130429-05_FTMSms2hcd	17.806	188	198	39.0	5.7e-8	1.9e-10	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	7	22.5	7.16	1.2e-12	562.3042	2	1.6	KSDVEAIFSK	KSDVEAIFSK		10	V20130429-05_FTMSms2hcd	29.576	30	39	29.8	6.9e-8	1.1e-10	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	7	22.5	7.16	1.2e-12	849.9637	2	6.3	MIAGQVLDINLAAEPK	M(Oxidation)IAGQVLDINLAAEPK	Oxidation@74	16	V20130429-05_FTMSms2hcd	48.649	74	89	16.5	3.8e-6	9.0e-9	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	7	22.5	7.16	1.2e-12	472.2899	2	0.17	VPPPPPIAR	VPPPPPIAR		9	V20130429-05_FTMSms2hcd	23.730	143	151	22.2	6.9e-5	1.9e-7	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30-1]	0	O60812	HNRCL_HUMAN	HNRNPCL1	3	7.5	7.16	1.2e-12	482.3008	3	-0.53	VFIGNLNTLVVKK	VFIGNLNTLVVKK		13	V20130429-05_FTMSms2hcd	44.676	18	30	42.1	1.2e-12	2.0e-14	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[30-1]	0	O60812	HNRCL_HUMAN	HNRNPCL1	3	7.5	7.16	1.2e-12	658.9011	2	0.97	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-05_FTMSms2hcd	51.455	18	29	36.7	8.8e-10	8.5e-12	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[30-1]	0	O60812	HNRCL_HUMAN	HNRNPCL1	3	7.5	7.16	1.2e-12	562.3042	2	1.6	KSDVEAIFSK	KSDVEAIFSK		10	V20130429-05_FTMSms2hcd	29.576	30	39	29.8	6.9e-8	1.1e-10	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[31]		P21333	FLNA_HUMAN	FLNA	6	3.4	8.86	8.4e-16	965.1914	3	2.7	VGSAADIPINISETDLSLLTATVVPPSGR	VGSAADIPINISETDLSLLTATVVPPSGR		29	V20130429-05_FTMSms2hcd	74.291	1965	1993	44.6	8.4e-16	3.1e-18	1	280741.3	HUMAN	Filamin-A
[31]		P21333	FLNA_HUMAN	FLNA	6	3.4	8.86	8.4e-16	715.3631	2	0.47	AFGPGLQGGSAGSPAR	AFGPGLQGGSAGSPAR		16	V20130429-05_FTMSms2hcd	26.224	1072	1087	47.6	2.6e-12	3.7e-15	1	280741.3	HUMAN	Filamin-A
[31]		P21333	FLNA_HUMAN	FLNA	6	3.4	8.86	8.4e-16	543.3160	2	0.55	LYSVSYLLK	LYSVSYLLK		9	V20130429-05_FTMSms2hcd	47.172	2613	2621	31.5	1.8e-8	4.4e-11	1	280741.3	HUMAN	Filamin-A
[31]		P21333	FLNA_HUMAN	FLNA	6	3.4	8.86	8.4e-16	717.8643	2	-0.70	ANLPQSFQVDTSK	ANLPQSFQVDTSK		13	V20130429-05_FTMSms2hcd	33.060	1465	1477	44.9	2.2e-8	3.1e-11	1	280741.3	HUMAN	Filamin-A
[31]		P21333	FLNA_HUMAN	FLNA	6	3.4	8.86	8.4e-16	823.9445	2	4.2	TGVAVNKPAEFTVDAK	TGVAVNKPAEFTVDAK		16	V20130429-05_FTMSms2hcd	30.377	685	700	35.4	2.3e-7	4.0e-10	1	280741.3	HUMAN	Filamin-A
[31]		P21333	FLNA_HUMAN	FLNA	6	3.4	8.86	8.4e-16	486.2877	2	0.87	LLGWIQNK	LLGWIQNK		8	V20130429-05_FTMSms2hcd	39.500	172	179	28.1	8.2e-4	2.1e-6	3	280741.3	HUMAN	Filamin-A
[31-1]	2	Q14315	FLNC_HUMAN	FLNC	3	1.6	4.52	1.8e-9	1162.5798	2	14	VEESTQVGGDPFPAVFGDFLGR	VEESTQVGGDPFPAVFGDFLGR		22	V20130429-05_FTMSms2hcd	70.844	2207	2228	30.8	1.8e-9	2.2e-12	1	291024.6	HUMAN	Filamin-C
[31-1]	2	Q14315	FLNC_HUMAN	FLNC	3	1.6	4.52	1.8e-9	627.8256	2	0.19	LEPGGGAEAQAVR	LEPGGGAEAQAVR		13	V20130429-05_FTMSms2hcd	18.807	1015	1027	28.9	5.8e-7	8.9e-10	1	291024.6	HUMAN	Filamin-C
[31-1]	2	Q14315	FLNC_HUMAN	FLNC	3	1.6	4.52	1.8e-9	486.2877	2	0.87	LLGWIQNK	LLGWIQNK		8	V20130429-05_FTMSms2hcd	39.500	165	172	28.1	8.2e-4	2.1e-6	3	291024.6	HUMAN	Filamin-C
[31-2]	0	O75369	FLNB_HUMAN	FLNB	1	0.3	1.20	8.2e-4	486.2877	2	0.87	LLGWIQNK	LLGWIQNK		8	V20130429-05_FTMSms2hcd	39.500	145	152	28.1	8.2e-4	2.1e-6	3	278166.3	HUMAN	Filamin-B
[32]		P00558	PGK1_HUMAN	PGK1	6	19.2	9.00	4.7e-16	545.6024	3	0.31	LGDVYVNDAFGTAHR	LGDVYVNDAFGTAHR		15	V20130429-05_FTMSms2hcd	36.800	157	171	40.0	4.7e-16	5.4e-19	2	44615.1	HUMAN	Phosphoglycerate kinase 1
[32]		P00558	PGK1_HUMAN	PGK1	6	19.2	9.00	4.7e-16	675.0179	3	0.44	ITLPVDFVTADKFDENAK	ITLPVDFVTADKFDENAK		18	V20130429-05_FTMSms2hcd	54.147	280	297	52.5	1.1e-15	1.4e-18	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[32]		P00558	PGK1_HUMAN	PGK1	6	19.2	9.00	4.7e-16	590.3375	3	1.3	ALESPERPFLAILGGAK	ALESPERPFLAILGGAK		17	V20130429-05_FTMSms2hcd	55.758	200	216	38.3	2.5e-7	1.0e-9	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[32]		P00558	PGK1_HUMAN	PGK1	6	19.2	9.00	4.7e-16	522.8169	2	-3.3	LTLDKLDVK	LTLDKLDVK		9	V20130429-05_FTMSms2hcd	32.271	7	15	32.4	3.1e-5	1.2e-7	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[32]		P00558	PGK1_HUMAN	PGK1	6	19.2	9.00	4.7e-16	566.3113	2	-0.32	AEPAKIEAFR	AEPAKIEAFR		10	V20130429-05_FTMSms2hcd	23.264	142	151	30.8	7.4e-5	1.1e-7	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[32]		P00558	PGK1_HUMAN	PGK1	6	19.2	9.00	4.7e-16	549.3210	2	13	VLPGVDALSNI	VLPGVDALSNI		11	V20130429-05_FTMSms2hcd	55.447	407	417	15.2	9.7e-5	4.2e-7	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[32-1]	0	P07205	PGK2_HUMAN	PGK2	1	3.6	9.00	4.7e-16	545.6024	3	0.31	LGDVYVNDAFGTAHR	LGDVYVNDAFGTAHR		15	V20130429-05_FTMSms2hcd	36.800	157	171	40.0	4.7e-16	5.4e-19	2	44796.5	HUMAN	Phosphoglycerate kinase 2
[33]		P10412	H14_HUMAN	HIST1H1E	6	26.9	6.66	1.0e-11	973.5158	2	0.71	MSETAPAAPAAPAPAEKTPVK	M(Met-loss+Acetyl)SETAPAAPAAPAPAEKTPVK	Met-loss+Acetyl@1	21	V20130429-05_FTMSms2hcd	26.626	1	21	38.6	1.0e-11	1.7e-14	1	21865.4	HUMAN	Histone H1.4
[33]		P10412	H14_HUMAN	HIST1H1E	6	26.9	6.66	1.0e-11	789.8973	2	0.17	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-05_FTMSms2hcd	20.947	65	79	70.6	1.9e-11	2.5e-14	5	21865.4	HUMAN	Histone H1.4
[33]		P10412	H14_HUMAN	HIST1H1E	6	26.9	6.66	1.0e-11	663.8853	2	0.44	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-05_FTMSms2hcd	29.722	34	46	45.9	2.5e-10	8.5e-13	3	21865.4	HUMAN	Histone H1.4
[33]		P10412	H14_HUMAN	HIST1H1E	6	26.9	6.66	1.0e-11	494.9591	3	-0.75	RKASGPPVSELITK	RKASGPPVSELITK		14	V20130429-05_FTMSms2hcd	25.797	33	46	31.9	7.0e-8	3.6e-10	2	21865.4	HUMAN	Histone H1.4
[33]		P10412	H14_HUMAN	HIST1H1E	6	26.9	6.66	1.0e-11	554.2866	2	-1.9	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-05_FTMSms2hcd	24.420	65	75	36.5	1.5e-7	2.4e-10	5	21865.4	HUMAN	Histone H1.4
[33]		P10412	H14_HUMAN	HIST1H1E	6	26.9	6.66	1.0e-11	423.2588	2	1.5	SGVSLAALK	SGVSLAALK		9	V20130429-05_FTMSms2hcd	31.918	55	63	26.6	5.8e-5	1.3e-7	3	21865.4	HUMAN	Histone H1.4
[33-1]	1	P16403	H12_HUMAN	HIST1H1C	5	27.2	6.51	1.9e-11	789.8973	2	0.17	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-05_FTMSms2hcd	20.947	65	79	70.6	1.9e-11	2.5e-14	5	21364.9	HUMAN	Histone H1.2
[33-1]	1	P16403	H12_HUMAN	HIST1H1C	5	27.2	6.51	1.9e-11	663.8853	2	0.44	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-05_FTMSms2hcd	29.722	34	46	45.9	2.5e-10	8.5e-13	3	21364.9	HUMAN	Histone H1.2
[33-1]	1	P16403	H12_HUMAN	HIST1H1C	5	27.2	6.51	1.9e-11	958.5110	2	1.2	MSETAPAAPAAAPPAEKAPVK	M(Met-loss+Acetyl)SETAPAAPAAAPPAEKAPVK	Met-loss+Acetyl@1	21	V20130429-05_FTMSms2hcd	26.153	1	21	30.2	6.2e-10	1.1e-12	1	21364.9	HUMAN	Histone H1.2
[33-1]	1	P16403	H12_HUMAN	HIST1H1C	5	27.2	6.51	1.9e-11	554.2866	2	-1.9	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-05_FTMSms2hcd	24.420	65	75	36.5	1.5e-7	2.4e-10	5	21364.9	HUMAN	Histone H1.2
[33-1]	1	P16403	H12_HUMAN	HIST1H1C	5	27.2	6.51	1.9e-11	423.2588	2	1.5	SGVSLAALK	SGVSLAALK		9	V20130429-05_FTMSms2hcd	31.918	55	63	26.6	5.8e-5	1.3e-7	3	21364.9	HUMAN	Histone H1.2
[33-2]	0	P16402	H13_HUMAN	HIST1H1D	5	17.2	6.51	1.9e-11	789.8973	2	0.17	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-05_FTMSms2hcd	20.947	66	80	70.6	1.9e-11	2.5e-14	5	22350.1	HUMAN	Histone H1.3
[33-2]	0	P16402	H13_HUMAN	HIST1H1D	5	17.2	6.51	1.9e-11	663.8853	2	0.44	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-05_FTMSms2hcd	29.722	35	47	45.9	2.5e-10	8.5e-13	3	22350.1	HUMAN	Histone H1.3
[33-2]	0	P16402	H13_HUMAN	HIST1H1D	5	17.2	6.51	1.9e-11	494.9591	3	-0.75	RKASGPPVSELITK	RKASGPPVSELITK		14	V20130429-05_FTMSms2hcd	25.797	34	47	31.9	7.0e-8	3.6e-10	2	22350.1	HUMAN	Histone H1.3
[33-2]	0	P16402	H13_HUMAN	HIST1H1D	5	17.2	6.51	1.9e-11	554.2866	2	-1.9	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-05_FTMSms2hcd	24.420	66	76	36.5	1.5e-7	2.4e-10	5	22350.1	HUMAN	Histone H1.3
[33-2]	0	P16402	H13_HUMAN	HIST1H1D	5	17.2	6.51	1.9e-11	423.2588	2	1.5	SGVSLAALK	SGVSLAALK		9	V20130429-05_FTMSms2hcd	31.918	56	64	26.6	5.8e-5	1.3e-7	3	22350.1	HUMAN	Histone H1.3
[33-3]	1	Q02539	H11_HUMAN	HIST1H1A	3	11.6	6.51	1.9e-11	789.8973	2	0.17	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-05_FTMSms2hcd	20.947	68	82	70.6	1.9e-11	2.5e-14	5	21842.3	HUMAN	Histone H1.1
[33-3]	1	Q02539	H11_HUMAN	HIST1H1A	3	11.6	6.51	1.9e-11	554.2866	2	-1.9	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-05_FTMSms2hcd	24.420	68	78	36.5	1.5e-7	2.4e-10	5	21842.3	HUMAN	Histone H1.1
[33-3]	1	Q02539	H11_HUMAN	HIST1H1A	3	11.6	6.51	1.9e-11	472.3008	2	0.88	GGVSLAALKK	GGVSLAALKK		10	V20130429-05_FTMSms2hcd	25.299	58	67	33.4	1.5e-6	9.2e-9	1	21842.3	HUMAN	Histone H1.1
[33-4]	0	P22492	H1T_HUMAN	HIST1H1T	2	7.2	6.51	1.9e-11	789.8973	2	0.17	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-05_FTMSms2hcd	20.947	69	83	70.6	1.9e-11	2.5e-14	5	22019.2	HUMAN	Histone H1t
[33-4]	0	P22492	H1T_HUMAN	HIST1H1T	2	7.2	6.51	1.9e-11	554.2866	2	-1.9	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-05_FTMSms2hcd	24.420	69	79	36.5	1.5e-7	2.4e-10	5	22019.2	HUMAN	Histone H1t
[34]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.48	3.1e-13	548.6124	3	-0.52	AQLGGPEAAKSDETAAK	AQLGGPEAAKSDETAAK		17	V20130429-05_FTMSms2hcd	15.120	189	205	54.2	3.1e-13	3.7e-16	1	22782.7	HUMAN	Heat shock protein beta-1
[34]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.48	3.1e-13	953.4995	2	0.048	LATQSNEITIPVTFESR	LATQSNEITIPVTFESR		17	V20130429-05_FTMSms2hcd	48.308	172	188	44.6	1.9e-12	2.8e-15	1	22782.7	HUMAN	Heat shock protein beta-1
[34]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.48	3.1e-13	595.3120	3	-0.59	VSLDVNHFAPDELTVK	VSLDVNHFAPDELTVK		16	V20130429-05_FTMSms2hcd	46.532	97	112	38.5	6.6e-10	9.5e-13	1	22782.7	HUMAN	Heat shock protein beta-1
[34]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.48	3.1e-13	569.7606	2	-0.063	QLSSGVSEIR	Q(Gln->pyro-Glu)LS(Phospho)SGVSEIR	Gln->pyro-Glu@80;Phospho@82=7	10	V20130429-05_FTMSms2hcd	40.073	80	89	39.2	4.7e-8	6.7e-11	1	22782.7	HUMAN	Heat shock protein beta-1
[34]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.48	3.1e-13	494.3083	2	-0.49	RVPFSLLR	RVPFSLLR		8	V20130429-05_FTMSms2hcd	38.560	5	12	31.9	1.9e-5	1.2e-7	1	22782.7	HUMAN	Heat shock protein beta-1
[34]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.48	3.1e-13	538.2916	2	1.6	QLSSGVSEIR	QLSSGVSEIR		10	V20130429-05_FTMSms2hcd	22.762	80	89	20.6	2.8e-4	4.5e-7	1	22782.7	HUMAN	Heat shock protein beta-1
[35]		P22392	NDKB_HUMAN	NME2	6	44.1	8.26	1.1e-14	901.4597	2	0.47	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-05_FTMSms2hcd	25.848	89	105	60.7	1.1e-14	1.3e-17	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[35]		P22392	NDKB_HUMAN	NME2	6	44.1	8.26	1.1e-14	771.0688	3	2.7	SAEKEISLWFKPEELVDYK	SAEKEISLWFKPEELVDYK		19	V20130429-05_FTMSms2hcd	56.773	125	143	43.0	1.3e-12	2.1e-15	1	17298.2	HUMAN	Nucleoside diphosphate kinase B
[35]		P22392	NDKB_HUMAN	NME2	6	44.1	8.26	1.1e-14	448.9258	3	-0.42	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-05_FTMSms2hcd	31.603	7	18	43.6	2.7e-11	6.6e-14	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[35]		P22392	NDKB_HUMAN	NME2	6	44.1	8.26	1.1e-14	588.3315	2	-1.2	DRPFFPGLVK	DRPFFPGLVK		10	V20130429-05_FTMSms2hcd	42.192	57	66	30.2	4.7e-6	1.0e-8	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[35]		P22392	NDKB_HUMAN	NME2	6	44.1	8.26	1.1e-14	492.8137	2	0.083	GLVGEIIKR	GLVGEIIKR		9	V20130429-05_FTMSms2hcd	31.707	19	27	39.1	6.2e-5	3.8e-7	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[35]		P22392	NDKB_HUMAN	NME2	6	44.1	8.26	1.1e-14	414.7631	2	-0.0084	GLVGEIIK	GLVGEIIK		8	V20130429-05_FTMSms2hcd	37.538	19	26	28.2	0.0020	5.2e-6	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[35-1]	0	P15531	NDKA_HUMAN	NME1	4	25.0	8.26	1.1e-14	901.4597	2	0.47	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-05_FTMSms2hcd	25.848	89	105	60.7	1.1e-14	1.3e-17	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[35-1]	0	P15531	NDKA_HUMAN	NME1	4	25.0	8.26	1.1e-14	448.9258	3	-0.42	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-05_FTMSms2hcd	31.603	7	18	43.6	2.7e-11	6.6e-14	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[35-1]	0	P15531	NDKA_HUMAN	NME1	4	25.0	8.26	1.1e-14	492.8137	2	0.083	GLVGEIIKR	GLVGEIIKR		9	V20130429-05_FTMSms2hcd	31.707	19	27	39.1	6.2e-5	3.8e-7	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[35-1]	0	P15531	NDKA_HUMAN	NME1	4	25.0	8.26	1.1e-14	414.7631	2	-0.0084	GLVGEIIK	GLVGEIIK		8	V20130429-05_FTMSms2hcd	37.538	19	26	28.2	0.0020	5.2e-6	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[35-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	8.26	1.1e-14	901.4597	2	0.47	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@75	17	V20130429-05_FTMSms2hcd	25.848	74	90	60.7	1.1e-14	1.3e-17	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[35-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	8.26	1.1e-14	634.3321	2	0.034	FKPEELVDYK	FKPEELVDYK		10	V20130429-05_FTMSms2hcd	35.330	119	128	36.2	5.2e-8	7.4e-11	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[35-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	8.26	1.1e-14	588.3315	2	-1.2	DRPFFPGLVK	DRPFFPGLVK		10	V20130429-05_FTMSms2hcd	42.192	42	51	30.2	4.7e-6	1.0e-8	2	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[36]		Q00839	HNRPU_HUMAN	HNRNPU	6	14.2	6.77	6.2e-12	857.9593	2	-0.55	SSGPTSLFAVTVAPPGAR	SSGPTSLFAVTVAPPGAR		18	V20130429-05_FTMSms2hcd	50.456	187	204	41.3	6.2e-12	1.0e-14	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[36]		Q00839	HNRPU_HUMAN	HNRNPU	6	14.2	6.77	6.2e-12	824.4269	2	0.98	NFILDQTNVSAAAQR	NFILDQTNVSAAAQR		15	V20130429-05_FTMSms2hcd	39.513	576	590	49.6	7.9e-10	1.1e-12	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[36]		Q00839	HNRPU_HUMAN	HNRNPU	6	14.2	6.77	6.2e-12	908.7896	3	-0.48	EKPYFPIPEEYTFIQNVPLEDR	EKPYFPIPEEYTFIQNVPLEDR		22	V20130429-05_FTMSms2hcd	61.535	463	484	41.4	2.0e-9	2.2e-12	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[36]		Q00839	HNRPU_HUMAN	HNRNPU	6	14.2	6.77	6.2e-12	1048.1449	3	-4.5	LQAALDDEEAGGRPAMEPGNGSLDLGGDSAGR	LQAALDDEEAGGRPAM(Oxidation)EPGNGSLDLGGDSAGR	Oxidation@53	32	V20130429-05_FTMSms2hcd	36.525	38	69	29.6	2.0e-9	2.0e-12	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[36]		Q00839	HNRPU_HUMAN	HNRNPU	6	14.2	6.77	6.2e-12	535.6188	3	-0.39	QMADTGKLNTLLQR	QM(Oxidation)ADTGKLNTLLQR	Oxidation@546	14	V20130429-05_FTMSms2hcd	32.148	545	558	25.8	1.5e-7	2.3e-10	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[36]		Q00839	HNRPU_HUMAN	HNRNPU	6	14.2	6.77	6.2e-12	441.4983	4	0.90	KAEVEGKDLPEHAVLK	KAEVEGKDLPEHAVLK		16	V20130429-05_FTMSms2hcd	22.841	620	635	15.8	3.8e-4	1.0e-6	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.71	1.2e-13	958.0387	2	2.8	TFVNITPAEVGVLVGKDR	TFVNITPAEVGVLVGKDR		18	V20130429-05_FTMSms2hcd	54.292	39	56	54.0	1.2e-13	5.0e-16	1	15054.4	HUMAN	Profilin-1
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.71	1.2e-13	822.4762	2	5.1	TFVNITPAEVGVLVGK	TFVNITPAEVGVLVGK		16	V20130429-05_FTMSms2hcd	58.472	39	54	45.2	1.4e-11	6.2e-14	1	15054.4	HUMAN	Profilin-1
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.71	1.2e-13	735.8815	2	-2.0	SSFYVNGLTLGGQK	SSFYVNGLTLGGQK		14	V20130429-05_FTMSms2hcd	43.626	57	70	42.2	9.6e-10	1.4e-12	1	15054.4	HUMAN	Profilin-1
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.71	1.2e-13	445.7726	2	-0.031	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-05_FTMSms2hcd	34.381	109	116	23.4	4.8e-9	2.4e-11	1	15054.4	HUMAN	Profilin-1
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.71	1.2e-13	690.3629	2	1.5	STGGAPTFNVTVTK	STGGAPTFNVTVTK		14	V20130429-05_FTMSms2hcd	32.515	92	105	31.8	1.7e-7	2.3e-10	1	15054.4	HUMAN	Profilin-1
[38]		P50990	TCPQ_HUMAN	CCT8	6	11.9	6.88	4.0e-12	489.7579	2	0.83	APGFAQMLK	APGFAQM(Oxidation)LK	Oxidation@14	9	V20130429-05_FTMSms2hcd	25.758	8	16	37.4	4.0e-12	6.1e-15	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[38]		P50990	TCPQ_HUMAN	CCT8	6	11.9	6.88	4.0e-12	689.8384	2	-0.077	ETEGDVTSVKDAK	ETEGDVTSVKDAK		13	V20130429-05_FTMSms2hcd	13.338	226	238	42.2	3.7e-9	5.2e-12	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[38]		P50990	TCPQ_HUMAN	CCT8	6	11.9	6.88	4.0e-12	677.8832	2	1.1	LVPGGGATEIELAK	LVPGGGATEIELAK		14	V20130429-05_FTMSms2hcd	35.630	408	421	41.6	4.1e-9	1.1e-11	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[38]		P50990	TCPQ_HUMAN	CCT8	6	11.9	6.88	4.0e-12	667.3768	2	-0.83	LFVTNDAATILR	LFVTNDAATILR		12	V20130429-05_FTMSms2hcd	47.606	63	74	49.3	3.0e-8	7.5e-11	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[38]		P50990	TCPQ_HUMAN	CCT8	6	11.9	6.88	4.0e-12	575.7979	2	-0.53	FAEAFEAIPR	FAEAFEAIPR		10	V20130429-05_FTMSms2hcd	41.029	441	450	34.4	5.9e-8	9.8e-11	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[38]		P50990	TCPQ_HUMAN	CCT8	6	11.9	6.88	4.0e-12	353.7156	2	-1.0	MALHVPK	M(Met-loss+Acetyl)ALHVPK	Met-loss+Acetyl@1	7	V20130429-05_FTMSms2hcd	23.277	1	7	18.4	0.0040	1.8e-5	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[39]		P18669	PGAM1_HUMAN	PGAM1	4	24.4	7.62	1.7e-13	811.7060	3	-1.4	SYDVPPPPMEPDHPFYSNISK	SYDVPPPPM(Oxidation)EPDHPFYSNISK	Oxidation@126	21	V20130429-05_FTMSms2hcd	39.007	118	138	35.4	1.7e-13	1.6e-16	2	28804.2	HUMAN	Phosphoglycerate mutase 1
[39]		P18669	PGAM1_HUMAN	PGAM1	4	24.4	7.62	1.7e-13	842.4601	2	1.5	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-05_FTMSms2hcd	61.858	163	176	40.1	3.9e-13	7.6e-16	3	28804.2	HUMAN	Phosphoglycerate mutase 1
[39]		P18669	PGAM1_HUMAN	PGAM1	4	24.4	7.62	1.7e-13	544.2902	3	0.80	HYGGLTGLNKAETAAK	HYGGLTGLNKAETAAK		16	V20130429-05_FTMSms2hcd	22.631	91	106	34.8	3.2e-10	4.7e-13	3	28804.2	HUMAN	Phosphoglycerate mutase 1
[39]		P18669	PGAM1_HUMAN	PGAM1	4	24.4	7.62	1.7e-13	384.2274	3	-1.3	VLIAAHGNSLR	VLIAAHGNSLR		11	V20130429-05_FTMSms2hcd	22.126	181	191	39.0	1.2e-9	4.1e-12	2	28804.2	HUMAN	Phosphoglycerate mutase 1
[39-1]	0	Q8N0Y7	PGAM4_HUMAN	PGAM4	3	20.1	7.62	1.7e-13	811.7060	3	-1.4	SYDVPPPPMEPDHPFYSNISK	SYDVPPPPM(Oxidation)EPDHPFYSNISK	Oxidation@126	21	V20130429-05_FTMSms2hcd	39.007	118	138	35.4	1.7e-13	1.6e-16	2	28777.1	HUMAN	Probable phosphoglycerate mutase 4
[39-1]	0	Q8N0Y7	PGAM4_HUMAN	PGAM4	3	20.1	7.62	1.7e-13	842.4601	2	1.5	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-05_FTMSms2hcd	61.858	163	176	40.1	3.9e-13	7.6e-16	3	28777.1	HUMAN	Probable phosphoglycerate mutase 4
[39-1]	0	Q8N0Y7	PGAM4_HUMAN	PGAM4	3	20.1	7.62	1.7e-13	544.2902	3	0.80	HYGGLTGLNKAETAAK	HYGGLTGLNKAETAAK		16	V20130429-05_FTMSms2hcd	22.631	91	106	34.8	3.2e-10	4.7e-13	3	28777.1	HUMAN	Probable phosphoglycerate mutase 4
[39-2]	0	P15259	PGAM2_HUMAN	PGAM2	3	16.2	7.42	3.9e-13	842.4601	2	1.5	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-05_FTMSms2hcd	61.858	163	176	40.1	3.9e-13	7.6e-16	3	28766.4	HUMAN	Phosphoglycerate mutase 2
[39-2]	0	P15259	PGAM2_HUMAN	PGAM2	3	16.2	7.42	3.9e-13	544.2902	3	0.80	HYGGLTGLNKAETAAK	HYGGLTGLNKAETAAK		16	V20130429-05_FTMSms2hcd	22.631	91	106	34.8	3.2e-10	4.7e-13	3	28766.4	HUMAN	Phosphoglycerate mutase 2
[39-2]	0	P15259	PGAM2_HUMAN	PGAM2	3	16.2	7.42	3.9e-13	384.2274	3	-1.3	VLIAAHGNSLR	VLIAAHGNSLR		11	V20130429-05_FTMSms2hcd	22.126	181	191	39.0	1.2e-9	4.1e-12	2	28766.4	HUMAN	Phosphoglycerate mutase 2
[40]		P31947	1433S_HUMAN	SFN	5	30.6	9.24	1.7e-16	844.9085	4	5.9	TTFDEAMADLHTLSEDSYKDSTLIMQLLR	TTFDEAM(Oxidation)ADLHTLSEDSYKDSTLIM(Oxidation)QLLR	Oxidation@202;Oxidation@220	29	V20130429-05_FTMSms2hcd	71.877	196	224	44.8	1.7e-16	1.8e-19	1	27774.3	HUMAN	14-3-3 protein sigma
[40]		P31947	1433S_HUMAN	SFN	5	30.6	9.24	1.7e-16	773.8565	2	5.0	SNEEGSEEKGPEVR	SNEEGSEEKGPEVR		14	V20130429-05_FTMSms2hcd	10.121	69	82	33.5	2.0e-10	2.5e-13	1	27774.3	HUMAN	14-3-3 protein sigma
[40]		P31947	1433S_HUMAN	SFN	5	30.6	9.24	1.7e-16	733.3871	2	1.6	YLAEVATGDDKKR	YLAEVATGDDKKR		13	V20130429-05_FTMSms2hcd	16.181	130	142	49.6	3.6e-8	4.9e-11	1	27774.3	HUMAN	14-3-3 protein sigma
[40]		P31947	1433S_HUMAN	SFN	5	30.6	9.24	1.7e-16	462.8901	3	-0.87	SAYQEAMDISKK	SAYQEAM(Oxidation)DISKK	Oxidation@155	12	V20130429-05_FTMSms2hcd	19.931	149	160	21.6	8.5e-7	1.1e-9	1	27774.3	HUMAN	14-3-3 protein sigma
[40]		P31947	1433S_HUMAN	SFN	5	30.6	9.24	1.7e-16	454.2659	2	-0.24	NLLSVAYK	NLLSVAYK		8	V20130429-05_FTMSms2hcd	35.247	42	49	23.9	5.6e-4	1.9e-6	7	27774.3	HUMAN	14-3-3 protein sigma
[40-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	18.8	6.65	1.0e-11	774.8604	2	-0.062	SVTEQGAELSNEER	SVTEQGAELSNEER		14	V20130429-05_FTMSms2hcd	20.527	28	41	53.6	1.0e-11	1.3e-14	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[40-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	18.8	6.65	1.0e-11	816.9443	2	0.63	VVSSIEQKTEGAEKK	VVSSIEQKTEGAEKK		15	V20130429-05_FTMSms2hcd	14.665	61	75	35.3	3.0e-8	5.6e-11	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[40-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	18.8	6.65	1.0e-11	581.7930	2	1.3	MDKNELVQK	Acetyl-M(Oxidation)DKNELVQK	Oxidation@1=8	9	V20130429-05_FTMSms2hcd	14.336	1	9	35.1	6.1e-8	8.8e-11	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[40-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	18.8	6.65	1.0e-11	454.2659	2	-0.24	NLLSVAYK	NLLSVAYK		8	V20130429-05_FTMSms2hcd	35.247	42	49	23.9	5.6e-4	1.9e-6	7	27745.3	HUMAN	14-3-3 protein zeta/delta
[40-2]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.30	4.6e-11	766.8637	2	0.93	AVTEQGAELSNEER	AVTEQGAELSNEER		14	V20130429-05_FTMSms2hcd	19.682	28	41	52.0	4.6e-11	5.8e-14	1	27764.5	HUMAN	14-3-3 protein theta
[40-2]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.30	4.6e-11	589.3091	2	-2.0	MEKTELIQK	Acetyl-M(Oxidation)EKTELIQK		9	V20130429-05_FTMSms2hcd	20.045	1	9	28.1	2.7e-5	3.9e-8	1	27764.5	HUMAN	14-3-3 protein theta
[40-2]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.30	4.6e-11	454.2659	2	-0.24	NLLSVAYK	NLLSVAYK		8	V20130429-05_FTMSms2hcd	35.247	42	49	23.9	5.6e-4	1.9e-6	7	27764.5	HUMAN	14-3-3 protein theta
[40-3]	1	P31946	1433B_HUMAN	YWHAB	2	8.9	7.86	5.9e-14	799.8740	2	0.14	AVTEQGHELSNEER	AVTEQGHELSNEER		14	V20130429-05_FTMSms2hcd	14.402	30	43	63.5	5.9e-14	6.7e-17	1	28082.6	HUMAN	14-3-3 protein beta/alpha
[40-3]	1	P31946	1433B_HUMAN	YWHAB	2	8.9	7.86	5.9e-14	454.2659	2	-0.24	NLLSVAYK	NLLSVAYK		8	V20130429-05_FTMSms2hcd	35.247	44	51	23.9	5.6e-4	1.9e-6	7	28082.6	HUMAN	14-3-3 protein beta/alpha
[40-4]	1	P62258	1433E_HUMAN	YWHAE	2	7.8	2.33	1.1e-6	770.8490	2	-2.6	MDDREDLVYQAK	Acetyl-M(Oxidation)DDREDLVYQAK	Oxidation@1=11	12	V20130429-05_FTMSms2hcd	26.788	1	12	21.8	1.1e-6	1.4e-9	1	29174.2	HUMAN	14-3-3 protein epsilon
[40-4]	1	P62258	1433E_HUMAN	YWHAE	2	7.8	2.33	1.1e-6	454.2659	2	-0.24	NLLSVAYK	NLLSVAYK		8	V20130429-05_FTMSms2hcd	35.247	43	50	23.9	5.6e-4	1.9e-6	7	29174.2	HUMAN	14-3-3 protein epsilon
[40-5]	1	P61981	1433G_HUMAN	YWHAG	2	7.3	0.87	5.6e-4	454.2659	2	-0.24	NLLSVAYK	NLLSVAYK		8	V20130429-05_FTMSms2hcd	35.247	43	50	23.9	5.6e-4	1.9e-6	7	28302.8	HUMAN	14-3-3 protein gamma
[40-5]	1	P61981	1433G_HUMAN	YWHAG	2	7.3	0.87	5.6e-4	578.8187	2	-1.7	MVDREQLVQK	M(Met-loss+Acetyl)VDREQLVQK	Met-loss+Acetyl@1	10	V20130429-05_FTMSms2hcd	23.033	1	10	16.8	0.0051	1.2e-5	1	28302.8	HUMAN	14-3-3 protein gamma
[40-6]	0	Q04917	1433F_HUMAN	YWHAH	1	3.3	0.87	5.6e-4	454.2659	2	-0.24	NLLSVAYK	NLLSVAYK		8	V20130429-05_FTMSms2hcd	35.247	43	50	23.9	5.6e-4	1.9e-6	7	28219.0	HUMAN	14-3-3 protein eta
[41]		Q06830	PRDX1_HUMAN	PRDX1	6	30.7	5.18	5.6e-9	554.3064	2	0.97	TIAQDYGVLK	TIAQDYGVLK		10	V20130429-05_FTMSms2hcd	32.334	111	120	30.5	5.6e-9	1.2e-11	1	22110.5	HUMAN	Peroxiredoxin-1
[41]		Q06830	PRDX1_HUMAN	PRDX1	6	30.7	5.18	5.6e-9	606.3408	2	0.051	QITVNDLPVGR	QITVNDLPVGR		11	V20130429-05_FTMSms2hcd	36.369	141	151	44.8	1.1e-8	3.1e-11	2	22110.5	HUMAN	Peroxiredoxin-1
[41]		Q06830	PRDX1_HUMAN	PRDX1	6	30.7	5.18	5.6e-9	680.4044	2	1.5	GLFIIDDKGILR	GLFIIDDKGILR		12	V20130429-05_FTMSms2hcd	52.212	129	140	37.6	2.8e-8	1.4e-10	2	22110.5	HUMAN	Peroxiredoxin-1
[41]		Q06830	PRDX1_HUMAN	PRDX1	6	30.7	5.18	5.6e-9	598.8185	2	-1.1	LVQAFQFTDK	LVQAFQFTDK		10	V20130429-05_FTMSms2hcd	38.872	159	168	38.5	5.7e-7	9.6e-10	1	22110.5	HUMAN	Peroxiredoxin-1
[41]		Q06830	PRDX1_HUMAN	PRDX1	6	30.7	5.18	5.6e-9	481.5171	4	-0.77	KQGGLGPMNIPLVSDPKR	KQGGLGPM(Oxidation)NIPLVSDPKR	Oxidation@100	18	V20130429-05_FTMSms2hcd	34.174	93	110	27.2	6.2e-7	1.7e-9	1	22110.5	HUMAN	Peroxiredoxin-1
[41]		Q06830	PRDX1_HUMAN	PRDX1	6	30.7	5.18	5.6e-9	460.7563	2	-3.7	GLFIIDDK	GLFIIDDK		8	V20130429-05_FTMSms2hcd	43.531	129	136	29.7	3.5e-4	7.1e-7	2	22110.5	HUMAN	Peroxiredoxin-1
[41-1]	0	Q13162	PRDX4_HUMAN	PRDX4	2	4.4	4.56	2.8e-8	680.4044	2	1.5	GLFIIDDKGILR	GLFIIDDKGILR		12	V20130429-05_FTMSms2hcd	52.212	201	212	37.6	2.8e-8	1.4e-10	2	30540.2	HUMAN	Peroxiredoxin-4
[41-1]	0	Q13162	PRDX4_HUMAN	PRDX4	2	4.4	4.56	2.8e-8	460.7563	2	-3.7	GLFIIDDK	GLFIIDDK		8	V20130429-05_FTMSms2hcd	43.531	201	208	29.7	3.5e-4	7.1e-7	2	30540.2	HUMAN	Peroxiredoxin-4
[41-2]	0	P32119	PRDX2_HUMAN	PRDX2	1	5.6	5.02	1.1e-8	606.3408	2	0.051	QITVNDLPVGR	QITVNDLPVGR		11	V20130429-05_FTMSms2hcd	36.369	140	150	44.8	1.1e-8	3.1e-11	2	21892.1	HUMAN	Peroxiredoxin-2
[42]		P06753	TPM3_HUMAN	TPM3	4	17.3	8.49	4.1e-15	551.2868	4	0.24	LATALQKLEEAEKAADESER	LATALQKLEEAEKAADESER		20	V20130429-05_FTMSms2hcd	42.204	106	125	51.8	4.1e-15	5.1e-18	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[42]		P06753	TPM3_HUMAN	TPM3	4	17.3	8.49	4.1e-15	908.4536	2	0.84	HIAEEADRKYEEVAR	HIAEEADRKYEEVAR		15	V20130429-05_FTMSms2hcd	19.826	153	167	42.7	9.0e-12	1.0e-14	2	32819.1	HUMAN	Tropomyosin alpha-3 chain
[42]		P06753	TPM3_HUMAN	TPM3	4	17.3	8.49	4.1e-15	492.8983	3	-0.62	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-05_FTMSms2hcd	13.301	113	125	49.1	3.1e-9	3.6e-12	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[42]		P06753	TPM3_HUMAN	TPM3	4	17.3	8.49	4.1e-15	576.6359	3	0.52	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-05_FTMSms2hcd	37.490	92	105	38.9	8.1e-8	1.2e-10	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[42-1]	0	P67936	TPM4_HUMAN	TPM4	4	19.8	8.49	4.1e-15	551.2868	4	0.24	LATALQKLEEAEKAADESER	LATALQKLEEAEKAADESER		20	V20130429-05_FTMSms2hcd	42.204	70	89	51.8	4.1e-15	5.1e-18	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[42-1]	0	P67936	TPM4_HUMAN	TPM4	4	19.8	8.49	4.1e-15	908.4536	2	0.84	HIAEEADRKYEEVAR	HIAEEADRKYEEVAR		15	V20130429-05_FTMSms2hcd	19.826	117	131	42.7	9.0e-12	1.0e-14	2	28522.0	HUMAN	Tropomyosin alpha-4 chain
[42-1]	0	P67936	TPM4_HUMAN	TPM4	4	19.8	8.49	4.1e-15	492.8983	3	-0.62	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-05_FTMSms2hcd	13.301	77	89	49.1	3.1e-9	3.6e-12	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[42-1]	0	P67936	TPM4_HUMAN	TPM4	4	19.8	8.49	4.1e-15	576.6359	3	0.52	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-05_FTMSms2hcd	37.490	56	69	38.9	8.1e-8	1.2e-10	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[42-2]	2	P09493	TPM1_HUMAN	TPM1	5	22.2	8.49	4.1e-15	551.2868	4	0.24	LATALQKLEEAEKAADESER	LATALQKLEEAEKAADESER		20	V20130429-05_FTMSms2hcd	42.204	106	125	51.8	4.1e-15	5.1e-18	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[42-2]	2	P09493	TPM1_HUMAN	TPM1	5	22.2	8.49	4.1e-15	492.8983	3	-0.62	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-05_FTMSms2hcd	13.301	113	125	49.1	3.1e-9	3.6e-12	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[42-2]	2	P09493	TPM1_HUMAN	TPM1	5	22.2	8.49	4.1e-15	576.6359	3	0.52	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-05_FTMSms2hcd	37.490	92	105	38.9	8.1e-8	1.2e-10	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[42-2]	2	P09493	TPM1_HUMAN	TPM1	5	22.2	8.49	4.1e-15	496.9200	3	3.6	ATDAEADVASLNRR	ATDAEADVASLNRR		14	V20130429-05_FTMSms2hcd	24.070	78	91	28.7	2.0e-7	2.6e-10	2	32708.8	HUMAN	Tropomyosin alpha-1 chain
[42-2]	2	P09493	TPM1_HUMAN	TPM1	5	22.2	8.49	4.1e-15	451.2229	4	-7.2	HIAEDADRKYEEVAR	HIAEDADRKYEEVAR		15	V20130429-05_FTMSms2hcd	19.563	153	167	11.2	0.030	3.4e-5	1	32708.8	HUMAN	Tropomyosin alpha-1 chain
[42-3]	1	P07951	TPM2_HUMAN	TPM2	4	16.9	8.49	4.1e-15	551.2868	4	0.24	LATALQKLEEAEKAADESER	LATALQKLEEAEKAADESER		20	V20130429-05_FTMSms2hcd	42.204	106	125	51.8	4.1e-15	5.1e-18	4	32851.0	HUMAN	Tropomyosin beta chain
[42-3]	1	P07951	TPM2_HUMAN	TPM2	4	16.9	8.49	4.1e-15	492.8983	3	-0.62	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-05_FTMSms2hcd	13.301	113	125	49.1	3.1e-9	3.6e-12	4	32851.0	HUMAN	Tropomyosin beta chain
[42-3]	1	P07951	TPM2_HUMAN	TPM2	4	16.9	8.49	4.1e-15	576.6359	3	0.52	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-05_FTMSms2hcd	37.490	92	105	38.9	8.1e-8	1.2e-10	4	32851.0	HUMAN	Tropomyosin beta chain
[42-3]	1	P07951	TPM2_HUMAN	TPM2	4	16.9	8.49	4.1e-15	496.9200	3	3.6	ATDAEADVASLNRR	ATDAEADVASLNRR		14	V20130429-05_FTMSms2hcd	24.070	78	91	28.7	2.0e-7	2.6e-10	2	32851.0	HUMAN	Tropomyosin beta chain
[43]		Q02878	RL6_HUMAN	RPL6	5	21.9	6.81	5.2e-12	482.9278	3	-3.5	SVFALTNGIYPHK	SVFALTNGIYPHK		13	V20130429-05_FTMSms2hcd	43.555	273	285	40.2	5.2e-12	8.3e-15	1	32728.2	HUMAN	60S ribosomal protein L6
[43]		Q02878	RL6_HUMAN	RPL6	5	21.9	6.81	5.2e-12	590.6664	3	-1.2	VLATVTKPVGGDKNGGTR	VLATVTKPVGGDKNGGTR		18	V20130429-05_FTMSms2hcd	17.334	88	105	46.0	1.3e-10	4.4e-13	1	32728.2	HUMAN	60S ribosomal protein L6
[43]		Q02878	RL6_HUMAN	RPL6	5	21.9	6.81	5.2e-12	570.2712	2	-1.4	YYPTEDVPR	YYPTEDVPR		9	V20130429-05_FTMSms2hcd	25.555	115	123	32.2	5.4e-8	7.2e-11	1	32728.2	HUMAN	60S ribosomal protein L6
[43]		Q02878	RL6_HUMAN	RPL6	5	21.9	6.81	5.2e-12	579.8345	2	-1.1	AIPQLQGYLR	AIPQLQGYLR		10	V20130429-05_FTMSms2hcd	42.879	263	272	42.6	3.6e-7	7.7e-10	1	32728.2	HUMAN	60S ribosomal protein L6
[43]		Q02878	RL6_HUMAN	RPL6	5	21.9	6.81	5.2e-12	823.9026	2	3.1	NPVLVRGIGRYSR	NPVLVRGIGRY(Phospho)S(Phospho)R	Phospho@57;Phospho@58	13	V20130429-05_FTMSms2hcd	41.107	47	59	10.9	0.0079	9.2e-6	1	32728.2	HUMAN	60S ribosomal protein L6
[44]		P00338	LDHA_HUMAN	LDHA	5	16.6	6.02	1.5e-10	787.9622	2	1.2	MATLKDQLIYNLLK	M(Met-loss+Acetyl)ATLKDQLIYNLLK	Met-loss+Acetyl@1	14	V20130429-05_FTMSms2hcd	63.756	1	14	41.1	1.5e-10	1.1e-12	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[44]		P00338	LDHA_HUMAN	LDHA	5	16.6	6.02	1.5e-10	748.3910	2	-0.25	IVSGKDYNVTANSK	IVSGKDYNVTANSK		14	V20130429-05_FTMSms2hcd	16.942	77	90	46.8	7.3e-9	1.1e-11	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[44]		P00338	LDHA_HUMAN	LDHA	5	16.6	6.02	1.5e-10	567.7857	2	0.37	VTLTSEEEAR	VTLTSEEEAR		10	V20130429-05_FTMSms2hcd	18.768	306	315	43.8	1.4e-8	2.1e-11	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[44]		P00338	LDHA_HUMAN	LDHA	5	16.6	6.02	1.5e-10	465.2938	2	-1.7	FIIPNVVK	FIIPNVVK		8	V20130429-05_FTMSms2hcd	44.755	119	126	30.0	9.3e-7	3.7e-9	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[44]		P00338	LDHA_HUMAN	LDHA	5	16.6	6.02	1.5e-10	457.2953	2	0.43	LVIITAGAR	LVIITAGAR		9	V20130429-05_FTMSms2hcd	30.859	91	99	33.9	1.4e-5	7.6e-8	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[45]		P06732	KCRM_HUMAN	CKM	4	17.1	8.24	1.2e-14	919.9576	4	-7.2	SMTEKEQQQLIDDHFLFDKPVSPLLLASGMAR	SM(Oxidation)TEKEQQQLIDDHFLFDKPVSPLLLASGM(Oxidation)AR	Oxidation@179;Oxidation@207	32	V20130429-05_FTMSms2hcd	60.856	178	209	42.1	1.2e-14	1.4e-17	1	43101.5	HUMAN	Creatine kinase M-type
[45]		P06732	KCRM_HUMAN	CKM	4	17.1	8.24	1.2e-14	659.8193	2	0.44	GQSIDDMIPAQK	GQSIDDM(Oxidation)IPAQK	Oxidation@376	12	V20130429-05_FTMSms2hcd	22.979	370	381	40.0	1.2e-11	1.7e-14	1	43101.5	HUMAN	Creatine kinase M-type
[45]		P06732	KCRM_HUMAN	CKM	4	17.1	8.24	1.2e-14	754.4048	2	1.4	LSVEALNSLTGEFK	LSVEALNSLTGEFK		14	V20130429-05_FTMSms2hcd	55.099	157	170	52.1	2.5e-9	3.7e-12	1	43101.5	HUMAN	Creatine kinase M-type
[45]		P06732	KCRM_HUMAN	CKM	4	17.1	8.24	1.2e-14	454.2477	2	-0.26	FEEILTR	FEEILTR		7	V20130429-05_FTMSms2hcd	29.732	308	314	27.3	1.8e-4	3.4e-7	1	43101.5	HUMAN	Creatine kinase M-type
[46]		P15311	EZRI_HUMAN	EZR	5	9.7	5.97	1.9e-10	746.3839	3	1.6	AKFYPEDVAEELIQDITQK	AKFYPEDVAEELIQDITQK		19	V20130429-05_FTMSms2hcd	73.968	82	100	41.9	1.9e-10	2.4e-13	1	69413.4	HUMAN	Ezrin
[46]		P15311	EZRI_HUMAN	EZR	5	9.7	5.97	1.9e-10	708.8406	2	1.8	AQEEAERLEADR	AQEEAERLEADR		12	V20130429-05_FTMSms2hcd	16.262	382	393	36.6	2.6e-8	3.5e-11	1	69413.4	HUMAN	Ezrin
[46]		P15311	EZRI_HUMAN	EZR	5	9.7	5.97	1.9e-10	591.7999	2	-1.4	APDFVFYAPR	APDFVFYAPR		10	V20130429-05_FTMSms2hcd	45.885	264	273	33.6	4.5e-8	6.5e-11	3	69413.4	HUMAN	Ezrin
[46]		P15311	EZRI_HUMAN	EZR	5	9.7	5.97	1.9e-10	552.7957	2	0.42	IGFPWSEIR	IGFPWSEIR		9	V20130429-05_FTMSms2hcd	53.011	238	246	38.2	1.1e-6	1.6e-9	3	69413.4	HUMAN	Ezrin
[46]		P15311	EZRI_HUMAN	EZR	5	9.7	5.97	1.9e-10	447.7762	2	0.42	LFFLQVK	LFFLQVK		7	V20130429-05_FTMSms2hcd	50.970	101	107	21.6	3.1e-5	2.4e-7	3	69413.4	HUMAN	Ezrin
[46-1]	1	P26038	MOES_HUMAN	MSN	4	6.4	4.51	4.5e-8	591.7999	2	-1.4	APDFVFYAPR	APDFVFYAPR		10	V20130429-05_FTMSms2hcd	45.885	264	273	33.6	4.5e-8	6.5e-11	3	67820.6	HUMAN	Moesin
[46-1]	1	P26038	MOES_HUMAN	MSN	4	6.4	4.51	4.5e-8	552.7957	2	0.42	IGFPWSEIR	IGFPWSEIR		9	V20130429-05_FTMSms2hcd	53.011	238	246	38.2	1.1e-6	1.6e-9	3	67820.6	HUMAN	Moesin
[46-1]	1	P26038	MOES_HUMAN	MSN	4	6.4	4.51	4.5e-8	694.3524	2	3.7	AQQELEEQTRR	AQQELEEQTRR		11	V20130429-05_FTMSms2hcd	10.778	361	371	23.0	1.3e-5	1.7e-8	1	67820.6	HUMAN	Moesin
[46-1]	1	P26038	MOES_HUMAN	MSN	4	6.4	4.51	4.5e-8	447.7762	2	0.42	LFFLQVK	LFFLQVK		7	V20130429-05_FTMSms2hcd	50.970	101	107	21.6	3.1e-5	2.4e-7	3	67820.6	HUMAN	Moesin
[46-2]	0	P35241	RADI_HUMAN	RDX	3	4.5	4.51	4.5e-8	591.7999	2	-1.4	APDFVFYAPR	APDFVFYAPR		10	V20130429-05_FTMSms2hcd	45.885	264	273	33.6	4.5e-8	6.5e-11	3	68564.5	HUMAN	Radixin
[46-2]	0	P35241	RADI_HUMAN	RDX	3	4.5	4.51	4.5e-8	552.7957	2	0.42	IGFPWSEIR	IGFPWSEIR		9	V20130429-05_FTMSms2hcd	53.011	238	246	38.2	1.1e-6	1.6e-9	3	68564.5	HUMAN	Radixin
[46-2]	0	P35241	RADI_HUMAN	RDX	3	4.5	4.51	4.5e-8	447.7762	2	0.42	LFFLQVK	LFFLQVK		7	V20130429-05_FTMSms2hcd	50.970	101	107	21.6	3.1e-5	2.4e-7	3	68564.5	HUMAN	Radixin
[47]		Q14974	IMB1_HUMAN	KPNB1	4	5.8	7.51	2.6e-13	803.4466	2	0.79	LAATNALLNSLEFTK	LAATNALLNSLEFTK		15	V20130429-05_FTMSms2hcd	57.686	192	206	52.6	2.6e-13	6.5e-16	1	97171.1	HUMAN	Importin subunit beta-1
[47]		Q14974	IMB1_HUMAN	KPNB1	4	5.8	7.51	2.6e-13	829.9606	2	1.6	AAVENLPTFLVELSR	AAVENLPTFLVELSR		15	V20130429-05_FTMSms2hcd	66.554	28	42	43.5	4.8e-10	1.2e-12	1	97171.1	HUMAN	Importin subunit beta-1
[47]		Q14974	IMB1_HUMAN	KPNB1	4	5.8	7.51	2.6e-13	613.3346	2	-2.3	VLANPGNSQVAR	VLANPGNSQVAR		12	V20130429-05_FTMSms2hcd	17.728	43	54	46.7	1.8e-9	4.1e-12	1	97171.1	HUMAN	Importin subunit beta-1
[47]		Q14974	IMB1_HUMAN	KPNB1	4	5.8	7.51	2.6e-13	574.3221	2	7.9	MELITILEK	Acetyl-M(Oxidation)ELITILEK		9	V20130429-05_FTMSms2hcd	65.123	1	9	29.9	2.3e-6	4.8e-9	1	97171.1	HUMAN	Importin subunit beta-1
[48]		P38646	GRP75_HUMAN	HSPA9	5	11.0	8.40	6.0e-15	1028.4901	2	5.4	STNGDTFLGGEDFDQALLR	STNGDTFLGGEDFDQALLR		19	V20130429-05_FTMSms2hcd	56.145	266	284	47.1	6.0e-15	6.0e-18	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[48]		P38646	GRP75_HUMAN	HSPA9	5	11.0	8.40	6.0e-15	506.6197	3	0.72	AQFEGIVTDLIRR	AQFEGIVTDLIRR		13	V20130429-05_FTMSms2hcd	51.979	349	361	38.6	3.4e-7	8.2e-10	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[48]		P38646	GRP75_HUMAN	HSPA9	5	11.0	8.40	6.0e-15	621.8436	2	-0.12	DAGQISGLNVLR	DAGQISGLNVLR		12	V20130429-05_FTMSms2hcd	41.303	207	218	35.3	5.2e-7	1.0e-9	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[48]		P38646	GRP75_HUMAN	HSPA9	5	11.0	8.40	6.0e-15	479.7509	2	-0.74	VLENAEGAR	VLENAEGAR		9	V20130429-05_FTMSms2hcd	11.045	77	85	26.6	1.0e-6	2.0e-9	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[48]		P38646	GRP75_HUMAN	HSPA9	5	11.0	8.40	6.0e-15	814.4083	3	18	KDSETGENIRQAASSLQQASLK	KDSETGENIRQAAS(Phospho)SLQQASLK	Phospho@629|638|639	22	V20130429-05_FTMSms2hcd	46.338	625	646	13.7	0.048	5.4e-5	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[49]		Q96AG4	LRC59_HUMAN	LRRC59	4	17.3	7.25	8.0e-13	708.4201	4	1.2	LVNLQHLDLLNNKLVTLPVSFAQLK	LVNLQHLDLLNNKLVTLPVSFAQLK		25	V20130429-05_FTMSms2hcd	69.483	84	108	46.6	8.0e-13	2.3e-14	1	34930.8	HUMAN	Leucine-rich repeat-containing protein 59
[49]		Q96AG4	LRC59_HUMAN	LRRC59	4	17.3	7.25	8.0e-13	658.4050	2	3.3	LVTLPVSFAQLK	LVTLPVSFAQLK		12	V20130429-05_FTMSms2hcd	56.835	97	108	38.0	4.0e-9	4.2e-11	1	34930.8	HUMAN	Leucine-rich repeat-containing protein 59
[49]		Q96AG4	LRC59_HUMAN	LRRC59	4	17.3	7.25	8.0e-13	759.6658	4	8.8	DKLDGNELDLSLSDLNEVPVKELAALPK	DKLDGNELDLSLSDLNEVPVKELAALPK		28	V20130429-05_FTMSms2hcd	66.045	13	40	24.1	7.1e-9	2.6e-11	1	34930.8	HUMAN	Leucine-rich repeat-containing protein 59
[49]		Q96AG4	LRC59_HUMAN	LRRC59	4	17.3	7.25	8.0e-13	511.9623	3	-1.6	LVNLQHLDLLNNK	LVNLQHLDLLNNK		13	V20130429-05_FTMSms2hcd	46.999	84	96	31.5	4.0e-7	1.5e-9	1	34930.8	HUMAN	Leucine-rich repeat-containing protein 59
[50]		P05387	RLA2_HUMAN	RPLP2	4	47.8	7.86	6.0e-14	935.0033	2	13	YVASYLLAALGGNSSPSAK	YVASYLLAALGGNSSPSAK		19	V20130429-05_FTMSms2hcd	58.129	3	21	50.8	6.0e-14	1.3e-16	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[50]		P05387	RLA2_HUMAN	RPLP2	4	47.8	7.86	6.0e-14	871.7974	3	1.8	ILDSVGIEADDDRLNKVISELNGK	ILDSVGIEADDDRLNKVISELNGK		24	V20130429-05_FTMSms2hcd	56.786	26	49	49.1	4.8e-11	1.1e-13	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[50]		P05387	RLA2_HUMAN	RPLP2	4	47.8	7.86	6.0e-14	628.8449	2	-1.6	NIEDVIAQGIGK	NIEDVIAQGIGK		12	V20130429-05_FTMSms2hcd	47.340	50	61	40.0	2.3e-7	4.3e-10	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[50]		P05387	RLA2_HUMAN	RPLP2	4	47.8	7.86	6.0e-14	591.6393	3	0.49	ILDSVGIEADDDRLNK	ILDSVGIEADDDRLNK		16	V20130429-05_FTMSms2hcd	34.915	26	41	22.8	2.1e-5	2.8e-8	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[51]		P02765	FETUA_HUMAN	AHSG	3	3.5	7.19	1.1e-12	704.8044	2	0.44	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-05_FTMSms2hcd	9.955	132	144	45.8	1.1e-12	1.8e-15	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[51]		P02765	FETUA_HUMAN	AHSG	3	3.5	7.19	1.1e-12	640.7566	2	-0.0094	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-05_FTMSms2hcd	13.185	132	143	34.3	2.3e-12	5.5e-15	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[51]		P02765	FETUA_HUMAN	AHSG	3	3.5	7.19	1.1e-12	744.7883	2	1.4	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@138=13	13	V20130429-05_FTMSms2hcd	10.898	132	144	42.9	5.5e-11	1.5e-13	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[52]		Q16658	FSCN1_HUMAN	FSCN1	3	10.1	7.80	7.7e-14	607.3286	3	0.62	LVARPEPATGYTLEFR	LVARPEPATGYTLEFR		16	V20130429-05_FTMSms2hcd	39.526	202	217	48.8	7.7e-14	1.4e-16	1	54530.4	HUMAN	Fascin
[52]		Q16658	FSCN1_HUMAN	FSCN1	3	10.1	7.80	7.7e-14	873.4467	3	0.49	VGKDELFALEQSCAQVVLQAANER	VGKDELFALEQSCAQVVLQAANER		24	V20130429-05_FTMSms2hcd	73.325	248	271	53.1	7.2e-13	9.6e-16	1	54530.4	HUMAN	Fascin
[52]		Q16658	FSCN1_HUMAN	FSCN1	3	10.1	7.80	7.7e-14	414.2679	3	0.25	LINRPIIVFR	LINRPIIVFR		10	V20130429-05_FTMSms2hcd	40.857	380	389	38.1	4.4e-8	7.4e-10	1	54530.4	HUMAN	Fascin
[53]		P04075	ALDOA_HUMAN	ALDOA	4	14.6	6.50	1.9e-11	872.1146	3	-1.0	VDKGVVPLAGTNGETTTQGLDGLSER	VDKGVVPLAGTNGETTTQGLDGLSER		26	V20130429-05_FTMSms2hcd	40.980	109	134	39.8	1.9e-11	2.8e-14	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[53]		P04075	ALDOA_HUMAN	ALDOA	4	14.6	6.50	1.9e-11	601.6422	3	0.93	RLQSIGTENTEENRR	RLQSIGTENTEENRR		15	V20130429-05_FTMSms2hcd	14.310	43	57	33.8	2.8e-9	3.5e-12	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[53]		P04075	ALDOA_HUMAN	ALDOA	4	14.6	6.50	1.9e-11	549.6081	3	0.30	LQSIGTENTEENRR	LQSIGTENTEENRR		14	V20130429-05_FTMSms2hcd	16.018	44	57	48.9	2.2e-8	2.6e-11	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[53]		P04075	ALDOA_HUMAN	ALDOA	4	14.6	6.50	1.9e-11	671.8599	2	0.85	ADDGRPFPQVIK	ADDGRPFPQVIK		12	V20130429-05_FTMSms2hcd	31.117	88	99	28.5	8.3e-5	1.4e-7	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[54]		P19338	NUCL_HUMAN	NCL	3	5.6	8.04	2.8e-14	834.4319	3	6.2	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-05_FTMSms2hcd	70.887	487	508	52.7	2.8e-14	4.1e-17	1	76615.0	HUMAN	Nucleolin
[54]		P19338	NUCL_HUMAN	NCL	3	5.6	8.04	2.8e-14	640.3517	3	9.0	TGISDVFAKNDLAVVDVR	TGISDVFAKNDLAVVDVR		18	V20130429-05_FTMSms2hcd	52.119	325	342	45.5	1.8e-13	4.1e-16	1	76615.0	HUMAN	Nucleolin
[54]		P19338	NUCL_HUMAN	NCL	3	5.6	8.04	2.8e-14	469.2526	2	-1.1	TGISDVFAK	TGISDVFAK		9	V20130429-05_FTMSms2hcd	35.132	325	333	25.1	2.7e-6	5.4e-9	1	76615.0	HUMAN	Nucleolin
[55]		P62081	RS7_HUMAN	RPS7	5	25.8	4.55	8.1e-10	841.8105	3	14	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-05_FTMSms2hcd	64.976	121	143	28.6	8.1e-10	5.2e-12	1	22127.0	HUMAN	40S ribosomal protein S7
[55]		P62081	RS7_HUMAN	RPS7	5	25.8	4.55	8.1e-10	789.7653	3	0.31	TLTAVHDAILEDLVFPSEIVGK	TLTAVHDAILEDLVFPSEIVGK		22	V20130429-05_FTMSms2hcd	68.567	121	142	29.2	3.2e-9	8.3e-12	1	22127.0	HUMAN	40S ribosomal protein S7
[55]		P62081	RS7_HUMAN	RPS7	5	25.8	4.55	8.1e-10	669.4377	2	9.4	AIIIFVPVPQLK	AIIIFVPVPQLK		12	V20130429-05_FTMSms2hcd	64.368	59	70	27.0	8.8e-9	3.7e-10	1	22127.0	HUMAN	40S ribosomal protein S7
[55]		P62081	RS7_HUMAN	RPS7	5	25.8	4.55	8.1e-10	692.8254	2	1.1	DVNFEFPEFQL	DVNFEFPEFQL		11	V20130429-05_FTMSms2hcd	72.360	184	194	18.9	3.7e-8	4.7e-11	1	22127.0	HUMAN	40S ribosomal protein S7
[55]		P62081	RS7_HUMAN	RPS7	5	25.8	4.55	8.1e-10	892.4583	2	11	LTGKDVNFEFPEFQL	LTGKDVNFEFPEFQL		15	V20130429-05_FTMSms2hcd	64.010	180	194	22.9	7.4e-6	9.5e-9	1	22127.0	HUMAN	40S ribosomal protein S7
[56]		P26373	RL13_HUMAN	RPL13	5	19.9	4.99	1.2e-8	737.8850	2	1.3	NKSTESLQANVQR	NKSTESLQANVQR		13	V20130429-05_FTMSms2hcd	15.446	104	116	48.1	1.2e-8	1.8e-11	1	24261.7	HUMAN	60S ribosomal protein L13
[56]		P26373	RL13_HUMAN	RPL13	5	19.9	4.99	1.2e-8	616.8100	2	-8.3	STESLQANVQR	STESLQANVQR		11	V20130429-05_FTMSms2hcd	17.979	106	116	29.6	4.4e-8	6.5e-11	1	24261.7	HUMAN	60S ribosomal protein L13
[56]		P26373	RL13_HUMAN	RPL13	5	19.9	4.99	1.2e-8	534.0000	3	3.1	IAPRPASGPIRPIVR	IAPRPASGPIRPIVR		15	V20130429-05_FTMSms2hcd	25.784	46	60	24.8	8.3e-8	1.9e-9	1	24261.7	HUMAN	60S ribosomal protein L13
[56]		P26373	RL13_HUMAN	RPL13	5	19.9	4.99	1.2e-8	475.7506	2	-0.26	GFSLEELR	GFSLEELR		8	V20130429-05_FTMSms2hcd	41.573	75	82	32.0	6.4e-5	1.2e-7	1	24261.7	HUMAN	60S ribosomal protein L13
[56]		P26373	RL13_HUMAN	RPL13	5	19.9	4.99	1.2e-8	379.7497	2	-0.26	LILFPR	LILFPR		6	V20130429-05_FTMSms2hcd	42.045	124	129	19.1	0.031	9.0e-5	1	24261.7	HUMAN	60S ribosomal protein L13
[57]		P22314	UBA1_HUMAN	UBA1	4	7.8	6.98	5.2e-13	873.8022	3	2.7	LAYVAAGDLAPINAFIGGLAAQEVMK	LAYVAAGDLAPINAFIGGLAAQEVM(Oxidation)K	Oxidation@410	26	V20130429-05_FTMSms2hcd	74.373	386	411	34.0	5.2e-13	1.2e-15	1	117850.0	HUMAN	Ubiquitin-like modifier-activating enzyme 1
[57]		P22314	UBA1_HUMAN	UBA1	4	7.8	6.98	5.2e-13	955.0092	2	8.3	SLVASLAEPDFVVTDFAK	SLVASLAEPDFVVTDFAK		18	V20130429-05_FTMSms2hcd	63.461	305	322	27.7	6.5e-10	1.1e-12	1	117850.0	HUMAN	Ubiquitin-like modifier-activating enzyme 1
[57]		P22314	UBA1_HUMAN	UBA1	4	7.8	6.98	5.2e-13	812.4554	2	-1.8	LAGTQPLEVLEAVQR	LAGTQPLEVLEAVQR		15	V20130429-05_FTMSms2hcd	53.273	679	693	36.2	1.1e-9	3.3e-12	1	117850.0	HUMAN	Ubiquitin-like modifier-activating enzyme 1
[57]		P22314	UBA1_HUMAN	UBA1	4	7.8	6.98	5.2e-13	842.0976	3	6.5	QLLHNFPPDQLTSSGAPFWSGPK	QLLHNFPPDQLTSSGAPFWSGPK		23	V20130429-05_FTMSms2hcd	47.146	724	746	11.7	0.022	2.9e-5	1	117850.0	HUMAN	Ubiquitin-like modifier-activating enzyme 1
[58]		O00299	CLIC1_HUMAN	CLIC1	3	24.1	7.88	5.5e-14	998.1395	3	4.5	VLDNYLTSPLPEEVDETSAEDEGVSQR	VLDNYLTSPLPEEVDETSAEDEGVSQR		27	V20130429-05_FTMSms2hcd	50.665	139	165	38.0	5.5e-14	5.0e-17	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[58]		O00299	CLIC1_HUMAN	CLIC1	3	24.1	7.88	5.5e-14	922.9925	2	1.3	LAALNPESNTAGLDIFAK	LAALNPESNTAGLDIFAK		18	V20130429-05_FTMSms2hcd	54.114	96	113	47.9	1.2e-13	2.1e-16	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[58]		O00299	CLIC1_HUMAN	CLIC1	3	24.1	7.88	5.5e-14	729.8800	2	3.6	MAEEQPQVELFVK	M(Met-loss+Acetyl)AEEQPQVELFVK	Met-loss+Acetyl@1	13	V20130429-05_FTMSms2hcd	49.106	1	13	14.3	1.0e-4	1.4e-7	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[59]		P0C0S8	H2A1_HUMAN	HIST1H2AG	5	35.4	6.09	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	14091.6	HUMAN	Histone H2A type 1
[59]		P0C0S8	H2A1_HUMAN	HIST1H2AG	5	35.4	6.09	2.5e-11	526.8016	4	-1.3	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-05_FTMSms2hcd	45.398	83	100	36.4	1.3e-7	6.9e-10	7	14091.6	HUMAN	Histone H2A type 1
[59]		P0C0S8	H2A1_HUMAN	HIST1H2AG	5	35.4	6.09	2.5e-11	424.8983	3	0.74	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-05_FTMSms2hcd	35.172	90	100	27.4	7.2e-6	1.3e-8	7	14091.6	HUMAN	Histone H2A type 1
[59]		P0C0S8	H2A1_HUMAN	HIST1H2AG	5	35.4	6.09	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	14091.6	HUMAN	Histone H2A type 1
[59]		P0C0S8	H2A1_HUMAN	HIST1H2AG	5	35.4	6.09	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	14091.6	HUMAN	Histone H2A type 1
[59-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	5	35.4	6.09	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	14107.6	HUMAN	Histone H2A type 1-D
[59-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	5	35.4	6.09	2.5e-11	526.8016	4	-1.3	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-05_FTMSms2hcd	45.398	83	100	36.4	1.3e-7	6.9e-10	7	14107.6	HUMAN	Histone H2A type 1-D
[59-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	5	35.4	6.09	2.5e-11	424.8983	3	0.74	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-05_FTMSms2hcd	35.172	90	100	27.4	7.2e-6	1.3e-8	7	14107.6	HUMAN	Histone H2A type 1-D
[59-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	5	35.4	6.09	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	14107.6	HUMAN	Histone H2A type 1-D
[59-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	5	35.4	6.09	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	14107.6	HUMAN	Histone H2A type 1-D
[59-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	5	35.7	6.09	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	13988.5	HUMAN	Histone H2A type 2-C
[59-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	5	35.7	6.09	2.5e-11	526.8016	4	-1.3	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-05_FTMSms2hcd	45.398	83	100	36.4	1.3e-7	6.9e-10	7	13988.5	HUMAN	Histone H2A type 2-C
[59-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	5	35.7	6.09	2.5e-11	424.8983	3	0.74	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-05_FTMSms2hcd	35.172	90	100	27.4	7.2e-6	1.3e-8	7	13988.5	HUMAN	Histone H2A type 2-C
[59-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	5	35.7	6.09	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	13988.5	HUMAN	Histone H2A type 2-C
[59-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	5	35.7	6.09	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	13988.5	HUMAN	Histone H2A type 2-C
[59-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	35.4	6.09	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	14095.6	HUMAN	Histone H2A type 2-A
[59-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	35.4	6.09	2.5e-11	526.8016	4	-1.3	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-05_FTMSms2hcd	45.398	83	100	36.4	1.3e-7	6.9e-10	7	14095.6	HUMAN	Histone H2A type 2-A
[59-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	35.4	6.09	2.5e-11	424.8983	3	0.74	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-05_FTMSms2hcd	35.172	90	100	27.4	7.2e-6	1.3e-8	7	14095.6	HUMAN	Histone H2A type 2-A
[59-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	35.4	6.09	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	14095.6	HUMAN	Histone H2A type 2-A
[59-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	5	35.4	6.09	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	14095.6	HUMAN	Histone H2A type 2-A
[59-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	5	35.9	6.09	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	13906.4	HUMAN	Histone H2A type 1-H
[59-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	5	35.9	6.09	2.5e-11	526.8016	4	-1.3	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-05_FTMSms2hcd	45.398	83	100	36.4	1.3e-7	6.9e-10	7	13906.4	HUMAN	Histone H2A type 1-H
[59-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	5	35.9	6.09	2.5e-11	424.8983	3	0.74	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-05_FTMSms2hcd	35.172	90	100	27.4	7.2e-6	1.3e-8	7	13906.4	HUMAN	Histone H2A type 1-H
[59-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	5	35.9	6.09	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	13906.4	HUMAN	Histone H2A type 1-H
[59-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	5	35.9	6.09	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	13906.4	HUMAN	Histone H2A type 1-H
[59-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	5	35.9	6.09	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	13936.4	HUMAN	Histone H2A type 1-J
[59-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	5	35.9	6.09	2.5e-11	526.8016	4	-1.3	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-05_FTMSms2hcd	45.398	83	100	36.4	1.3e-7	6.9e-10	7	13936.4	HUMAN	Histone H2A type 1-J
[59-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	5	35.9	6.09	2.5e-11	424.8983	3	0.74	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-05_FTMSms2hcd	35.172	90	100	27.4	7.2e-6	1.3e-8	7	13936.4	HUMAN	Histone H2A type 1-J
[59-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	5	35.9	6.09	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	13936.4	HUMAN	Histone H2A type 1-J
[59-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	5	35.9	6.09	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	13936.4	HUMAN	Histone H2A type 1-J
[59-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	5	35.7	6.09	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	14019.5	HUMAN	Histone H2A.J
[59-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	5	35.7	6.09	2.5e-11	526.8016	4	-1.3	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-05_FTMSms2hcd	45.398	83	100	36.4	1.3e-7	6.9e-10	7	14019.5	HUMAN	Histone H2A.J
[59-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	5	35.7	6.09	2.5e-11	424.8983	3	0.74	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-05_FTMSms2hcd	35.172	90	100	27.4	7.2e-6	1.3e-8	7	14019.5	HUMAN	Histone H2A.J
[59-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	5	35.7	6.09	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	14019.5	HUMAN	Histone H2A.J
[59-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	5	35.7	6.09	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	14019.5	HUMAN	Histone H2A.J
[59-7]	2	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	3	35.4	5.96	1.0e-10	1038.5946	3	4.0	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-05_FTMSms2hcd	75.459	90	119	38.5	1.0e-10	1.6e-12	3	13995.4	HUMAN	Histone H2A type 2-B
[59-7]	2	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	3	35.4	5.96	1.0e-10	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	13995.4	HUMAN	Histone H2A type 2-B
[59-7]	2	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	3	35.4	5.96	1.0e-10	418.7588	2	0.27	HLQLAVR	HLQLAVR		7	V20130429-05_FTMSms2hcd	20.921	83	89	25.1	9.7e-5	9.3e-7	1	13995.4	HUMAN	Histone H2A type 2-B
[59-8]	1	P16104	H2AX_HUMAN	H2AFX	3	32.2	5.96	1.0e-10	1038.5946	3	4.0	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-05_FTMSms2hcd	75.459	90	119	38.5	1.0e-10	1.6e-12	3	15144.7	HUMAN	Histone H2A.x
[59-8]	1	P16104	H2AX_HUMAN	H2AFX	3	32.2	5.96	1.0e-10	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	15144.7	HUMAN	Histone H2A.x
[59-8]	1	P16104	H2AX_HUMAN	H2AFX	3	32.2	5.96	1.0e-10	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	15144.7	HUMAN	Histone H2A.x
[59-9]	1	Q96QV6	H2A1A_HUMAN	HIST1H2AA	3	35.1	5.96	1.0e-10	1038.5946	3	4.0	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-05_FTMSms2hcd	75.459	90	119	38.5	1.0e-10	1.6e-12	3	14233.6	HUMAN	Histone H2A type 1-A
[59-9]	1	Q96QV6	H2A1A_HUMAN	HIST1H2AA	3	35.1	5.96	1.0e-10	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	14233.6	HUMAN	Histone H2A type 1-A
[59-9]	1	Q96QV6	H2A1A_HUMAN	HIST1H2AA	3	35.1	5.96	1.0e-10	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	14233.6	HUMAN	Histone H2A type 1-A
[59-10]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	5.89	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	14135.6	HUMAN	Histone H2A type 1-B/E
[59-10]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	5.89	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	14135.6	HUMAN	Histone H2A type 1-B/E
[59-10]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	5.89	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	14135.6	HUMAN	Histone H2A type 1-B/E
[59-11]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	5.89	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	14121.6	HUMAN	Histone H2A type 3
[59-11]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	5.89	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	14121.6	HUMAN	Histone H2A type 3
[59-11]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	5.89	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	14121.6	HUMAN	Histone H2A type 3
[59-12]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	5.89	2.5e-11	644.3954	3	1.5	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-05_FTMSms2hcd	65.271	101	119	31.1	2.5e-11	7.1e-13	10	14105.6	HUMAN	Histone H2A type 1-C
[59-12]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	5.89	2.5e-11	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	22	30	34.4	8.3e-5	1.4e-7	15	14105.6	HUMAN	Histone H2A type 1-C
[59-12]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	5.89	2.5e-11	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	83	89	31.1	1.3e-4	1.2e-6	14	14105.6	HUMAN	Histone H2A type 1-C
[59-13]	1	P0C0S5	H2AZ_HUMAN	H2AFZ	3	23.4	4.11	4.9e-8	685.8975	2	-1.9	ATIAGGGVIPHIHK	ATIAGGGVIPHIHK		14	V20130429-05_FTMSms2hcd	28.776	103	116	31.1	4.9e-8	1.6e-10	2	13552.8	HUMAN	Histone H2A.Z
[59-13]	1	P0C0S5	H2AZ_HUMAN	H2AFZ	3	23.4	4.11	4.9e-8	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	24	32	34.4	8.3e-5	1.4e-7	15	13552.8	HUMAN	Histone H2A.Z
[59-13]	1	P0C0S5	H2AZ_HUMAN	H2AFZ	3	23.4	4.11	4.9e-8	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	86	92	31.1	1.3e-4	1.2e-6	14	13552.8	HUMAN	Histone H2A.Z
[59-14]	1	Q71UI9	H2AV_HUMAN	H2AFV	3	23.4	4.11	4.9e-8	685.8975	2	-1.9	ATIAGGGVIPHIHK	ATIAGGGVIPHIHK		14	V20130429-05_FTMSms2hcd	28.776	103	116	31.1	4.9e-8	1.6e-10	2	13508.8	HUMAN	Histone H2A.V
[59-14]	1	Q71UI9	H2AV_HUMAN	H2AFV	3	23.4	4.11	4.9e-8	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-05_FTMSms2hcd	36.030	24	32	34.4	8.3e-5	1.4e-7	15	13508.8	HUMAN	Histone H2A.V
[59-14]	1	Q71UI9	H2AV_HUMAN	H2AFV	3	23.4	4.11	4.9e-8	425.7668	2	0.68	HLQLAIR	HLQLAIR		7	V20130429-05_FTMSms2hcd	25.460	86	92	31.1	1.3e-4	1.2e-6	14	13508.8	HUMAN	Histone H2A.V
[60]		P07195	LDHB_HUMAN	LDHB	4	13.2	6.50	2.0e-11	755.8917	2	0.90	IVADKDYSVTANSK	IVADKDYSVTANSK		14	V20130429-05_FTMSms2hcd	18.741	78	91	54.9	2.0e-11	2.8e-14	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[60]		P07195	LDHB_HUMAN	LDHB	4	13.2	6.50	2.0e-11	429.5821	3	0.24	LKDDEVAQLKK	LKDDEVAQLKK		11	V20130429-05_FTMSms2hcd	17.162	309	319	36.5	3.3e-8	7.5e-11	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[60]		P07195	LDHB_HUMAN	LDHB	4	13.2	6.50	2.0e-11	457.2948	2	-0.66	IVVVTAGVR	IVVVTAGVR		9	V20130429-05_FTMSms2hcd	27.195	92	100	35.0	5.8e-6	3.1e-8	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[60]		P07195	LDHB_HUMAN	LDHB	4	13.2	6.50	2.0e-11	588.7980	2	-0.68	SADTLWDIQK	SADTLWDIQK		10	V20130429-05_FTMSms2hcd	38.612	320	329	25.6	1.2e-5	1.6e-8	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[61]		P26641	EF1G_HUMAN	EEF1G	3	7.8	6.32	4.2e-11	792.3785	2	0.53	MAAGTLYTYPENWR	M(Met-loss+Acetyl)AAGTLYTYPENWR	Met-loss+Acetyl@1	14	V20130429-05_FTMSms2hcd	50.270	1	14	33.4	4.2e-11	5.0e-14	1	50119.2	HUMAN	Elongation factor 1-gamma
[61]		P26641	EF1G_HUMAN	EEF1G	3	7.8	6.32	4.2e-11	414.5556	3	-0.17	STFVLDEFKR	STFVLDEFKR		10	V20130429-05_FTMSms2hcd	39.382	286	295	41.9	4.3e-11	8.5e-14	1	50119.2	HUMAN	Elongation factor 1-gamma
[61]		P26641	EF1G_HUMAN	EEF1G	3	7.8	6.32	4.2e-11	375.2130	3	-1.3	AKDPFAHLPK	AKDPFAHLPK		10	V20130429-05_FTMSms2hcd	24.916	276	285	31.8	3.7e-9	1.0e-11	1	50119.2	HUMAN	Elongation factor 1-gamma
[62]		P61604	CH10_HUMAN	HSPE1	4	42.2	5.94	2.1e-10	599.8423	2	-1.4	GKGGEIQPVSVK	GKGGEIQPVSVK		12	V20130429-05_FTMSms2hcd	17.715	55	66	42.9	2.1e-10	5.7e-13	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[62]		P61604	CH10_HUMAN	HSPE1	4	42.2	5.94	2.1e-10	658.3840	2	2.1	VLQATVVAVGSGSK	VLQATVVAVGSGSK		14	V20130429-05_FTMSms2hcd	29.643	41	54	49.1	9.4e-9	3.0e-11	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[62]		P61604	CH10_HUMAN	HSPE1	4	42.2	5.94	2.1e-10	538.8029	2	-0.11	VLLPEYGGTK	VLLPEYGGTK		10	V20130429-05_FTMSms2hcd	32.097	71	80	32.1	2.7e-7	6.0e-10	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[62]		P61604	CH10_HUMAN	HSPE1	4	42.2	5.94	2.1e-10	454.2554	2	-0.10	FLPLFDR	FLPLFDR		7	V20130429-05_FTMSms2hcd	48.729	9	15	30.4	8.7e-4	2.0e-6	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[63]		P63313	TYB10_HUMAN	TMSB10	3	70.5	6.65	1.0e-11	594.2857	3	0.20	MADKPDMGEIASFDKAK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDKAK	Met-loss+Acetyl@1;Oxidation@7	17	V20130429-05_FTMSms2hcd	28.080	1	17	43.3	1.0e-11	1.1e-14	1	5025.7	HUMAN	Thymosin beta-10
[63]		P63313	TYB10_HUMAN	TMSB10	3	70.5	6.65	1.0e-11	791.3590	2	0.38	MADKPDMGEIASFDK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-05_FTMSms2hcd	30.811	1	15	45.0	1.2e-10	1.5e-13	1	5025.7	HUMAN	Thymosin beta-10
[63]		P63313	TYB10_HUMAN	TMSB10	3	70.5	6.65	1.0e-11	562.9717	3	-0.91	NTLPTKETIEQEKR	NTLPTKETIEQEKR		14	V20130429-05_FTMSms2hcd	19.352	27	40	46.0	1.9e-8	3.4e-11	1	5025.7	HUMAN	Thymosin beta-10
[64]		P55072	TERA_HUMAN	VCP	5	7.8	5.78	4.2e-11	845.9292	2	1.0	MASGADSKGDDLSTAILK	M(Met-loss+Acetyl)ASGADSKGDDLSTAILK	Met-loss+Acetyl@1	18	V20130429-05_FTMSms2hcd	37.822	1	18	31.1	4.2e-11	5.1e-14	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[64]		P55072	TERA_HUMAN	VCP	5	7.8	5.78	4.2e-11	553.7960	4	-1.2	ELQELVQYPVEHPDKFLK	ELQELVQYPVEHPDKFLK		18	V20130429-05_FTMSms2hcd	47.364	488	505	21.8	1.2e-6	2.2e-9	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[64]		P55072	TERA_HUMAN	VCP	5	7.8	5.78	4.2e-11	534.2600	2	-5.9	MDELQLFR	M(Oxidation)DELQLFR	Oxidation@46	8	V20130429-05_FTMSms2hcd	41.389	46	53	19.1	1.7e-6	2.4e-9	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[64]		P55072	TERA_HUMAN	VCP	5	7.8	5.78	4.2e-11	602.3204	2	0.61	LAGESESNLRK	LAGESESNLRK		11	V20130429-05_FTMSms2hcd	12.279	278	288	34.6	2.9e-5	4.5e-8	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[64]		P55072	TERA_HUMAN	VCP	5	7.8	5.78	4.2e-11	474.2853	2	-4.2	KGDIFLVR	KGDIFLVR		8	V20130429-05_FTMSms2hcd	30.893	148	155	28.6	5.4e-5	2.1e-7	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[65]		Q15084	PDIA6_HUMAN	PDIA6	3	9.5	6.41	2.9e-11	742.3624	2	-0.040	GSFSEQGINEFLR	GSFSEQGINEFLR		13	V20130429-05_FTMSms2hcd	48.145	374	386	35.6	2.9e-11	3.5e-14	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[65]		Q15084	PDIA6_HUMAN	PDIA6	3	9.5	6.41	2.9e-11	764.4308	2	3.5	LAAVDATVNQVLASR	LAAVDATVNQVLASR		15	V20130429-05_FTMSms2hcd	47.241	217	231	45.2	2.3e-10	5.9e-13	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[65]		Q15084	PDIA6_HUMAN	PDIA6	3	9.5	6.41	2.9e-11	693.8901	2	10	TGEAIVDAALSALR	TGEAIVDAALSALR		14	V20130429-05_FTMSms2hcd	61.010	119	132	46.5	5.7e-9	1.2e-11	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[66]		P54646	AAPK2_HUMAN	PRKAA2	3	8.0	7.89	5.3e-14	967.9338	2	-1.0	IADFGLSNMMSDGEFLR	IADFGLSNM(Oxidation)M(Oxidation)SDGEFLR	Oxidation@163;Oxidation@164	17	V20130429-05_FTMSms2hcd	48.386	155	171	41.0	5.3e-14	6.0e-17	2	62320.2	HUMAN	5'-AMP-activated protein kinase catalytic subunit alpha-2
[66]		P54646	AAPK2_HUMAN	PRKAA2	3	8.0	7.89	5.3e-14	578.6400	3	-9.6	IGHYVLGDTLGVGTFGK	IGHYVLGDTLGVGTFGK		17	V20130429-05_FTMSms2hcd	47.378	13	29	34.3	1.5e-9	2.2e-12	1	62320.2	HUMAN	5'-AMP-activated protein kinase catalytic subunit alpha-2
[66]		P54646	AAPK2_HUMAN	PRKAA2	3	8.0	7.89	5.3e-14	542.7881	2	-1.6	MPPLIADSPK	M(Oxidation)PPLIADSPK	Oxidation@370	10	V20130429-05_FTMSms2hcd	25.428	370	379	30.0	4.2e-6	8.2e-9	1	62320.2	HUMAN	5'-AMP-activated protein kinase catalytic subunit alpha-2
[66-1]	0	Q13131	AAPK1_HUMAN	PRKAA1	1	3.0	7.89	5.3e-14	967.9338	2	-1.0	IADFGLSNMMSDGEFLR	IADFGLSNM(Oxidation)M(Oxidation)SDGEFLR	Oxidation@174;Oxidation@175	17	V20130429-05_FTMSms2hcd	48.386	166	182	41.0	5.3e-14	6.0e-17	2	64009.8	HUMAN	5'-AMP-activated protein kinase catalytic subunit alpha-1
[67]		P20700	LMNB1_HUMAN	LMNB1	3	8.5	9.22	1.8e-16	1137.8685	3	5.8	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR		30	V20130429-05_FTMSms2hcd	61.051	548	577	49.9	1.8e-16	1.8e-19	1	66408.9	HUMAN	Lamin-B1
[67]		P20700	LMNB1_HUMAN	LMNB1	3	8.5	9.22	1.8e-16	577.8110	2	-1.5	AGGPTTPLSPTR	AGGPTTPLSPTR		12	V20130429-05_FTMSms2hcd	21.529	15	26	34.2	3.8e-7	7.7e-10	1	66408.9	HUMAN	Lamin-B1
[67]		P20700	LMNB1_HUMAN	LMNB1	3	8.5	9.22	1.8e-16	487.7427	2	-0.81	LLEGEEER	LLEGEEER		8	V20130429-05_FTMSms2hcd	15.133	380	387	25.4	1.9e-5	3.9e-8	3	66408.9	HUMAN	Lamin-B1
[67-1]	3	P02545	LMNA_HUMAN	LMNA	4	7.4	4.40	6.3e-8	783.8900	2	14	SVGGSGGGSFGDNLVTR	SVGGSGGGSFGDNLVTR		17	V20130429-05_FTMSms2hcd	32.109	628	644	24.5	6.3e-8	7.8e-11	1	74140.1	HUMAN	Prelamin-A/C
[67-1]	3	P02545	LMNA_HUMAN	LMNA	4	7.4	4.40	6.3e-8	567.3281	3	-0.21	IRIDSLSAQLSQLQK	IRIDSLSAQLSQLQK		15	V20130429-05_FTMSms2hcd	46.830	297	311	37.9	1.8e-6	7.9e-9	1	74140.1	HUMAN	Prelamin-A/C
[67-1]	3	P02545	LMNA_HUMAN	LMNA	4	7.4	4.40	6.3e-8	487.7427	2	-0.81	LLEGEEER	LLEGEEER		8	V20130429-05_FTMSms2hcd	15.133	379	386	25.4	1.9e-5	3.9e-8	3	74140.1	HUMAN	Prelamin-A/C
[67-1]	3	P02545	LMNA_HUMAN	LMNA	4	7.4	4.40	6.3e-8	514.7900	2	-0.74	LADALQELR	LADALQELR		9	V20130429-05_FTMSms2hcd	35.728	241	249	37.9	6.4e-5	1.5e-7	1	74140.1	HUMAN	Prelamin-A/C
[67-2]	0	Q03252	LMNB2_HUMAN	LMNB2	1	1.3	1.81	1.9e-5	487.7427	2	-0.81	LLEGEEER	LLEGEEER		8	V20130429-05_FTMSms2hcd	15.133	374	381	25.4	1.9e-5	3.9e-8	3	67689.4	HUMAN	Lamin-B2
[68]		P52292	IMA2_HUMAN	KPNA2	3	9.5	8.86	8.4e-16	729.0898	3	9.6	NKNPAPPIDAVEQILPTLVR	NKNPAPPIDAVEQILPTLVR		20	V20130429-05_FTMSms2hcd	65.912	239	258	44.0	8.4e-16	7.3e-18	1	57862.4	HUMAN	Importin subunit alpha-2
[68]		P52292	IMA2_HUMAN	KPNA2	3	9.5	8.86	8.4e-16	775.4707	2	1.9	LLGASELPIVTPALR	LLGASELPIVTPALR		15	V20130429-05_FTMSms2hcd	56.655	301	315	19.3	9.8e-11	1.3e-12	1	57862.4	HUMAN	Importin subunit alpha-2
[68]		P52292	IMA2_HUMAN	KPNA2	3	9.5	8.86	8.4e-16	832.4600	2	-5.4	IGMVVKTGVVPQLVK	IGM(Oxidation)VVKT(Phospho)GVVPQLVK	Oxidation@288;Phospho@292	15	V20130429-05_FTMSms2hcd	29.034	286	300	13.2	0.089	2.1e-4	1	57862.4	HUMAN	Importin subunit alpha-2
[69]		P08865	RSSA_HUMAN	RPSA	3	14.2	7.06	1.8e-12	916.9697	2	0.61	MSGALDVLQMKEEDVLK	M(Met-loss+Acetyl)SGALDVLQM(Oxidation)KEEDVLK	Met-loss+Acetyl@1;Oxidation@10	17	V20130429-05_FTMSms2hcd	53.975	1	17	43.5	1.8e-12	2.3e-15	1	32854.4	HUMAN	40S ribosomal protein SA
[69]		P08865	RSSA_HUMAN	RPSA	3	14.2	7.06	1.8e-12	870.9781	2	-0.067	AIVAIENPADVSVISSR	AIVAIENPADVSVISSR		17	V20130429-05_FTMSms2hcd	47.159	64	80	39.3	3.2e-11	7.7e-14	1	32854.4	HUMAN	40S ribosomal protein SA
[69]		P08865	RSSA_HUMAN	RPSA	3	14.2	7.06	1.8e-12	456.7790	2	-0.62	LLVVTDPR	LLVVTDPR		8	V20130429-05_FTMSms2hcd	29.409	121	128	27.2	2.6e-4	1.5e-6	1	32854.4	HUMAN	40S ribosomal protein SA
[70]		P52565	GDIR1_HUMAN	ARHGDIA	2	23.5	10.55	6.3e-19	902.4243	4	-2.1	MAEQEPTAEQLAQIAAENEEDEHSVNYKPPAQK	M(Met-loss+Acetyl)AEQEPTAEQLAQIAAENEEDEHSVNYKPPAQK	Met-loss+Acetyl@1	33	V20130429-05_FTMSms2hcd	45.847	1	33	54.2	6.3e-19	6.7e-22	1	23207.3	HUMAN	Rho GDP-dissociation inhibitor 1
[70]		P52565	GDIR1_HUMAN	ARHGDIA	2	23.5	10.55	6.3e-19	876.4274	2	5.8	AEEYEFLTPVEEAPK	AEEYEFLTPVEEAPK		15	V20130429-05_FTMSms2hcd	46.426	153	167	29.6	1.4e-9	1.5e-12	1	23207.3	HUMAN	Rho GDP-dissociation inhibitor 1
[71]		P23246	SFPQ_HUMAN	SFPQ	3	8.8	8.18	1.5e-14	1320.1672	2	11	NLSPYVSNELLEEAFSQFGPIER	NLSPYVSNELLEEAFSQFGPIER		23	V20130429-05_FTMSms2hcd	74.868	377	399	43.9	1.5e-14	2.0e-17	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[71]		P23246	SFPQ_HUMAN	SFPQ	3	8.8	8.18	1.5e-14	655.3412	3	-1.7	LFVGNLPADITEDEFKR	LFVGNLPADITEDEFKR		17	V20130429-05_FTMSms2hcd	52.342	299	315	40.0	4.9e-10	6.6e-13	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[71]		P23246	SFPQ_HUMAN	SFPQ	3	8.8	8.18	1.5e-14	478.0277	5	0.37	QHHPPYHQQHHQGPPPGGPGGR	Q(Gln->pyro-Glu)HHPPYHQQHHQGPPPGGPGGR	Gln->pyro-Glu@246	22	V20130429-05_FTMSms2hcd	10.264	246	267	12.8	0.0049	4.6e-6	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[72]		P29692	EF1D_HUMAN	EEF1D	4	15.7	4.79	2.9e-8	536.7748	2	0.13	MATNFLAHEK	M(Met-loss+Acetyl)ATNFLAHEK	Met-loss+Acetyl@1	10	V20130429-05_FTMSms2hcd	31.895	1	10	39.9	2.9e-8	4.8e-11	1	31122.1	HUMAN	Elongation factor 1-delta
[72]		P29692	EF1D_HUMAN	EEF1D	4	15.7	4.79	2.9e-8	687.3806	2	8.4	SIQLDGLVWGASK	SIQLDGLVWGASK		13	V20130429-05_FTMSms2hcd	52.184	220	232	35.6	7.5e-8	1.4e-10	1	31122.1	HUMAN	Elongation factor 1-delta
[72]		P29692	EF1D_HUMAN	EEF1D	4	15.7	4.79	2.9e-8	679.8683	2	1.4	IASLEVENQSLR	IASLEVENQSLR		12	V20130429-05_FTMSms2hcd	32.613	84	95	44.4	5.3e-6	9.1e-9	1	31122.1	HUMAN	Elongation factor 1-delta
[72]		P29692	EF1D_HUMAN	EEF1D	4	15.7	4.79	2.9e-8	487.2951	2	-0.0044	LVPVGYGIR	LVPVGYGIR		9	V20130429-05_FTMSms2hcd	33.495	233	241	23.5	8.7e-5	2.8e-7	1	31122.1	HUMAN	Elongation factor 1-delta
[73]		P25705	ATPA_HUMAN	ATP5A1	3	7.4	5.87	5.6e-11	720.3384	2	0.88	TGTAEMSSILEER	TGTAEM(Oxidation)SSILEER	Oxidation@51	13	V20130429-05_FTMSms2hcd	25.911	46	58	36.2	5.6e-11	7.2e-14	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[73]		P25705	ATPA_HUMAN	ATP5A1	3	7.4	5.87	5.6e-11	570.9845	3	0.28	VVDALGNAIDGKGPIGSK	VVDALGNAIDGKGPIGSK		18	V20130429-05_FTMSms2hcd	36.811	150	167	30.9	8.4e-10	2.0e-12	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[73]		P25705	ATPA_HUMAN	ATP5A1	3	7.4	5.87	5.6e-11	513.8010	2	0.49	AVDSLVPIGR	AVDSLVPIGR		10	V20130429-05_FTMSms2hcd	36.570	195	204	29.8	2.3e-8	9.8e-11	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[74]		P30101	PDIA3_HUMAN	PDIA3	3	9.3	8.34	7.9e-15	859.1124	3	7.3	TFSHELSDFGLESTAGEIPVVAIR	TFSHELSDFGLESTAGEIPVVAIR		24	V20130429-05_FTMSms2hcd	60.178	306	329	42.9	7.9e-15	1.1e-17	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[74]		P30101	PDIA3_HUMAN	PDIA3	3	9.3	8.34	7.9e-15	596.3040	2	0.25	LAPEYEAAATR	LAPEYEAAATR		11	V20130429-05_FTMSms2hcd	21.765	63	73	37.2	1.9e-8	2.7e-11	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[74]		P30101	PDIA3_HUMAN	PDIA3	3	9.3	8.34	7.9e-15	505.9244	3	-0.27	FLQDYFDGNLKR	FLQDYFDGNLKR		12	V20130429-05_FTMSms2hcd	41.929	352	363	11.9	0.0014	1.9e-6	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[75]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	7.62	1.7e-13	744.8835	2	1.1	IFVGGLSPDTPEEK	IFVGGLSPDTPEEK		14	V20130429-05_FTMSms2hcd	37.596	184	197	44.7	1.7e-13	2.4e-16	1	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[75]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	7.62	1.7e-13	514.9150	3	0.58	HSEAATAQREEWK	HSEAATAQREEWK		13	V20130429-05_FTMSms2hcd	12.266	86	98	27.2	1.6e-7	2.0e-10	1	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[75]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	7.62	1.7e-13	457.7622	2	4.0	GFGFVLFK	GFGFVLFK		8	V20130429-05_FTMSms2hcd	57.229	139	146	25.9	2.4e-5	6.3e-8	2	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[75-1]	0	O14979	HNRDL_HUMAN	HNRPDL	1	1.9	1.81	2.4e-5	457.7622	2	4.0	GFGFVLFK	GFGFVLFK		8	V20130429-05_FTMSms2hcd	57.229	190	197	25.9	2.4e-5	6.3e-8	2	46437.9	HUMAN	Heterogeneous nuclear ribonucleoprotein D-like
[76]		P62913	RL11_HUMAN	RPL11	3	23.0	6.01	1.6e-10	730.8253	2	-0.074	MAQDQGEKENPMR	M(Met-loss+Acetyl)AQDQGEKENPM(Oxidation)R	Met-loss+Acetyl@1;Oxidation@12	13	V20130429-05_FTMSms2hcd	8.583	1	13	30.3	1.6e-10	2.2e-13	1	20252.6	HUMAN	60S ribosomal protein L11
[76]		P62913	RL11_HUMAN	RPL11	3	23.0	6.01	1.6e-10	773.9276	2	0.25	VLEQLTGQTPVFSK	VLEQLTGQTPVFSK		14	V20130429-05_FTMSms2hcd	42.152	39	52	43.0	2.4e-9	5.3e-12	1	20252.6	HUMAN	60S ribosomal protein L11
[76]		P62913	RL11_HUMAN	RPL11	3	23.0	6.01	1.6e-10	564.9742	3	-1.6	WFQQKYDGIILPGK	WFQQKYDGIILPGK		14	V20130429-05_FTMSms2hcd	45.526	165	178	19.8	3.2e-6	5.8e-9	1	20252.6	HUMAN	60S ribosomal protein L11
[77]		P55060	XPO2_HUMAN	CSE1L	2	2.7	9.22	1.8e-16	1028.0317	2	12	MELSDANLQTLTEYLKK	Acetyl-M(Oxidation)ELSDANLQTLTEYLKK		17	V20130429-05_FTMSms2hcd	60.416	1	17	54.4	1.8e-16	2.3e-19	1	110417.6	HUMAN	Exportin-2
[77]		P55060	XPO2_HUMAN	CSE1L	2	2.7	9.22	1.8e-16	560.7950	2	0.70	VIVPNMEFR	VIVPNM(Oxidation)EFR	Oxidation@352	9	V20130429-05_FTMSms2hcd	30.730	347	355	25.4	5.8e-10	9.3e-13	1	110417.6	HUMAN	Exportin-2
[78]		P09429	HMGB1_HUMAN	HMGB1	3	18.1	5.63	7.9e-10	507.6185	3	-1.4	IKGEHPGLSIGDVAK	IKGEHPGLSIGDVAK		15	V20130429-05_FTMSms2hcd	26.932	113	127	42.5	7.9e-10	1.8e-12	2	24894.0	HUMAN	High mobility group protein B1
[78]		P09429	HMGB1_HUMAN	HMGB1	3	18.1	5.63	7.9e-10	430.9714	4	-0.89	KHPDASVNFSEFSKK	KHPDASVNFSEFSKK		15	V20130429-05_FTMSms2hcd	25.736	30	44	31.6	1.0e-9	1.2e-12	1	24894.0	HUMAN	High mobility group protein B1
[78]		P09429	HMGB1_HUMAN	HMGB1	3	18.1	5.63	7.9e-10	376.8616	3	1.6	YEKDIAAYR	YEKDIAAYR		9	V20130429-05_FTMSms2hcd	18.267	155	163	22.6	1.7e-5	2.8e-8	2	24894.0	HUMAN	High mobility group protein B1
[78-1]	0	B2RPK0	HGB1A_HUMAN	HMGB1P1	1	7.1	5.63	7.9e-10	507.6185	3	-1.4	IKGEHPGLSIGDVAK	IKGEHPGLSIGDVAK		15	V20130429-05_FTMSms2hcd	26.932	113	127	42.5	7.9e-10	1.8e-12	2	24238.2	HUMAN	Putative high mobility group protein B1-like 1
[78-2]	0	P26583	HMGB2_HUMAN	HMGB2	1	4.3	1.56	1.7e-5	376.8616	3	1.6	YEKDIAAYR	YEKDIAAYR		9	V20130429-05_FTMSms2hcd	18.267	155	163	22.6	1.7e-5	2.8e-8	2	24034.0	HUMAN	High mobility group protein B2
[79]		P62826	RAN_HUMAN	RAN	4	19.4	5.36	5.8e-10	595.6429	3	1.3	SNYNFEKPFLWLAR	SNYNFEKPFLWLAR		14	V20130429-05_FTMSms2hcd	57.726	153	166	36.5	5.8e-10	8.1e-13	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[79]		P62826	RAN_HUMAN	RAN	4	19.4	5.36	5.8e-10	622.8167	2	-0.69	MAAQGEPQVQFK	M(Met-loss+Acetyl)AAQGEPQVQFK	Met-loss+Acetyl@1	12	V20130429-05_FTMSms2hcd	31.143	1	12	33.8	8.8e-7	1.2e-9	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[79]		P62826	RAN_HUMAN	RAN	4	19.4	5.36	5.8e-10	379.7194	2	0.97	SIVFHR	SIVFHR		6	V20130429-05_FTMSms2hcd	17.061	135	140	22.6	2.4e-5	4.8e-8	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[79]		P62826	RAN_HUMAN	RAN	4	19.4	5.36	5.8e-10	607.8085	2	3.7	NLQYYDISAK	NLQYYDISAK		10	V20130429-05_FTMSms2hcd	31.714	143	152	21.6	6.8e-5	1.1e-7	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[80]		Q15365	PCBP1_HUMAN	PCBP1	2	12.4	9.48	5.9e-17	853.4293	4	0.69	AFAMIIDKLEEDINSSMTNSTAASRPPVTLR	AFAM(Oxidation)IIDKLEEDINSSM(Oxidation)TNSTAASRPPVTLR	Oxidation@74;Oxidation@87	31	V20130429-05_FTMSms2hcd	61.422	71	101	51.9	5.9e-17	7.5e-20	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[80]		Q15365	PCBP1_HUMAN	PCBP1	2	12.4	9.48	5.9e-17	694.9119	2	1.3	IITLTGPTNAIFK	IITLTGPTNAIFK		13	V20130429-05_FTMSms2hcd	51.443	58	70	36.1	2.2e-8	9.5e-11	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[81]		P49368	TCPG_HUMAN	CCT3	4	10.1	6.21	6.9e-11	878.4672	3	10	NVLLDPQLVPGGGASEMAVAHALTEK	NVLLDPQLVPGGGASEM(Oxidation)AVAHALTEK	Oxidation@416	26	V20130429-05_FTMSms2hcd	56.405	400	425	43.6	6.9e-11	1.4e-13	1	60534.5	HUMAN	T-complex protein 1 subunit gamma
[81]		P49368	TCPG_HUMAN	CCT3	4	10.1	6.21	6.9e-11	583.8480	2	-0.39	AVAQALEVIPR	AVAQALEVIPR		11	V20130429-05_FTMSms2hcd	40.453	439	449	34.7	1.2e-7	8.6e-10	1	60534.5	HUMAN	T-complex protein 1 subunit gamma
[81]		P49368	TCPG_HUMAN	CCT3	4	10.1	6.21	6.9e-11	677.3134	2	-4.5	AMTGVEQWPYR	AM(Oxidation)TGVEQWPYR	Oxidation@429	11	V20130429-05_FTMSms2hcd	32.135	428	438	12.2	0.0028	4.0e-6	1	60534.5	HUMAN	T-complex protein 1 subunit gamma
[81]		P49368	TCPG_HUMAN	CCT3	4	10.1	6.21	6.9e-11	401.2457	2	1.6	TIADIIR	TIADIIR		7	V20130429-05_FTMSms2hcd	33.635	32	38	22.8	0.035	6.1e-5	2	60534.5	HUMAN	T-complex protein 1 subunit gamma
[82]		P23284	PPIB_HUMAN	PPIB	3	13.4	5.60	9.2e-10	574.6451	3	-0.78	IGDEDVGRVIFGLFGK	IGDEDVGRVIFGLFGK		16	V20130429-05_FTMSms2hcd	67.435	52	67	33.6	9.2e-10	1.8e-12	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[82]		P23284	PPIB_HUMAN	PPIB	3	13.4	5.60	9.2e-10	682.8578	2	2.0	TVDNFVALATGEK	TVDNFVALATGEK		13	V20130429-05_FTMSms2hcd	45.163	72	84	42.8	4.2e-8	5.8e-11	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[82]		P23284	PPIB_HUMAN	PPIB	3	13.4	5.60	9.2e-10	440.7682	2	0.025	VIFGLFGK	VIFGLFGK		8	V20130429-05_FTMSms2hcd	52.594	60	67	24.1	9.0e-6	7.3e-8	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[83]		P43243	MATR3_HUMAN	MATR3	2	5.4	9.15	2.5e-16	796.4265	3	2.1	DLSAAGIGLLAAATQSLSMPASLGR	DLSAAGIGLLAAATQSLSM(Oxidation)PASLGR	Oxidation@38	25	V20130429-05_FTMSms2hcd	75.629	20	44	49.2	2.5e-16	5.2e-19	1	94624.0	HUMAN	Matrin-3
[83]		P43243	MATR3_HUMAN	MATR3	2	5.4	9.15	2.5e-16	813.4648	3	-0.31	YQLLQLVEPFGVISNHLILNK	YQLLQLVEPFGVISNHLILNK		21	V20130429-05_FTMSms2hcd	75.097	413	433	24.2	8.0e-8	6.5e-10	1	94624.0	HUMAN	Matrin-3
[84]		P62241	RS8_HUMAN	RPS8	3	12.5	5.41	2.0e-9	753.8939	2	0.45	ISSLLEEQFQQGK	ISSLLEEQFQQGK		13	V20130429-05_FTMSms2hcd	39.317	158	170	47.5	2.0e-9	2.8e-12	1	24205.4	HUMAN	40S ribosomal protein S8
[84]		P62241	RS8_HUMAN	RPS8	3	12.5	5.41	2.0e-9	400.4741	4	-0.15	LTPEEEEILNKKR	LTPEEEEILNKKR		13	V20130429-05_FTMSms2hcd	24.364	129	141	31.6	7.4e-7	1.6e-9	1	24205.4	HUMAN	40S ribosomal protein S8
[84]		P62241	RS8_HUMAN	RPS8	3	12.5	5.41	2.0e-9	657.8431	2	0.14	LTPEEEEILNK	LTPEEEEILNK		11	V20130429-05_FTMSms2hcd	32.245	129	139	36.0	2.0e-6	3.1e-9	1	24205.4	HUMAN	40S ribosomal protein S8
[85]		P11586	C1TC_HUMAN	MTHFD1	4	4.5	5.57	4.2e-10	752.8603	2	0.51	TDPTTLTDEEINR	TDPTTLTDEEINR		13	V20130429-05_FTMSms2hcd	29.778	505	517	37.9	4.2e-10	5.2e-13	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[85]		P11586	C1TC_HUMAN	MTHFD1	4	4.5	5.57	4.2e-10	600.3163	2	-1.1	TPVPSDIDISR	TPVPSDIDISR		11	V20130429-05_FTMSms2hcd	31.650	314	324	36.1	2.5e-7	4.1e-10	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[85]		P11586	C1TC_HUMAN	MTHFD1	4	4.5	5.57	4.2e-10	450.7791	2	-0.41	VLLSALER	VLLSALER		8	V20130429-05_FTMSms2hcd	36.724	355	362	32.7	0.0011	2.7e-6	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[85]		P11586	C1TC_HUMAN	MTHFD1	4	4.5	5.57	4.2e-10	456.7600	2	-2.4	MAPAEILNGK	M(Met-loss)APAEILNGK	Met-loss@1	10	V20130429-05_FTMSms2hcd	43.384	1	10	12.2	0.040	1.7e-4	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[86]		P40926	MDHM_HUMAN	MDH2	2	12.1	6.51	1.9e-11	897.0588	2	12	VAVLGASGGIGQPLSLLLK	VAVLGASGGIGQPLSLLLK		19	V20130429-05_FTMSms2hcd	67.340	27	45	51.7	1.9e-11	9.5e-13	1	35503.6	HUMAN	Malate dehydrogenase, mitochondrial
[86]		P40926	MDHM_HUMAN	MDH2	2	12.1	6.51	1.9e-11	592.0741	4	15	LTLYDIAHTPGVAADLSHIETK	LTLYDIAHTPGVAADLSHIETK		22	V20130429-05_FTMSms2hcd	55.414	53	74	41.0	3.4e-11	9.2e-14	1	35503.6	HUMAN	Malate dehydrogenase, mitochondrial
[87]		P25398	RS12_HUMAN	RPS12	2	25.0	8.36	7.1e-15	1137.0679	2	-1.9	MAEEGIAAGGVMDVNTALQEVLK	M(Met-loss+Acetyl)AEEGIAAGGVM(Oxidation)DVNTALQEVLK	Met-loss+Acetyl@1;Oxidation@12	23	V20130429-05_FTMSms2hcd	71.782	1	23	51.0	7.1e-15	8.2e-18	1	14515.1	HUMAN	40S ribosomal protein S12
[87]		P25398	RS12_HUMAN	RPS12	2	25.0	8.36	7.1e-15	533.8000	2	-7.2	TALIHDGLAR	TALIHDGLAR		10	V20130429-05_FTMSms2hcd	23.586	24	33	34.1	3.5e-7	7.8e-10	1	14515.1	HUMAN	40S ribosomal protein S12
[88]		P52272	HNRPM_HUMAN	HNRNPM	2	6.0	7.89	3.3e-14	924.7198	4	0.37	GIGTVTFEQSIEAVQAISMFNGQLLFDRPMHVK	GIGTVTFEQSIEAVQAISM(Oxidation)FNGQLLFDRPM(Oxidation)HVK	Oxidation@263;Oxidation@274	33	V20130429-05_FTMSms2hcd	76.165	245	277	38.9	3.3e-14	5.2e-17	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[88]		P52272	HNRPM_HUMAN	HNRNPM	2	6.0	7.89	3.3e-14	632.8506	2	0.26	AFITNIPFDVK	AFITNIPFDVK		11	V20130429-05_FTMSms2hcd	53.519	73	83	29.4	4.3e-8	9.4e-11	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[89]		P62424	RL7A_HUMAN	RPL7A	2	10.2	7.12	1.4e-12	604.3481	3	6.8	LKVPPAINQFTQALDR	LKVPPAINQFTQALDR		16	V20130429-05_FTMSms2hcd	54.451	74	89	51.5	1.4e-12	7.0e-15	1	29995.9	HUMAN	60S ribosomal protein L7a
[89]		P62424	RL7A_HUMAN	RPL7A	2	10.2	7.12	1.4e-12	608.8202	2	0.87	NFGIGQDIQPK	NFGIGQDIQPK		11	V20130429-05_FTMSms2hcd	33.548	38	48	29.3	1.7e-8	2.6e-11	1	29995.9	HUMAN	60S ribosomal protein L7a
[90]		P68431	H31_HUMAN	HIST1H3A	4	21.3	3.87	8.7e-7	516.8000	2	-2.1	YRPGTVALR	YRPGTVALR		9	V20130429-05_FTMSms2hcd	19.867	42	50	38.8	8.7e-7	2.2e-9	5	15404.2	HUMAN	Histone H3.1
[90]		P68431	H31_HUMAN	HIST1H3A	4	21.3	3.87	8.7e-7	445.9015	3	-0.27	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-05_FTMSms2hcd	30.438	74	84	28.9	1.2e-6	1.7e-9	4	15404.2	HUMAN	Histone H3.1
[90]		P68431	H31_HUMAN	HIST1H3A	4	21.3	3.87	8.7e-7	477.6121	3	-0.64	YRPGTVALREIR	YRPGTVALREIR		12	V20130429-05_FTMSms2hcd	26.120	42	53	12.4	4.0e-4	1.4e-6	5	15404.2	HUMAN	Histone H3.1
[90]		P68431	H31_HUMAN	HIST1H3A	4	21.3	3.87	8.7e-7	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-05_FTMSms2hcd	22.684	65	70	23.2	0.016	4.8e-5	5	15404.2	HUMAN	Histone H3.1
[90-1]	0	P84243	H33_HUMAN	H3F3A	4	21.3	3.87	8.7e-7	516.8000	2	-2.1	YRPGTVALR	YRPGTVALR		9	V20130429-05_FTMSms2hcd	19.867	42	50	38.8	8.7e-7	2.2e-9	5	15328.0	HUMAN	Histone H3.3
[90-1]	0	P84243	H33_HUMAN	H3F3A	4	21.3	3.87	8.7e-7	445.9015	3	-0.27	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-05_FTMSms2hcd	30.438	74	84	28.9	1.2e-6	1.7e-9	4	15328.0	HUMAN	Histone H3.3
[90-1]	0	P84243	H33_HUMAN	H3F3A	4	21.3	3.87	8.7e-7	477.6121	3	-0.64	YRPGTVALREIR	YRPGTVALREIR		12	V20130429-05_FTMSms2hcd	26.120	42	53	12.4	4.0e-4	1.4e-6	5	15328.0	HUMAN	Histone H3.3
[90-1]	0	P84243	H33_HUMAN	H3F3A	4	21.3	3.87	8.7e-7	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-05_FTMSms2hcd	22.684	65	70	23.2	0.016	4.8e-5	5	15328.0	HUMAN	Histone H3.3
[90-2]	0	Q16695	H31T_HUMAN	HIST3H3	4	21.3	3.87	8.7e-7	516.8000	2	-2.1	YRPGTVALR	YRPGTVALR		9	V20130429-05_FTMSms2hcd	19.867	42	50	38.8	8.7e-7	2.2e-9	5	15508.4	HUMAN	Histone H3.1t
[90-2]	0	Q16695	H31T_HUMAN	HIST3H3	4	21.3	3.87	8.7e-7	445.9015	3	-0.27	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-05_FTMSms2hcd	30.438	74	84	28.9	1.2e-6	1.7e-9	4	15508.4	HUMAN	Histone H3.1t
[90-2]	0	Q16695	H31T_HUMAN	HIST3H3	4	21.3	3.87	8.7e-7	477.6121	3	-0.64	YRPGTVALREIR	YRPGTVALREIR		12	V20130429-05_FTMSms2hcd	26.120	42	53	12.4	4.0e-4	1.4e-6	5	15508.4	HUMAN	Histone H3.1t
[90-2]	0	Q16695	H31T_HUMAN	HIST3H3	4	21.3	3.87	8.7e-7	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-05_FTMSms2hcd	22.684	65	70	23.2	0.016	4.8e-5	5	15508.4	HUMAN	Histone H3.1t
[90-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	4	21.3	3.87	8.7e-7	516.8000	2	-2.1	YRPGTVALR	YRPGTVALR		9	V20130429-05_FTMSms2hcd	19.867	42	50	38.8	8.7e-7	2.2e-9	5	15388.2	HUMAN	Histone H3.2
[90-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	4	21.3	3.87	8.7e-7	445.9015	3	-0.27	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-05_FTMSms2hcd	30.438	74	84	28.9	1.2e-6	1.7e-9	4	15388.2	HUMAN	Histone H3.2
[90-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	4	21.3	3.87	8.7e-7	477.6121	3	-0.64	YRPGTVALREIR	YRPGTVALREIR		12	V20130429-05_FTMSms2hcd	26.120	42	53	12.4	4.0e-4	1.4e-6	5	15388.2	HUMAN	Histone H3.2
[90-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	4	21.3	3.87	8.7e-7	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-05_FTMSms2hcd	22.684	65	70	23.2	0.016	4.8e-5	5	15388.2	HUMAN	Histone H3.2
[90-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	3	13.3	3.87	8.7e-7	516.8000	2	-2.1	YRPGTVALR	YRPGTVALR		9	V20130429-05_FTMSms2hcd	19.867	41	49	38.8	8.7e-7	2.2e-9	5	15213.9	HUMAN	Histone H3.3C
[90-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	3	13.3	3.87	8.7e-7	477.6121	3	-0.64	YRPGTVALREIR	YRPGTVALREIR		12	V20130429-05_FTMSms2hcd	26.120	41	52	12.4	4.0e-4	1.4e-6	5	15213.9	HUMAN	Histone H3.3C
[90-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	3	13.3	3.87	8.7e-7	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-05_FTMSms2hcd	22.684	64	69	23.2	0.016	4.8e-5	5	15213.9	HUMAN	Histone H3.3C
[91]		P08758	ANXA5_HUMAN	ANXA5	2	10.0	6.05	1.4e-10	617.6663	3	5.3	DLLDDLKSELTGKFEK	DLLDDLKSELTGKFEK		16	V20130429-05_FTMSms2hcd	65.242	64	79	43.6	1.4e-10	2.4e-13	1	35937.1	HUMAN	Annexin A5
[91]		P08758	ANXA5_HUMAN	ANXA5	2	10.0	6.05	1.4e-10	568.9800	3	14	GLGTDEESILTLLTSR	GLGTDEESILTLLTSR		16	V20130429-05_FTMSms2hcd	67.379	30	45	22.6	2.8e-9	5.4e-12	1	35937.1	HUMAN	Annexin A5
[92]		P83731	RL24_HUMAN	RPL24	2	13.4	7.49	3.0e-13	639.3418	2	-0.50	AITGASLADIMAK	AITGASLADIM(Oxidation)AK	Oxidation@91	13	V20130429-05_FTMSms2hcd	35.715	81	93	48.8	3.0e-13	4.6e-16	1	17779.1	HUMAN	60S ribosomal protein L24
[92]		P83731	RL24_HUMAN	RPL24	2	13.4	7.49	3.0e-13	483.7738	2	-0.42	VFQFLNAK	VFQFLNAK		8	V20130429-05_FTMSms2hcd	40.522	28	35	24.6	8.1e-6	2.3e-8	1	17779.1	HUMAN	60S ribosomal protein L24
[93]		P02768	ALBU_HUMAN	ALB	3	4.8	6.41	2.9e-11	547.3191	3	3.0	KVPQVSTPTLVEVSR	KVPQVSTPTLVEVSR		15	V20130429-05_FTMSms2hcd	36.246	438	452	45.7	2.9e-11	1.5e-13	1	69367.4	HUMAN	Serum albumin
[93]		P02768	ALBU_HUMAN	ALB	3	4.8	6.41	2.9e-11	395.2388	2	-1.7	LVTDLTK	LVTDLTK		7	V20130429-05_FTMSms2hcd	21.590	258	264	30.4	0.0013	3.8e-6	1	69367.4	HUMAN	Serum albumin
[93]		P02768	ALBU_HUMAN	ALB	3	4.8	6.41	2.9e-11	464.2503	2	-0.13	YLYEIAR	YLYEIAR		7	V20130429-05_FTMSms2hcd	30.651	162	168	29.8	0.0017	4.0e-6	1	69367.4	HUMAN	Serum albumin
[94]		P62269	RS18_HUMAN	RPS18	3	19.1	5.25	4.1e-9	541.3235	3	8.3	MSLVIPEKFQHILR	M(Met-loss+Acetyl)SLVIPEKFQHILR	Met-loss+Acetyl@1	14	V20130429-05_FTMSms2hcd	54.715	1	14	45.4	4.1e-9	4.5e-11	1	17718.8	HUMAN	40S ribosomal protein S18
[94]		P62269	RS18_HUMAN	RPS18	3	19.1	5.25	4.1e-9	501.2725	2	0.29	VLNTNIDGR	VLNTNIDGR		9	V20130429-05_FTMSms2hcd	20.957	15	23	21.2	5.3e-5	9.2e-8	1	17718.8	HUMAN	40S ribosomal protein S18
[94]		P62269	RS18_HUMAN	RPS18	3	19.1	5.25	4.1e-9	408.2187	2	-1.2	HFWGLR	HFWGLR		6	V20130429-05_FTMSms2hcd	30.598	125	130	21.7	6.1e-4	1.5e-6	1	17718.8	HUMAN	40S ribosomal protein S18
[95]		P50395	GDIB_HUMAN	GDI2	2	6.7	6.72	4.3e-12	1071.0618	2	4.5	SPYLYPLYGLGELPQGFAR	SPYLYPLYGLGELPQGFAR		19	V20130429-05_FTMSms2hcd	66.877	222	240	38.6	4.3e-12	7.2e-15	2	50663.7	HUMAN	Rab GDP dissociation inhibitor beta
[95]		P50395	GDIB_HUMAN	GDI2	2	6.7	6.72	4.3e-12	609.3615	2	1.4	FVSISDLLVPK	FVSISDLLVPK		11	V20130429-05_FTMSms2hcd	59.211	380	390	26.1	1.2e-6	5.1e-9	1	50663.7	HUMAN	Rab GDP dissociation inhibitor beta
[95-1]	0	P31150	GDIA_HUMAN	GDI1	1	4.3	6.72	4.3e-12	1071.0618	2	4.5	SPYLYPLYGLGELPQGFAR	SPYLYPLYGLGELPQGFAR		19	V20130429-05_FTMSms2hcd	66.877	222	240	38.6	4.3e-12	7.2e-15	2	50583.2	HUMAN	Rab GDP dissociation inhibitor alpha
[96]		P36578	RL4_HUMAN	RPL4	3	8.7	3.71	3.4e-7	478.7807	2	1.8	AAAAAAALQAK	AAAAAAALQAK		11	V20130429-05_FTMSms2hcd	16.486	354	364	33.0	3.4e-7	1.1e-9	1	47697.7	HUMAN	60S ribosomal protein L4
[96]		P36578	RL4_HUMAN	RPL4	3	8.7	3.71	3.4e-7	498.2899	4	1.6	APIRPDIVNFVHTNLRK	APIRPDIVNFVHTNLRK		17	V20130429-05_FTMSms2hcd	41.882	30	46	22.1	3.4e-7	2.7e-9	1	47697.7	HUMAN	60S ribosomal protein L4
[96]		P36578	RL4_HUMAN	RPL4	3	8.7	3.71	3.4e-7	361.8887	3	-0.48	ILKSPEIQR	ILKSPEIQR		9	V20130429-05_FTMSms2hcd	20.190	292	300	34.9	6.4e-6	3.8e-8	1	47697.7	HUMAN	60S ribosomal protein L4
[97]		P60866	RS20_HUMAN	RPS20	2	26.1	5.28	3.5e-9	510.0246	4	0.10	MAFKDTGKTPVEPEVAIHR	M(Met-loss+Acetyl)AFKDTGKTPVEPEVAIHR	Met-loss+Acetyl@1	19	V20130429-05_FTMSms2hcd	33.485	1	19	42.6	3.5e-9	6.2e-12	1	13372.8	HUMAN	40S ribosomal protein S20
[97]		P60866	RS20_HUMAN	RPS20	2	26.1	5.28	3.5e-9	675.8852	2	0.28	LIDLHSPSEIVK	LIDLHSPSEIVK		12	V20130429-05_FTMSms2hcd	37.747	88	99	33.3	4.1e-8	1.2e-10	1	13372.8	HUMAN	40S ribosomal protein S20
[98]		P46778	RL21_HUMAN	RPL21	2	20.6	5.13	4.6e-9	1047.5145	2	5.6	TNGKEPELLEPIPYEFMA	TNGKEPELLEPIPYEFM(Oxidation)A	Oxidation@159	18	V20130429-05_FTMSms2hcd	57.242	143	160	28.0	4.6e-9	4.7e-12	1	18565.0	HUMAN	60S ribosomal protein L21
[98]		P46778	RL21_HUMAN	RPL21	2	20.6	5.13	4.6e-9	820.9589	2	-0.82	VYNVTQHAVGIVVNK	VYNVTQHAVGIVVNK		15	V20130429-05_FTMSms2hcd	34.367	64	78	39.1	1.7e-8	4.7e-11	1	18565.0	HUMAN	60S ribosomal protein L21
[99]		P62917	RL8_HUMAN	RPL8	3	10.1	3.80	6.0e-8	471.2793	2	-1.5	AVVGVVAGGGR	AVVGVVAGGGR		11	V20130429-05_FTMSms2hcd	20.356	164	174	31.8	6.0e-8	2.6e-10	1	28024.9	HUMAN	60S ribosomal protein L8
[99]		P62917	RL8_HUMAN	RPL8	3	10.1	3.80	6.0e-8	583.6968	3	0.76	AVVGVVAGGGRIDKPILK	AVVGVVAGGGRIDKPILK		18	V20130429-05_FTMSms2hcd	34.394	164	181	21.5	3.5e-7	1.5e-8	1	28024.9	HUMAN	60S ribosomal protein L8
[99]		P62917	RL8_HUMAN	RPL8	3	10.1	3.80	6.0e-8	351.1937	3	-1.7	VVFRDPYR	VVFRDPYR		8	V20130429-05_FTMSms2hcd	25.599	61	68	20.4	6.0e-5	1.3e-7	1	28024.9	HUMAN	60S ribosomal protein L8
[100]		P62328	TYB4_HUMAN	TMSB4X	3	61.4	4.86	2.1e-8	570.9339	3	-1.1	MSDKPDMAEIEKFDK	M(Met-loss+Acetyl)SDKPDM(Oxidation)AEIEKFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-05_FTMSms2hcd	27.742	1	15	44.2	2.1e-8	2.4e-11	1	5052.7	HUMAN	Thymosin beta-4
[100]		P62328	TYB4_HUMAN	TMSB4X	3	61.4	4.86	2.1e-8	660.8024	2	-0.95	MSDKPDMAEIEK	M(Met-loss+Acetyl)SDKPDM(Oxidation)AEIEK	Met-loss+Acetyl@1;Oxidation@7	12	V20130429-05_FTMSms2hcd	16.314	1	12	17.9	1.3e-4	2.1e-7	2	5052.7	HUMAN	Thymosin beta-4
[100]		P62328	TYB4_HUMAN	TMSB4X	3	61.4	4.86	2.1e-8	674.8159	2	1.4	ETIEQEKQAGES	ETIEQEKQAGES		12	V20130429-05_FTMSms2hcd	10.303	33	44	10.2	0.058	7.9e-5	2	5052.7	HUMAN	Thymosin beta-4
[100-1]	0	A8MW06	TMSL3_HUMAN	TMSL3	1	27.3	0.61	1.3e-4	660.8024	2	-0.95	MSDKPDMAEIEK	M(Met-loss+Acetyl)SDKPDM(Oxidation)AEIEK	Met-loss+Acetyl@1;Oxidation@7	12	V20130429-05_FTMSms2hcd	16.314	1	12	17.9	1.3e-4	2.1e-7	2	5062.7	HUMAN	Thymosin beta-4-like protein 3
[101]		P05141	ADT2_HUMAN	SLC25A5	2	13.8	6.56	1.5e-11	718.0518	3	5.8	MTDAAVSFAKDFLAGGVAAAISK	M(Met-loss+Acetyl)TDAAVSFAKDFLAGGVAAAISK	Met-loss+Acetyl@1	23	V20130429-05_FTMSms2hcd	77.176	1	23	40.8	1.5e-11	3.0e-14	1	32852.5	HUMAN	ADP/ATP translocase 2
[101]		P05141	ADT2_HUMAN	SLC25A5	2	13.8	6.56	1.5e-11	674.0209	3	1.1	GMGGAFVLVLYDEIKKYT	GM(Oxidation)GGAFVLVLYDEIKKYT	Oxidation@282	18	V20130429-05_FTMSms2hcd	75.231	281	298	10.5	5.4e-4	7.5e-7	1	32852.5	HUMAN	ADP/ATP translocase 2
[102]		Q9NR30	DDX21_HUMAN	DDX21	2	4.2	4.69	1.1e-8	703.3744	3	-0.38	GAVEALAAALAHISGATSVDQR	GAVEALAAALAHISGATSVDQR		22	V20130429-05_FTMSms2hcd	67.513	606	627	25.3	1.1e-8	1.9e-11	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[102]		Q9NR30	DDX21_HUMAN	DDX21	2	4.2	4.69	1.1e-8	633.3682	2	12	TFSFAIPLIEK	TFSFAIPLIEK		11	V20130429-05_FTMSms2hcd	62.017	237	247	36.8	5.7e-8	2.6e-10	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[103]		P61313	RL15_HUMAN	RPL15	2	12.3	5.90	7.8e-11	853.4619	2	1.9	GATYGKPVHHGVNQLK	GATYGKPVHHGVNQLK		16	V20130429-05_FTMSms2hcd	13.064	78	93	37.2	7.8e-11	1.6e-13	1	24146.3	HUMAN	60S ribosomal protein L15
[103]		P61313	RL15_HUMAN	RPL15	2	12.3	5.90	7.8e-11	509.7623	2	0.94	SLQSVAEER	SLQSVAEER		9	V20130429-05_FTMSms2hcd	20.032	97	105	31.4	1.4e-5	2.2e-8	1	24146.3	HUMAN	60S ribosomal protein L15
[104]		P09382	LEG1_HUMAN	LGALS1	3	19.3	3.27	1.8e-6	538.7416	2	0.34	DGGAWGTEQR	DGGAWGTEQR		10	V20130429-05_FTMSms2hcd	15.473	65	74	34.4	1.8e-6	3.6e-9	1	14715.8	HUMAN	Galectin-1
[104]		P09382	LEG1_HUMAN	LGALS1	3	19.3	3.27	1.8e-6	439.2602	2	-1.2	SFVLNLGK	SFVLNLGK		8	V20130429-05_FTMSms2hcd	40.509	30	37	26.2	3.2e-6	1.3e-8	1	14715.8	HUMAN	Galectin-1
[104]		P09382	LEG1_HUMAN	LGALS1	3	19.3	3.27	1.8e-6	484.7397	2	-0.26	LPDGYEFK	LPDGYEFK		8	V20130429-05_FTMSms2hcd	30.470	101	108	22.9	3.8e-5	5.4e-8	1	14715.8	HUMAN	Galectin-1
[105]		P30050	RL12_HUMAN	RPL12	2	15.2	5.39	1.8e-10	833.9908	2	0.32	QAQIEVVPSASALIIK	QAQIEVVPSASALIIK		16	V20130429-05_FTMSms2hcd	51.752	68	83	32.6	1.8e-10	1.3e-12	1	17818.7	HUMAN	60S ribosomal protein L12
[105]		P30050	RL12_HUMAN	RPL12	2	15.2	5.39	1.8e-10	441.2763	2	-0.18	IGPLGLSPK	IGPLGLSPK		9	V20130429-05_FTMSms2hcd	33.474	32	40	34.1	9.2e-7	1.0e-8	1	17818.7	HUMAN	60S ribosomal protein L12
[106]		Q6DN03	H2B2C_HUMAN	HIST2H2BC	3	6.2	3.60	2.9e-8	640.3312	2	-1.4	KESYSIYVYK	KESYSIYVYK		10	V20130429-05_FTMSms2hcd	28.656	35	44	28.1	2.9e-8	4.1e-11	7	21472.3	HUMAN	Putative histone H2B type 2-C
[106]		Q6DN03	H2B2C_HUMAN	HIST2H2BC	3	6.2	3.60	2.9e-8	508.2674	3	-1.6	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-05_FTMSms2hcd	25.167	33	44	18.8	1.6e-6	2.1e-9	6	21472.3	HUMAN	Putative histone H2B type 2-C
[106]		Q6DN03	H2B2C_HUMAN	HIST2H2BC	3	6.2	3.60	2.9e-8	576.2852	2	1.0	ESYSIYVYK	ESYSIYVYK		9	V20130429-05_FTMSms2hcd	34.030	36	44	17.4	3.4e-6	4.9e-9	7	21472.3	HUMAN	Putative histone H2B type 2-C
[106-1]	0	Q6DRA6	H2B2D_HUMAN	HIST2H2BD	3	7.3	3.60	2.9e-8	640.3312	2	-1.4	KESYSIYVYK	KESYSIYVYK		10	V20130429-05_FTMSms2hcd	28.656	35	44	28.1	2.9e-8	4.1e-11	7	18018.3	HUMAN	Putative histone H2B type 2-D
[106-1]	0	Q6DRA6	H2B2D_HUMAN	HIST2H2BD	3	7.3	3.60	2.9e-8	508.2674	3	-1.6	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-05_FTMSms2hcd	25.167	33	44	18.8	1.6e-6	2.1e-9	6	18018.3	HUMAN	Putative histone H2B type 2-D
[106-1]	0	Q6DRA6	H2B2D_HUMAN	HIST2H2BD	3	7.3	3.60	2.9e-8	576.2852	2	1.0	ESYSIYVYK	ESYSIYVYK		9	V20130429-05_FTMSms2hcd	34.030	36	44	17.4	3.4e-6	4.9e-9	7	18018.3	HUMAN	Putative histone H2B type 2-D
[107]		P35232	PHB_HUMAN	PHB	2	8.5	4.45	7.5e-8	466.2854	3	-0.49	ILFRPVASQLPR	ILFRPVASQLPR		12	V20130429-05_FTMSms2hcd	39.282	94	105	38.8	7.5e-8	6.1e-10	1	29804.3	HUMAN	Prohibitin
[107]		P35232	PHB_HUMAN	PHB	2	8.5	4.45	7.5e-8	607.3740	2	0.42	VLPSITTEILK	VLPSITTEILK		11	V20130429-05_FTMSms2hcd	49.844	118	128	29.0	5.0e-7	2.7e-9	1	29804.3	HUMAN	Prohibitin
[108]		P67809	YBOX1_HUMAN	YBX1	1	7.4	8.43	5.4e-15	928.7401	3	0.21	EDGNEEDKENQGDETQGQQPPQRR	EDGNEEDKENQGDETQGQQPPQRR		24	V20130429-05_FTMSms2hcd	10.212	257	280	53.7	5.4e-15	5.4e-18	1	35924.5	HUMAN	Nuclease-sensitive element-binding protein 1
[109]		P40227	TCPZ_HUMAN	CCT6A	3	6.8	4.68	4.7e-8	631.8358	2	1.3	GIDPFSLDALSK	GIDPFSLDALSK		12	V20130429-05_FTMSms2hcd	53.659	296	307	41.0	4.7e-8	7.2e-11	1	58024.7	HUMAN	T-complex protein 1 subunit zeta
[109]		P40227	TCPZ_HUMAN	CCT6A	3	6.8	4.68	4.7e-8	387.2599	2	-0.77	SVTLLIK	SVTLLIK		7	V20130429-05_FTMSms2hcd	36.108	371	377	12.9	0.0085	1.1e-4	1	58024.7	HUMAN	T-complex protein 1 subunit zeta
[109]		P40227	TCPZ_HUMAN	CCT6A	3	6.8	4.68	4.7e-8	884.5159	2	-6.9	AQLGVQAFADALLIIPK	AQLGVQAFADALLIIPK		17	V20130429-05_FTMSms2hcd	75.760	433	449	12.2	0.012	9.6e-5	1	58024.7	HUMAN	T-complex protein 1 subunit zeta
[110]		P62306	RUXF_HUMAN	SNRPF	1	25.6	8.22	1.3e-14	770.1160	3	10	MSLPLNPKPFLNGLTGKPVMVK	M(Met-loss+Acetyl)SLPLNPKPFLNGLTGKPVM(Oxidation)VK	Met-loss+Acetyl@1;Oxidation@20	22	V20130429-05_FTMSms2hcd	58.912	1	22	42.9	1.3e-14	1.5e-16	1	9725.3	HUMAN	Small nuclear ribonucleoprotein F
[111]		P62753	RS6_HUMAN	RPS6	3	12.4	3.34	2.2e-7	445.9019	3	0.63	LFNLSKEDDVR	LFNLSKEDDVR		11	V20130429-05_FTMSms2hcd	31.515	144	154	30.2	2.2e-7	3.2e-10	1	28680.9	HUMAN	40S ribosomal protein S6
[111]		P62753	RS6_HUMAN	RPS6	3	12.4	3.34	2.2e-7	642.8428	2	-0.84	DIPGLTDTTVPR	DIPGLTDTTVPR		12	V20130429-05_FTMSms2hcd	38.803	120	131	21.4	2.5e-7	4.7e-10	1	28680.9	HUMAN	40S ribosomal protein S6
[111]		P62753	RS6_HUMAN	RPS6	3	12.4	3.34	2.2e-7	494.7508	2	-0.25	LIEVDDER	LIEVDDER		8	V20130429-05_FTMSms2hcd	21.831	15	22	24.4	0.0016	2.9e-6	1	28680.9	HUMAN	40S ribosomal protein S6
[112]		Q92688	AN32B_HUMAN	ANP32B	2	12.0	5.79	2.0e-10	653.6057	4	3.7	IFGGLDMLAEKLPNLTHLNLSGNK	IFGGLDM(Oxidation)LAEKLPNLTHLNLSGNK	Oxidation@82	24	V20130429-05_FTMSms2hcd	66.179	76	99	38.4	2.0e-10	5.5e-13	1	28787.9	HUMAN	Acidic leucine-rich nuclear phosphoprotein 32 family member B
[112]		Q92688	AN32B_HUMAN	ANP32B	2	12.0	5.79	2.0e-10	390.7399	2	-0.16	IHLELR	IHLELR		6	V20130429-05_FTMSms2hcd	25.859	7	12	27.0	0.0021	1.5e-5	2	28787.9	HUMAN	Acidic leucine-rich nuclear phosphoprotein 32 family member B
[112-1]	0	P39687	AN32A_HUMAN	ANP32A	1	2.4	0.86	0.0021	390.7399	2	-0.16	IHLELR	IHLELR		6	V20130429-05_FTMSms2hcd	25.859	7	12	27.0	0.0021	1.5e-5	2	28585.6	HUMAN	Acidic leucine-rich nuclear phosphoprotein 32 family member A
[113]		P84103	SRSF3_HUMAN	SRSF3	2	26.2	5.62	4.6e-10	626.3220	3	0.15	VYVGNLGNNGNKTELER	VYVGNLGNNGNKTELER		17	V20130429-05_FTMSms2hcd	27.323	12	28	38.6	4.6e-10	6.0e-13	1	19329.8	HUMAN	Serine/arginine-rich splicing factor 3
[113]		P84103	SRSF3_HUMAN	SRSF3	2	26.2	5.62	4.6e-10	723.3554	4	8.4	NPPGFAFVEFEDPRDAADAVRELDGR	NPPGFAFVEFEDPRDAADAVRELDGR		26	V20130429-05_FTMSms2hcd	60.337	44	69	13.8	0.0022	2.1e-6	1	19329.8	HUMAN	Serine/arginine-rich splicing factor 3
[114]		P49915	GUAA_HUMAN	GMPS	1	4.3	7.56	1.8e-14	1082.2654	3	-1.6	VVYIFGPPVKEPPTDVTPTFLTTGVLSTLR	VVYIFGPPVKEPPTDVTPTFLTTGVLSTLR		30	V20130429-05_FTMSms2hcd	72.963	560	589	34.2	1.8e-14	1.2e-16	1	76716.1	HUMAN	GMP synthase [glutamine-hydrolyzing]
[115]		P25205	MCM3_HUMAN	MCM3	1	2.6	7.55	2.3e-13	820.4181	3	2.3	TVDLQDAEEAVELVQYAYFKK	TVDLQDAEEAVELVQYAYFKK		21	V20130429-05_FTMSms2hcd	69.389	636	656	45.3	2.3e-13	3.0e-16	1	90981.6	HUMAN	DNA replication licensing factor MCM3
[116]		P06744	G6PI_HUMAN	GPI	2	4.3	3.77	4.1e-9	860.4785	2	2.0	ILLANFLAQTEALMR	ILLANFLAQTEALM(Oxidation)R	Oxidation@437	15	V20130429-05_FTMSms2hcd	65.696	424	438	24.6	4.1e-9	9.8e-12	1	63147.7	HUMAN	Glucose-6-phosphate isomerase
[116]		P06744	G6PI_HUMAN	GPI	2	4.3	3.77	4.1e-9	546.7700	2	-2.4	NLVTEDVMR	NLVTEDVM(Oxidation)R	Oxidation@65	9	V20130429-05_FTMSms2hcd	23.691	58	66	25.2	5.1e-9	8.7e-12	1	63147.7	HUMAN	Glucose-6-phosphate isomerase
[117]		P62750	RL23A_HUMAN	RPL23A	2	18.6	4.06	4.3e-7	685.3942	2	0.97	VNTLIRPDGEKK	VNTLIRPDGEKK		12	V20130429-05_FTMSms2hcd	16.005	124	135	39.0	4.3e-7	1.3e-9	1	17695.2	HUMAN	60S ribosomal protein L23a
[117]		P62750	RL23A_HUMAN	RPL23A	2	18.6	4.06	4.3e-7	900.9984	2	8.5	LAPDYDALDVANKIGII	LAPDYDALDVANKIGII		17	V20130429-05_FTMSms2hcd	63.143	140	156	17.2	7.4e-6	2.0e-8	1	17695.2	HUMAN	60S ribosomal protein L23a
[118]		P61247	RS3A_HUMAN	RPS3A	1	6.8	7.42	3.9e-13	694.0298	3	1.9	VFEVSLADLQNDEVAFRK	VFEVSLADLQNDEVAFRK		18	V20130429-05_FTMSms2hcd	55.164	66	83	49.8	3.9e-13	5.7e-16	1	29945.2	HUMAN	40S ribosomal protein S3a
[119]		P62851	RS25_HUMAN	RPS25	2	15.2	3.84	1.3e-6	486.7895	2	-0.72	AALQELLSK	AALQELLSK		9	V20130429-05_FTMSms2hcd	38.862	86	94	39.5	1.3e-6	2.8e-9	1	13742.2	HUMAN	40S ribosomal protein S25
[119]		P62851	RS25_HUMAN	RPS25	2	15.2	3.84	1.3e-6	542.8218	2	0.22	LITPAVVSER	LITPAVVSER		10	V20130429-05_FTMSms2hcd	32.161	67	76	38.1	4.5e-6	1.7e-8	1	13742.2	HUMAN	40S ribosomal protein S25
[120]		P39023	RL3_HUMAN	RPL3	2	4.5	4.37	1.8e-7	596.3395	2	-1.2	IGQGYLIKDGK	IGQGYLIKDGK		11	V20130429-05_FTMSms2hcd	23.150	287	297	44.4	1.8e-7	4.6e-10	1	46109.3	HUMAN	60S ribosomal protein L3
[120]		P39023	RL3_HUMAN	RPL3	2	4.5	4.37	1.8e-7	375.2190	2	0.37	VAFSVAR	VAFSVAR		7	V20130429-05_FTMSms2hcd	23.678	262	268	34.2	7.8e-5	2.2e-7	1	46109.3	HUMAN	60S ribosomal protein L3
[121]		P62899	RL31_HUMAN	RPL31	1	18.4	7.17	3.5e-13	891.7863	3	5.6	NEDEDSPNKLYTLVTYVPVTTFK	NEDEDSPNKLYTLVTYVPVTTFK		23	V20130429-05_FTMSms2hcd	61.196	93	115	37.2	3.5e-13	4.6e-16	1	14463.0	HUMAN	60S ribosomal protein L31
[122]		P50454	SERPH_HUMAN	SERPINH1	1	3.1	7.15	3.5e-13	546.6335	3	1.3	LFYADHPFIFLVR	LFYADHPFIFLVR		13	V20130429-05_FTMSms2hcd	61.289	381	393	37.1	3.5e-13	8.5e-16	1	46440.9	HUMAN	Serpin H1
[123]		P14174	MIF_HUMAN	MIF	2	18.3	4.54	1.1e-8	652.3448	2	-0.30	MPMFIVNTNVPR	M(Met-loss)PM(Oxidation)FIVNTNVPR	Met-loss@1;Oxidation@3	12	V20130429-05_FTMSms2hcd	36.442	1	12	29.4	1.1e-8	1.6e-11	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[123]		P14174	MIF_HUMAN	MIF	2	18.3	4.54	1.1e-8	494.2867	2	0.57	LLCGLLAER	LLCGLLAER		9	V20130429-05_FTMSms2hcd	46.544	79	87	35.3	5.5e-5	9.6e-8	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[124]		P06576	ATPB_HUMAN	ATP5B	1	3.6	7.01	2.2e-12	640.3702	3	0.0045	VLDSGAPIKIPVGPETLGR	VLDSGAPIKIPVGPETLGR		19	V20130429-05_FTMSms2hcd	47.931	125	143	44.0	2.2e-12	1.5e-14	1	56560.4	HUMAN	ATP synthase subunit beta, mitochondrial
[125]		P46782	RS5_HUMAN	RPS5	1	10.8	6.88	1.7e-12	1158.6016	2	8.7	MTEWETAAPAVAETPDIKLFGK	M(Met-loss+Acetyl)TEWETAAPAVAETPDIKLFGK	Met-loss+Acetyl@1	22	V20130429-05_FTMSms2hcd	59.598	1	22	38.1	1.7e-12	2.8e-15	1	22876.6	HUMAN	40S ribosomal protein S5
[126]		P05388	RLA0_HUMAN	RPLP0	2	6.6	3.59	1.2e-6	611.3151	2	0.57	GHLENNPALEK	GHLENNPALEK		11	V20130429-05_FTMSms2hcd	14.786	67	77	36.8	1.2e-6	1.9e-9	2	34273.8	HUMAN	60S acidic ribosomal protein P0
[126]		P05388	RLA0_HUMAN	RPLP0	2	6.6	3.59	1.2e-6	609.3420	2	-0.73	IIQLLDDYPK	IIQLLDDYPK		10	V20130429-05_FTMSms2hcd	45.637	17	26	34.9	5.1e-6	1.0e-8	2	34273.8	HUMAN	60S acidic ribosomal protein P0
[126-1]	0	Q8NHW5	RLA0L_HUMAN	RPLP0P6	2	6.6	3.59	1.2e-6	611.3151	2	0.57	GHLENNPALEK	GHLENNPALEK		11	V20130429-05_FTMSms2hcd	14.786	67	77	36.8	1.2e-6	1.9e-9	2	34364.8	HUMAN	60S acidic ribosomal protein P0-like
[126-1]	0	Q8NHW5	RLA0L_HUMAN	RPLP0P6	2	6.6	3.59	1.2e-6	609.3420	2	-0.73	IIQLLDDYPK	IIQLLDDYPK		10	V20130429-05_FTMSms2hcd	45.637	17	26	34.9	5.1e-6	1.0e-8	2	34364.8	HUMAN	60S acidic ribosomal protein P0-like
[127]		P18206	VINC_HUMAN	VCL	1	2.5	6.80	3.6e-12	780.1504	4	0.81	TIESILEPVAQQISHLVIMHEEGEVDGK	TIESILEPVAQQISHLVIM(Oxidation)HEEGEVDGK	Oxidation@26	28	V20130429-05_FTMSms2hcd	74.556	8	35	39.0	3.6e-12	5.6e-15	1	123800.4	HUMAN	Vinculin
[128]		P15880	RS2_HUMAN	RPS2	2	7.8	3.94	9.5e-9	513.3025	2	-1.2	GTGIVSAPVPK	GTGIVSAPVPK		11	V20130429-05_FTMSms2hcd	26.801	201	211	28.9	9.5e-9	4.7e-11	1	31324.7	HUMAN	40S ribosomal protein S2
[128]		P15880	RS2_HUMAN	RPS2	2	7.8	3.94	9.5e-9	488.5775	3	0.97	SPYQEFTDHLVK	SPYQEFTDHLVK		12	V20130429-05_FTMSms2hcd	39.435	264	275	18.4	1.6e-6	1.9e-9	1	31324.7	HUMAN	40S ribosomal protein S2
[129]		P08708	RS17_HUMAN	RPS17	1	19.3	6.43	3.3e-12	1002.8230	3	1.5	DNYVPEVSALDQEIIEVDPDTKEMLK	DNYVPEVSALDQEIIEVDPDTKEM(Oxidation)LK	Oxidation@105	26	V20130429-05_FTMSms2hcd	59.224	82	107	35.1	3.3e-12	3.7e-15	2	15550.3	HUMAN	40S ribosomal protein S17
[129-1]	0	P0CW22	RS17L_HUMAN	RPS17L	1	19.3	6.43	3.3e-12	1002.8230	3	1.5	DNYVPEVSALDQEIIEVDPDTKEMLK	DNYVPEVSALDQEIIEVDPDTKEM(Oxidation)LK	Oxidation@105	26	V20130429-05_FTMSms2hcd	59.224	82	107	35.1	3.3e-12	3.7e-15	2	15550.3	HUMAN	40S ribosomal protein S17-like
[130]		O43175	SERA_HUMAN	PHGDH	3	5.3	2.19	2.1e-4	431.2509	2	0.48	MAFANLRK	M(Met-loss+Acetyl)AFANLRK	Met-loss+Acetyl@1	8	V20130429-05_FTMSms2hcd	27.821	1	8	30.8	2.1e-4	3.9e-7	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[130]		O43175	SERA_HUMAN	PHGDH	3	5.3	2.19	2.1e-4	550.3097	2	1.4	GGIVDEGALLR	GGIVDEGALLR		11	V20130429-05_FTMSms2hcd	38.751	237	247	34.8	2.6e-4	5.8e-7	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[130]		O43175	SERA_HUMAN	PHGDH	3	5.3	2.19	2.1e-4	450.2900	2	6.1	TLGILGLGR	TLGILGLGR		9	V20130429-05_FTMSms2hcd	45.691	147	155	30.4	3.7e-4	2.0e-6	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[131]		P61254	RL26_HUMAN	RPL26	2	12.4	3.50	5.0e-7	360.1898	3	0.70	HFNAPSHIR	HFNAPSHIR		9	V20130429-05_FTMSms2hcd	14.747	18	26	33.8	5.0e-7	7.6e-10	1	17258.4	HUMAN	60S ribosomal protein L26
[131]		P61254	RL26_HUMAN	RPL26	2	12.4	3.50	5.0e-7	541.7668	2	-0.20	FNPFVTSDR	FNPFVTSDR		9	V20130429-05_FTMSms2hcd	35.291	3	11	27.1	9.9e-6	1.3e-8	2	17258.4	HUMAN	60S ribosomal protein L26
[131-1]	0	Q9UNX3	RL26L_HUMAN	RPL26L1	1	6.2	2.13	9.9e-6	541.7668	2	-0.20	FNPFVTSDR	FNPFVTSDR		9	V20130429-05_FTMSms2hcd	35.291	3	11	27.1	9.9e-6	1.3e-8	2	17256.4	HUMAN	60S ribosomal protein L26-like 1
[132]		P34932	HSP74_HUMAN	HSPA4	1	3.5	6.27	1.5e-11	1041.8821	3	2.2	AFSDPFVEAEKSNLAYDIVQLPTGLTGIK	AFSDPFVEAEKSNLAYDIVQLPTGLTGIK		29	V20130429-05_FTMSms2hcd	72.373	74	102	37.1	1.5e-11	3.2e-14	1	94331.8	HUMAN	Heat shock 70 kDa protein 4
[133]		P46776	RL27A_HUMAN	RPL27A	1	7.4	6.19	7.4e-11	556.3268	2	-0.59	TGAAPIIDVVR	TGAAPIIDVVR		11	V20130429-05_FTMSms2hcd	38.534	95	105	41.3	7.4e-11	3.8e-13	1	16561.5	HUMAN	60S ribosomal protein L27a
[134]		P26599	PTBP1_HUMAN	PTBP1	1	4.3	6.19	3.3e-11	759.1028	3	7.5	IAIPGLAGAGNSVLLVSNLNPER	IAIPGLAGAGNSVLLVSNLNPER		23	V20130429-05_FTMSms2hcd	64.538	326	348	38.1	3.3e-11	2.7e-13	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[135]		P07305	H10_HUMAN	H1F0	1	7.2	6.13	1.6e-12	745.8618	2	0.53	MTENSTSAPAAKPK	M(Acetyl+Oxidation)TENSTSAPAAKPK		14	V20130429-05_FTMSms2hcd	10.655	1	14	30.4	1.6e-12	1.9e-15	1	20863.1	HUMAN	Histone H1.0
[136]		Q9Y490	TLN1_HUMAN	TLN1	1	0.6	6.10	2.7e-11	761.4354	2	7.4	TLAESALQLLYTAK	TLAESALQLLYTAK		14	V20130429-05_FTMSms2hcd	62.512	1767	1780	36.7	2.7e-11	7.9e-14	1	269769.4	HUMAN	Talin-1
[137]		P11413	G6PD_HUMAN	G6PD	2	4.9	3.11	2.8e-7	913.0178	2	7.5	LFYLALPPTVYEAVTK	LFYLALPPTVYEAVTK		16	V20130429-05_FTMSms2hcd	67.996	137	152	25.1	2.8e-7	1.4e-9	1	59257.3	HUMAN	Glucose-6-phosphate 1-dehydrogenase
[137]		P11413	G6PD_HUMAN	G6PD	2	4.9	3.11	2.8e-7	380.2131	3	-0.68	LKLEDFFAR	LKLEDFFAR		9	V20130429-05_FTMSms2hcd	49.564	96	104	28.6	5.1e-7	1.2e-9	1	59257.3	HUMAN	Glucose-6-phosphate 1-dehydrogenase
[138]		O60506	HNRPQ_HUMAN	SYNCRIP	2	4.0	5.20	6.4e-10	797.4085	2	3.2	DLFEDELVPLFEK	DLFEDELVPLFEK		13	V20130429-05_FTMSms2hcd	69.178	172	184	35.1	6.4e-10	7.5e-13	1	69603.2	HUMAN	Heterogeneous nuclear ribonucleoprotein Q
[138]		O60506	HNRPQ_HUMAN	SYNCRIP	2	4.0	5.20	6.4e-10	696.3378	2	-9.1	SAFLCGVMKTYR	SAFLCGVM(Oxidation)KTYR	Oxidation@99	12	V20130429-05_FTMSms2hcd	42.315	92	103	12.2	0.089	1.2e-4	2	69603.2	HUMAN	Heterogeneous nuclear ribonucleoprotein Q
[138-1]	1	O43390	HNRPR_HUMAN	HNRNPR	2	3.9	4.93	9.6e-10	805.4048	2	1.7	DLYEDELVPLFEK	DLYEDELVPLFEK		13	V20130429-05_FTMSms2hcd	61.302	175	187	33.4	9.6e-10	1.2e-12	1	70943.6	HUMAN	Heterogeneous nuclear ribonucleoprotein R
[138-1]	1	O43390	HNRPR_HUMAN	HNRNPR	2	3.9	4.93	9.6e-10	696.3378	2	-9.1	SAFLCGVMKTYR	SAFLCGVM(Oxidation)KTYR	Oxidation@102	12	V20130429-05_FTMSms2hcd	42.315	95	106	12.2	0.089	1.2e-4	2	70943.6	HUMAN	Heterogeneous nuclear ribonucleoprotein R
[139]		Q15149	PLEC_HUMAN	PLEC	2	0.5	4.16	1.5e-8	778.9158	2	-2.3	LQEAGILSAEELQR	LQEAGILSAEELQR		14	V20130429-05_FTMSms2hcd	40.778	2795	2808	32.1	1.5e-8	2.3e-11	1	531795.0	HUMAN	Plectin
[139]		Q15149	PLEC_HUMAN	PLEC	2	0.5	4.16	1.5e-8	451.7502	2	-1.2	LTVDEAVR	LTVDEAVR		8	V20130429-05_FTMSms2hcd	23.085	3213	3220	19.1	3.4e-4	5.7e-7	1	531795.0	HUMAN	Plectin
[140]		P07814	SYEP_HUMAN	EPRS	1	1.5	5.95	2.8e-12	715.0179	3	0.81	KDPSKNQGGGLSSSGAGEGQGPK	KDPSKNQGGGLSSSGAGEGQGPK		23	V20130429-05_FTMSms2hcd	10.830	987	1009	29.9	2.8e-12	2.8e-15	1	170592.4	HUMAN	Bifunctional glutamate/proline--tRNA ligase
[141]		Q5JRK9	GGEE3_HUMAN	PAGE2B	1	10.8	5.91	4.6e-11	649.7971	2	0.79	IEDEPGDGPDVR	IEDEPGDGPDVR		12	V20130429-05_FTMSms2hcd	19.550	80	91	36.1	4.6e-11	6.7e-14	2	12041.1	HUMAN	Putative G antigen family E member 3
[141-1]	0	Q7Z2X7	GGEE2_HUMAN	PAGE2	1	10.8	5.91	4.6e-11	649.7971	2	0.79	IEDEPGDGPDVR	IEDEPGDGPDVR		12	V20130429-05_FTMSms2hcd	19.550	80	91	36.1	4.6e-11	6.7e-14	2	12090.2	HUMAN	G antigen family E member 2
[142]		P62906	RL10A_HUMAN	RPL10A	1	6.0	5.90	2.0e-10	742.9025	2	-1.2	KYDAFLASESLIK	KYDAFLASESLIK		13	V20130429-05_FTMSms2hcd	44.498	106	118	39.4	2.0e-10	3.6e-13	1	24831.5	HUMAN	60S ribosomal protein L10a
[143]		P27797	CALR_HUMAN	CALR	1	7.0	5.85	3.0e-11	1090.1714	3	1.2	SGTIFDNFLITNDEAYAEEFGNETWGVTK	SGTIFDNFLITNDEAYAEEFGNETWGVTK		29	V20130429-05_FTMSms2hcd	73.891	323	351	34.5	3.0e-11	3.0e-14	1	48141.9	HUMAN	Calreticulin
[144]		P39019	RS19_HUMAN	RPS19	2	14.5	3.86	3.1e-8	438.5868	3	-0.39	LKVPEWVDTVK	LKVPEWVDTVK		11	V20130429-05_FTMSms2hcd	42.006	28	38	30.8	3.1e-8	8.7e-11	1	16060.6	HUMAN	40S ribosomal protein S19
[144]		P39019	RS19_HUMAN	RPS19	2	14.5	3.86	3.1e-8	563.8505	2	-0.48	RVLQALEGLK	RVLQALEGLK		10	V20130429-05_FTMSms2hcd	34.017	102	111	29.9	1.3e-4	9.2e-7	1	16060.6	HUMAN	40S ribosomal protein S19
[145]		O76003	GLRX3_HUMAN	GLRX3	1	8.1	5.75	1.3e-11	853.4299	3	0.73	MAAGAAEAAVAAVEEVGSAGQFEELLR	M(Met-loss+Acetyl)AAGAAEAAVAAVEEVGSAGQFEELLR	Met-loss+Acetyl@1	27	V20130429-05_FTMSms2hcd	77.778	1	27	31.6	1.3e-11	1.6e-14	1	37432.4	HUMAN	Glutaredoxin-3
[146]		P31689	DNJA1_HUMAN	DNAJA1	1	3.8	5.75	1.3e-11	934.8826	2	-0.19	HYNGEAYEDDEHHPR	HYNGEAYEDDEHHPR		15	V20130429-05_FTMSms2hcd	10.447	375	389	31.5	1.3e-11	2.0e-14	1	44868.6	HUMAN	DnaJ homolog subfamily A member 1
[147]		P50914	RL14_HUMAN	RPL14	1	5.6	5.63	8.2e-10	677.8871	2	-1.5	LVAIVDVIDQNR	LVAIVDVIDQNR		12	V20130429-05_FTMSms2hcd	49.818	24	35	44.2	8.2e-10	2.9e-12	1	23432.1	HUMAN	60S ribosomal protein L14
[148]		P47914	RL29_HUMAN	RPL29	1	9.4	5.55	7.8e-10	689.3768	2	-1.6	AQAAAPASVPAQAPK	AQAAAPASVPAQAPK		15	V20130429-05_FTMSms2hcd	20.395	135	149	39.1	7.8e-10	1.4e-12	1	17752.2	HUMAN	60S ribosomal protein L29
[149]		P05198	IF2A_HUMAN	EIF2S1	1	3.8	5.47	1.6e-10	674.8335	2	0.49	VVTDTDETELAR	VVTDTDETELAR		12	V20130429-05_FTMSms2hcd	22.966	277	288	34.6	1.6e-10	2.0e-13	1	36112.5	HUMAN	Eukaryotic translation initiation factor 2 subunit 1
[150]		P43490	NAMPT_HUMAN	NAMPT	1	5.9	5.46	1.4e-10	802.6503	4	-1.6	TPAGNFVTLEEGKGDLEEYGQDLLHTVFK	TPAGNFVTLEEGKGDLEEYGQDLLHTVFK		29	V20130429-05_FTMSms2hcd	72.627	435	463	34.2	1.4e-10	1.7e-13	1	55521.6	HUMAN	Nicotinamide phosphoribosyltransferase
[151]		Q07020	RL18_HUMAN	RPL18	1	6.9	5.41	2.1e-9	730.9038	2	0.55	ILTFDQLALDSPK	ILTFDQLALDSPK		13	V20130429-05_FTMSms2hcd	52.568	120	132	47.1	2.1e-9	4.0e-12	1	21634.7	HUMAN	60S ribosomal protein L18
[152]		Q01518	CAP1_HUMAN	CAP1	1	4.8	5.29	1.7e-10	784.4238	3	12	AGAAPYVQAFDSLLAGPVAEYLK	AGAAPYVQAFDSLLAGPVAEYLK		23	V20130429-05_FTMSms2hcd	77.256	38	60	33.0	1.7e-10	4.2e-13	1	51901.9	HUMAN	Adenylyl cyclase-associated protein 1
[153]		P04632	CPNS1_HUMAN	CAPNS1	1	3.4	5.25	4.7e-10	578.8135	2	11	MFLVNSFLK	Acetyl-M(Oxidation)FLVNSFLK	Oxidation@1=8	9	V20130429-05_FTMSms2hcd	68.344	1	9	34.9	4.7e-10	1.0e-12	1	28316.0	HUMAN	Calpain small subunit 1
[154]		P62280	RS11_HUMAN	RPS11	1	7.6	5.21	1.5e-9	733.3925	2	-1.4	AYQKQPTIFQNK	AYQKQPTIFQNK		12	V20130429-05_FTMSms2hcd	22.524	9	20	37.2	1.5e-9	2.3e-12	1	18430.9	HUMAN	40S ribosomal protein S11
[155]		Q13765	NACA_HUMAN	NACA	1	7.0	5.16	5.9e-9	807.9203	2	-0.011	IEDLSQQAQLAAAEK	IEDLSQQAQLAAAEK		15	V20130429-05_FTMSms2hcd	32.463	128	142	49.6	5.9e-9	8.1e-12	1	23384.1	HUMAN	Nascent polypeptide-associated complex subunit alpha
[156]		P48643	TCPE_HUMAN	CCT5	2	3.7	4.14	8.5e-8	547.2674	2	0.24	IADGYEQAAR	IADGYEQAAR		10	V20130429-05_FTMSms2hcd	16.044	133	142	36.0	8.5e-8	1.6e-10	1	59671.6	HUMAN	T-complex protein 1 subunit epsilon
[156]		P48643	TCPE_HUMAN	CCT5	2	3.7	4.14	8.5e-8	584.8080	2	19	ISDSVLVDIK	ISDS(Phospho)VLVDIK	Phospho@154=10	10	V20130429-05_FTMSms2hcd	36.838	151	160	11.5	0.051	8.3e-5	1	59671.6	HUMAN	T-complex protein 1 subunit epsilon
[157]		P62266	RS23_HUMAN	RPS23	1	7.7	5.12	2.3e-9	595.8614	2	1.00	VANVSLLALYK	VANVSLLALYK		11	V20130429-05_FTMSms2hcd	48.871	125	135	37.3	2.3e-9	1.9e-11	1	15807.7	HUMAN	40S ribosomal protein S23
[158]		P84090	ERH_HUMAN	ERH	1	16.3	5.11	1.4e-9	469.2705	4	-0.26	MSHTILLVQPTKRPEGR	M(Met-loss+Acetyl)SHTILLVQPTKRPEGR	Met-loss+Acetyl@1	17	V20130429-05_FTMSms2hcd	29.742	1	17	36.0	1.4e-9	6.6e-12	1	12259.1	HUMAN	Enhancer of rudimentary homolog
[159]		P55209	NP1L1_HUMAN	NAP1L1	1	4.3	5.07	2.6e-9	930.4971	2	6.5	LDGLVETPTGYIESLPR	LDGLVETPTGYIESLPR		17	V20130429-05_FTMSms2hcd	54.410	56	72	37.1	2.6e-9	4.4e-12	1	45374.5	HUMAN	Nucleosome assembly protein 1-like 1
[160]		Q9UK76	HN1_HUMAN	HN1	1	9.7	5.05	2.6e-9	526.5882	3	-0.86	SSGGREDLESSGLQR	SSGGREDLESSGLQR		15	V20130429-05_FTMSms2hcd	18.097	70	84	36.9	2.6e-9	3.0e-12	1	16014.6	HUMAN	Hematological and neurological expressed 1 protein
[161]		O00764	PDXK_HUMAN	PDXK	1	6.7	4.99	3.8e-10	761.4205	3	3.4	VVPLADIITPNQFEAELLSGR	VVPLADIITPNQFEAELLSGR		21	V20130429-05_FTMSms2hcd	73.606	140	160	31.9	3.8e-10	1.2e-12	1	35102.6	HUMAN	Pyridoxal kinase
[162]		P40925	MDHC_HUMAN	MDH1	2	6.6	3.84	1.8e-8	697.3599	2	1.1	FVEGLPINDFSR	FVEGLPINDFSR		12	V20130429-05_FTMSms2hcd	48.372	299	310	29.3	1.8e-8	2.6e-11	1	36426.4	HUMAN	Malate dehydrogenase, cytoplasmic
[162]		P40925	MDHC_HUMAN	MDH1	2	6.6	3.84	1.8e-8	577.2501	2	18	KLSSAMSAAK	KLS(Phospho)S(Phospho)AMSAAK	Phospho@241=12;Phospho@242|245	10	V20130429-05_FTMSms2hcd	16.646	239	248	11.8	0.0024	5.1e-6	1	36426.4	HUMAN	Malate dehydrogenase, cytoplasmic
[163]		P62701	RS4X_HUMAN	RPS4X	2	7.2	2.77	4.5e-6	495.8023	2	-0.93	LSNIFVIGK	LSNIFVIGK		9	V20130429-05_FTMSms2hcd	44.218	222	230	31.6	4.5e-6	2.9e-8	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[163]		P62701	RS4X_HUMAN	RPS4X	2	7.2	2.77	4.5e-6	526.7412	2	-0.42	DANGNSFATR	DANGNSFATR		10	V20130429-05_FTMSms2hcd	11.166	212	221	23.4	1.1e-4	2.2e-7	3	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[163-1]	0	P22090	RS4Y1_HUMAN	RPS4Y1	1	3.8	1.20	1.1e-4	526.7412	2	-0.42	DANGNSFATR	DANGNSFATR		10	V20130429-05_FTMSms2hcd	11.166	212	221	23.4	1.1e-4	2.2e-7	3	29455.9	HUMAN	40S ribosomal protein S4, Y isoform 1
[163-2]	0	Q8TD47	RS4Y2_HUMAN	RPS4Y2	1	3.8	1.20	1.1e-4	526.7412	2	-0.42	DANGNSFATR	DANGNSFATR		10	V20130429-05_FTMSms2hcd	11.166	212	221	23.4	1.1e-4	2.2e-7	3	29295.7	HUMAN	40S ribosomal protein S4, Y isoform 2
[164]		P60660	MYL6_HUMAN	MYL6	1	10.6	4.77	1.4e-9	635.3422	3	7.0	VLDFEHFLPMLQTVAK	VLDFEHFLPM(Oxidation)LQTVAK	Oxidation@73	16	V20130429-05_FTMSms2hcd	63.156	64	79	32.7	1.4e-9	2.4e-12	1	16930.2	HUMAN	Myosin light polypeptide 6
[165]		Q13268	DHRS2_HUMAN	DHRS2	2	7.0	2.89	3.1e-6	520.7775	2	-0.59	DGAHVVISSR	DGAHVVISSR		10	V20130429-05_FTMSms2hcd	14.613	37	46	31.9	3.1e-6	6.2e-9	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[165]		Q13268	DHRS2_HUMAN	DHRS2	2	7.0	2.89	3.1e-6	422.7637	2	-5.9	TALLGLTR	TALLGLTR		8	V20130429-05_FTMSms2hcd	34.354	168	175	31.4	3.5e-4	8.6e-7	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[166]		P43487	RANG_HUMAN	RANBP1	1	5.5	4.63	1.4e-8	691.3219	2	-0.30	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-05_FTMSms2hcd	44.095	40	50	36.8	1.4e-8	2.0e-11	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[167]		P17844	DDX5_HUMAN	DDX5	1	2.0	4.62	1.7e-9	613.8582	2	-0.97	APILIATDVASR	APILIATDVASR		12	V20130429-05_FTMSms2hcd	38.143	392	403	31.6	1.7e-9	6.4e-12	2	69148.7	HUMAN	Probable ATP-dependent RNA helicase DDX5
[167-1]	0	Q92841	DDX17_HUMAN	DDX17	1	1.6	4.62	1.7e-9	613.8582	2	-0.97	APILIATDVASR	APILIATDVASR		12	V20130429-05_FTMSms2hcd	38.143	469	480	31.6	1.7e-9	6.4e-12	2	80273.1	HUMAN	Probable ATP-dependent RNA helicase DDX17
[168]		P55854	SUMO3_HUMAN	SUMO3	1	11.7	4.55	7.9e-8	617.8246	2	-0.57	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-05_FTMSms2hcd	26.825	21	32	41.1	7.9e-8	1.2e-10	3	11637.1	HUMAN	Small ubiquitin-related modifier 3
[168-1]	0	P61956	SUMO2_HUMAN	SUMO2	1	12.6	4.55	7.9e-8	617.8246	2	-0.57	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-05_FTMSms2hcd	26.825	22	33	41.1	7.9e-8	1.2e-10	3	10871.3	HUMAN	Small ubiquitin-related modifier 2
[168-2]	0	Q6EEV6	SUMO4_HUMAN	SUMO4	1	12.6	4.55	7.9e-8	617.8246	2	-0.57	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-05_FTMSms2hcd	26.825	22	33	41.1	7.9e-8	1.2e-10	3	10685.2	HUMAN	Small ubiquitin-related modifier 4
[169]		P62861	RS30_HUMAN	FAU	1	16.9	4.51	1.4e-9	554.3114	2	-3.8	FVNVVPTFGK	FVNVVPTFGK		10	V20130429-05_FTMSms2hcd	43.635	42	51	30.1	1.4e-9	3.6e-12	1	6647.9	HUMAN	40S ribosomal protein S30
[170]		P05386	RLA1_HUMAN	RPLP1	1	14.0	4.49	5.9e-9	851.9594	2	9.6	AAGVNVEPFWPGLFAK	AAGVNVEPFWPGLFAK		16	V20130429-05_FTMSms2hcd	64.381	34	49	33.3	5.9e-9	1.0e-11	1	11514.0	HUMAN	60S acidic ribosomal protein P1
[171]		P62847	RS24_HUMAN	RPS24	1	9.0	4.48	3.8e-9	699.8748	2	0.51	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-05_FTMSms2hcd	65.525	50	61	32.1	3.8e-9	6.9e-12	1	15423.3	HUMAN	40S ribosomal protein S24
[172]		P63173	RL38_HUMAN	RPL38	1	18.6	4.40	1.3e-9	525.9741	3	-1.7	KIEEIKDFLLTAR	KIEEIKDFLLTAR		13	V20130429-05_FTMSms2hcd	45.859	4	16	28.7	1.3e-9	7.3e-12	1	8218.0	HUMAN	60S ribosomal protein L38
[173]		P63220	RS21_HUMAN	RPS21	1	18.1	4.38	3.2e-9	906.4289	2	13	MQNDAGEFVDLYVPR	M(Acetyl+Oxidation)QNDAGEFVDLYVPR		15	V20130429-05_FTMSms2hcd	55.520	1	15	30.8	3.2e-9	3.8e-12	1	9111.5	HUMAN	40S ribosomal protein S21
[174]		P31948	STIP1_HUMAN	STIP1	1	2.4	4.15	9.2e-9	744.9003	2	-0.75	LAYINPDLALEEK	LAYINPDLALEEK		13	V20130429-05_FTMSms2hcd	46.389	352	364	30.9	9.2e-9	1.7e-11	1	62639.8	HUMAN	Stress-induced-phosphoprotein 1
[175]		P29401	TKT_HUMAN	TKT	1	2.7	4.12	1.2e-7	680.3414	3	-0.85	NMAEQIIQEIYSQIQSK	NM(Oxidation)AEQIIQEIYSQIQSK	Oxidation@266	17	V20130429-05_FTMSms2hcd	68.751	265	281	36.7	1.2e-7	1.4e-10	1	67878.2	HUMAN	Transketolase
[176]		P49006	MRP_HUMAN	MARCKSL1	1	4.1	4.05	3.7e-8	494.2550	2	0.42	LSGLSFKR	LSGLS(Phospho)FKR	Phospho@104=16	8	V20130429-05_FTMSms2hcd	29.630	100	107	33.2	3.7e-8	6.6e-11	1	19528.9	HUMAN	MARCKS-related protein
[177]		P12268	IMDH2_HUMAN	IMPDH2	2	3.7	2.69	9.4e-6	578.8184	2	-2.2	NLIDAGVDALR	NLIDAGVDALR		11	V20130429-05_FTMSms2hcd	46.158	312	322	32.5	9.4e-6	2.0e-8	1	55805.5	HUMAN	Inosine-5'-monophosphate dehydrogenase 2
[177]		P12268	IMDH2_HUMAN	IMPDH2	2	3.7	2.69	9.4e-6	422.7658	2	-0.89	LVGIISSR	LVGIISSR		8	V20130429-05_FTMSms2hcd	28.643	154	161	16.9	0.0035	9.5e-6	1	55805.5	HUMAN	Inosine-5'-monophosphate dehydrogenase 2
[178]		P30040	ERP29_HUMAN	ERP29	1	3.8	3.86	2.8e-7	567.8291	2	-0.72	SLNILTAFQK	SLNILTAFQK		10	V20130429-05_FTMSms2hcd	52.607	244	253	36.0	2.8e-7	1.0e-9	1	28993.7	HUMAN	Endoplasmic reticulum resident protein 29
[179]		P13010	XRCC5_HUMAN	XRCC5	2	4.0	3.00	1.7e-6	516.3105	2	0.16	TLFPLIEAK	TLFPLIEAK		9	V20130429-05_FTMSms2hcd	50.546	535	543	31.6	1.7e-6	7.2e-9	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[179]		P13010	XRCC5_HUMAN	XRCC5	2	4.0	3.00	1.7e-6	748.3478	3	3.5	DQVTAQEIFQDNHEDGPTAK	DQVTAQEIFQDNHEDGPTAK		20	V20130429-05_FTMSms2hcd	34.709	546	565	10.9	0.026	2.6e-5	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[180]		Q8NC51	PAIRB_HUMAN	SERBP1	1	3.4	3.72	1.1e-7	784.4192	2	0.76	VGRRPDQQLQGEGK	VGRRPDQQLQGEGK		14	V20130429-05_FTMSms2hcd	11.625	109	122	32.3	1.1e-7	1.6e-10	1	44965.7	HUMAN	Plasminogen activator inhibitor 1 RNA-binding protein
[181]		P46777	RL5_HUMAN	RPL5	1	6.4	3.68	4.0e-9	611.7876	4	-1.7	YLMEEDEDAYKKQFSQYIK	YLM(Oxidation)EEDEDAYKKQFSQYIK	Oxidation@212	19	V20130429-05_FTMSms2hcd	40.739	210	228	24.2	4.0e-9	3.7e-12	1	34362.9	HUMAN	60S ribosomal protein L5
[182]		P17096	HMGA1_HUMAN	HMGA1	1	17.8	3.64	1.8e-8	1198.9675	2	0.47	KLEKEEEEGISQESSEEEQ	KLEKEEEEGISQES(Phospho)S(Phospho)EEEQ	Phospho@102=11;Phospho@103=11	19	V20130429-05_FTMSms2hcd	20.983	89	107	27.4	1.8e-8	3.5e-11	1	11676.1	HUMAN	High mobility group protein HMG-I/HMG-Y
[183]		Q56VL3	OCAD2_HUMAN	OCIAD2	1	9.1	3.63	1.7e-9	700.3266	2	0.79	HGLSEKGDSQPSAS	HGLSEKGDSQPSAS		14	V20130429-05_FTMSms2hcd	9.602	141	154	21.8	1.7e-9	2.4e-12	1	16953.7	HUMAN	OCIA domain-containing protein 2
[184]		P61026	RAB10_HUMAN	RAB10	1	5.5	3.60	1.7e-7	631.3647	2	5.6	AFLTLAEDILR	AFLTLAEDILR		11	V20130429-05_FTMSms2hcd	66.058	162	172	32.2	1.7e-7	5.0e-10	1	22541.1	HUMAN	Ras-related protein Rab-10
[185]		P18124	RL7_HUMAN	RPL7	1	4.4	3.52	6.6e-6	585.8458	2	0.19	IALTDNALIAR	IALTDNALIAR		11	V20130429-05_FTMSms2hcd	39.960	167	177	43.4	6.6e-6	2.3e-8	1	29226.0	HUMAN	60S ribosomal protein L7
[186]		P0CG47	UBB_HUMAN	UBB	1	7.0	3.51	2.5e-8	894.4666	2	-0.77	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-05_FTMSms2hcd	44.440	12	27	26.9	2.5e-8	3.4e-11	4	25761.8	HUMAN	Polyubiquitin-B
[186-1]	0	P0CG48	UBC_HUMAN	UBC	1	2.3	3.51	2.5e-8	894.4666	2	-0.77	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-05_FTMSms2hcd	44.440	12	27	26.9	2.5e-8	3.4e-11	4	77029.2	HUMAN	Polyubiquitin-C
[186-2]	0	P62979	RS27A_HUMAN	RPS27A	1	10.3	3.51	2.5e-8	894.4666	2	-0.77	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-05_FTMSms2hcd	44.440	12	27	26.9	2.5e-8	3.4e-11	4	17965.1	HUMAN	Ubiquitin-40S ribosomal protein S27a
[186-3]	0	P62987	RL40_HUMAN	UBA52	1	12.5	3.51	2.5e-8	894.4666	2	-0.77	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-05_FTMSms2hcd	44.440	12	27	26.9	2.5e-8	3.4e-11	4	14728.5	HUMAN	Ubiquitin-60S ribosomal protein L40
[187]		P31949	S10AB_HUMAN	S100A11	1	8.6	3.49	1.7e-6	510.2534	2	-0.84	ISSPTETER	ISSPTETER		9	V20130429-05_FTMSms2hcd	12.121	4	12	36.5	1.7e-6	2.7e-9	1	11740.6	HUMAN	Protein S100-A11
[188]		P22234	PUR6_HUMAN	PAICS	1	2.8	3.37	1.1e-6	593.3456	2	0.13	MATAEVLNIGKK	M(Met-loss+Acetyl)ATAEVLNIGKK	Met-loss+Acetyl@1	12	V20130429-05_FTMSms2hcd	36.583	1	12	34.4	1.1e-6	2.3e-9	1	47079.7	HUMAN	Multifunctional protein ADE2
[189]		Q14116	IL18_HUMAN	IL18	1	4.1	3.28	3.6e-7	513.2734	2	-1.9	SDIIFFQR	SDIIFFQR		8	V20130429-05_FTMSms2hcd	44.453	133	140	30.8	3.6e-7	7.0e-10	1	22326.4	HUMAN	Interleukin-18
[190]		P42766	RL35_HUMAN	RPL35	1	10.6	3.19	5.8e-7	519.6261	3	-0.32	QLDDLKVELSQLR	QLDDLKVELSQLR		13	V20130429-05_FTMSms2hcd	46.478	20	32	31.0	5.8e-7	1.3e-9	1	14551.6	HUMAN	60S ribosomal protein L35
[191]		P09132	SRP19_HUMAN	SRP19	1	10.4	3.17	1.6e-7	731.8427	2	0.88	TGGADQSLQQGEGSK	TGGADQSLQQGEGSK		15	V20130429-05_FTMSms2hcd	10.486	122	136	27.8	1.6e-7	2.0e-10	1	16155.8	HUMAN	Signal recognition particle 19 kDa protein
[192]		Q16531	DDB1_HUMAN	DDB1	1	1.4	3.12	7.9e-8	601.3228	3	-0.19	EATADDLIKVVEELTR	EATADDLIKVVEELTR		16	V20130429-05_FTMSms2hcd	72.735	1123	1138	25.7	7.9e-8	1.3e-10	1	126969.0	HUMAN	DNA damage-binding protein 1
[193]		Q12849	GRSF1_HUMAN	GRSF1	1	6.5	3.08	2.0e-8	1206.5995	3	-8.6	TTYLEDLPPPPEYELAPSKLEEEVDDVFLIR	TTYLEDLPPPPEYELAPSKLEEEVDDVFLIR		31	V20130429-05_FTMSms2hcd	76.975	123	153	22.1	2.0e-8	2.7e-11	1	53126.8	HUMAN	G-rich sequence factor 1
[194]		P46783	RS10_HUMAN	RPS10	1	5.5	3.05	6.9e-7	555.3355	2	2.9	IAIYELLFK	IAIYELLFK		9	V20130429-05_FTMSms2hcd	64.761	9	17	30.0	6.9e-7	4.6e-9	1	18897.9	HUMAN	40S ribosomal protein S10
[195]		Q01469	FABP5_HUMAN	FABP5	1	7.4	2.99	2.9e-6	522.2777	2	0.12	MATVQQLEGR	M(Met-loss+Acetyl)ATVQQLEGR	Met-loss+Acetyl@1	10	V20130429-05_FTMSms2hcd	30.572	1	10	32.8	2.9e-6	5.4e-9	1	15164.6	HUMAN	Fatty acid-binding protein, epidermal
[196]		Q99832	TCPH_HUMAN	CCT7	1	1.8	2.85	2.3e-6	354.8818	3	0.23	LLDVVHPAAK	LLDVVHPAAK		10	V20130429-05_FTMSms2hcd	26.094	68	77	30.9	2.3e-6	1.3e-8	1	59367.2	HUMAN	T-complex protein 1 subunit eta
[197]		Q9NP79	VTA1_HUMAN	VTA1	1	4.9	2.76	7.1e-8	738.4413	2	9.0	MAALAPLPPLPAQFK	M(Met-loss+Acetyl)AALAPLPPLPAQFK	Met-loss+Acetyl@1	15	V20130429-05_FTMSms2hcd	62.750	1	15	21.8	7.1e-8	6.0e-10	1	33879.5	HUMAN	Vacuolar protein sorting-associated protein VTA1 homolog
[198]		P52597	HNRPF_HUMAN	HNRNPF	2	5.5	1.84	1.1e-5	934.4792	2	4.0	ITGEAFVQFASQELAEK	ITGEAFVQFASQELAEK		17	V20130429-05_FTMSms2hcd	60.191	151	167	24.3	1.1e-5	1.4e-8	1	45672.3	HUMAN	Heterogeneous nuclear ribonucleoprotein F
[198]		P52597	HNRPF_HUMAN	HNRNPF	2	5.5	1.84	1.1e-5	399.7236	2	0.38	YIEVFK	YIEVFK		6	V20130429-05_FTMSms2hcd	31.775	82	87	15.9	7.1e-4	3.0e-6	1	45672.3	HUMAN	Heterogeneous nuclear ribonucleoprotein F
[199]		P00441	SODC_HUMAN	SOD1	1	8.4	2.66	4.6e-7	700.8781	2	-3.1	ESNGPVKVWGSIK	ESNGPVKVWGSIK		13	V20130429-05_FTMSms2hcd	32.365	25	37	25.2	4.6e-7	8.1e-10	1	15935.9	HUMAN	Superoxide dismutase [Cu-Zn]
[200]		P11940	PABP1_HUMAN	PABPC1	1	2.2	2.57	1.7e-7	514.9836	3	-0.24	IVATKPLYVALAQR	IVATKPLYVALAQR		14	V20130429-05_FTMSms2hcd	39.888	357	370	21.9	1.7e-7	2.9e-9	2	70671.5	HUMAN	Polyadenylate-binding protein 1
[200-1]	0	Q9H361	PABP3_HUMAN	PABPC3	1	2.2	2.57	1.7e-7	514.9836	3	-0.24	IVATKPLYVALAQR	IVATKPLYVALAQR		14	V20130429-05_FTMSms2hcd	39.888	357	370	21.9	1.7e-7	2.9e-9	2	70031.5	HUMAN	Polyadenylate-binding protein 3
[201]		P62277	RS13_HUMAN	RPS13	2	18.5	1.87	1.4e-6	565.3154	3	9.3	GLAPDLPEDLYHLIK	GLAPDLPEDLYHLIK		15	V20130429-05_FTMSms2hcd	62.043	79	93	19.9	1.4e-6	3.7e-9	1	17222.4	HUMAN	40S ribosomal protein S13
[201]		P62277	RS13_HUMAN	RPS13	2	18.5	1.87	1.4e-6	461.2897	3	1.4	KGLTPSQIGVILR	KGLTPSQIGVILR		13	V20130429-05_FTMSms2hcd	42.477	43	55	16.5	2.1e-4	3.2e-6	1	17222.4	HUMAN	40S ribosomal protein S13
[202]		P62263	RS14_HUMAN	RPS14	1	7.3	2.40	4.3e-6	527.7856	2	-0.057	TPGPGAQSALR	TPGPGAQSALR		11	V20130429-05_FTMSms2hcd	17.238	107	117	27.8	4.3e-6	9.1e-9	1	16272.9	HUMAN	40S ribosomal protein S14
[203]		Q9UHV9	PFD2_HUMAN	PFDN2	1	13.0	2.35	6.7e-7	683.3251	3	0.33	LMGEDEKPAAKENSEGAGAK	LM(Oxidation)GEDEKPAAKENSEGAGAK	Oxidation@127	20	V20130429-05_FTMSms2hcd	10.094	126	145	22.9	6.7e-7	6.8e-10	1	16648.0	HUMAN	Prefoldin subunit 2
[204]		Q6ZQQ6	WDR87_HUMAN	WDR87	1	0.3	2.22	3.3e-6	610.8135	2	0.50	EEKALNLEMK	EEKALNLEM(Oxidation)K	Oxidation@1967	10	V20130429-05_FTMSms2hcd	37.284	1959	1968	25.4	3.3e-6	4.8e-9	1	333188.0	HUMAN	WD repeat-containing protein 87
[205]		P35268	RL22_HUMAN	RPL22	1	10.2	2.21	1.0e-5	621.8438	2	0.20	AGNLGGGVVTIER	AGNLGGGVVTIER		13	V20130429-05_FTMSms2hcd	31.430	53	65	28.0	1.0e-5	2.1e-8	1	14787.1	HUMAN	60S ribosomal protein L22
[206]		P60842	IF4A1_HUMAN	EIF4A1	1	5.9	2.19	6.7e-7	938.4780	3	10.0	TLRDIETFYNTSIEEMPLNVADLI	TLRDIETFYNTSIEEM(Oxidation)PLNVADLI	Oxidation@398	24	V20130429-05_FTMSms2hcd	73.408	383	406	21.3	6.7e-7	9.0e-10	1	46154.4	HUMAN	Eukaryotic initiation factor 4A-I
[207]		O95678	K2C75_HUMAN	KRT75	1	1.6	2.05	5.2e-6	540.2597	2	0.47	AQYEDIANR	AQYEDIANR		9	V20130429-05_FTMSms2hcd	18.781	325	333	24.8	5.2e-6	9.7e-9	2	59560.9	HUMAN	Keratin, type II cytoskeletal 75
[207-1]	0	P05787	K2C8_HUMAN	KRT8	1	1.9	2.05	5.2e-6	540.2597	2	0.47	AQYEDIANR	AQYEDIANR		9	V20130429-05_FTMSms2hcd	18.781	265	273	24.8	5.2e-6	9.7e-9	2	53704.7	HUMAN	Keratin, type II cytoskeletal 8
[208]		P62333	PRS10_HUMAN	PSMC6	1	2.8	2.02	1.3e-5	582.7750	2	-19	LSDGFNGADLR	LSDGFNGADLR		11	V20130429-05_FTMSms2hcd	31.027	334	344	26.6	1.3e-5	2.0e-8	1	44173.4	HUMAN	26S protease regulatory subunit 10B
[209]		P40429	RL13A_HUMAN	RPL13A	1	4.9	1.94	2.1e-4	618.8627	2	-1.4	KIDKYTEVLK	KIDKYTEVLK		10	V20130429-05_FTMSms2hcd	22.367	188	197	32.4	2.1e-4	8.9e-7	1	23577.4	HUMAN	60S ribosomal protein L13a
[210]		P16949	STMN1_HUMAN	STMN1	1	6.0	1.94	2.8e-5	537.7875	2	-0.0071	DLSLEEIQK	DLSLEEIQK		9	V20130429-05_FTMSms2hcd	35.208	44	52	27.6	2.8e-5	4.5e-8	2	17302.7	HUMAN	Stathmin
[210-1]	0	Q93045	STMN2_HUMAN	STMN2	1	5.0	1.94	2.8e-5	537.7875	2	-0.0071	DLSLEEIQK	DLSLEEIQK		9	V20130429-05_FTMSms2hcd	35.208	78	86	27.6	2.8e-5	4.5e-8	2	20828.2	HUMAN	Stathmin-2
[211]		Q68DN1	CB016_HUMAN	C2orf16	2	0.6	0.97	1.5e-5	709.2814	2	10	IGATQTSTASLK	IGATQT(Phospho)S(Phospho)TAS(Phospho)LK	Phospho@1332&1333&1334|1332&1333&1336|1332&1334&1336|1333&1334&1336	12	V20130429-05_FTMSms2hcd	14.518	1327	1338	16.4	1.5e-5	3.8e-8	1	224323.2	HUMAN	Uncharacterized protein C2orf16
[211]		Q68DN1	CB016_HUMAN	C2orf16	2	0.6	0.97	1.5e-5	473.1897	3	9.4	IGATQTSTASLK	IGATQT(Phospho)S(Phospho)T(Phospho)ASLK	Phospho@1332&1333&1334|1332&1333&1336|1332&1334&1336|1333&1334&1336	12	V20130429-05_FTMSms2hcd	14.544	1327	1338	14.2	2.6e-5	6.7e-8	1	224323.2	HUMAN	Uncharacterized protein C2orf16
[212]		O75426	FBX24_HUMAN	FBXO24	1	2.1	1.81	1.0e-6	671.7914	2	-3.6	VVGTPEPSLGAR	VVGT(Phospho)PEPS(Phospho)LGAR	Phospho@499;Phospho@503	12	V20130429-05_FTMSms2hcd	14.441	496	507	18.5	1.0e-6	1.8e-9	1	64889.6	HUMAN	F-box only protein 24
[213]		P06454	PTMA_HUMAN	PTMA	1	13.5	1.76	2.7e-6	733.8461	2	-0.51	MSDAAVDTSSEITTK	M(Met-loss+Acetyl)SDAAVDTSSEITTK	Met-loss+Acetyl@1	15	V20130429-05_FTMSms2hcd	28.516	1	15	20.3	2.7e-6	3.9e-9	1	12203.0	HUMAN	Prothymosin alpha
[214]		Q9HB71	CYBP_HUMAN	CACYBP	1	8.3	1.66	4.6e-6	714.7234	3	0.77	MASEELQKDLEEVKVLLEK	M(Met-loss+Acetyl)ASEELQKDLEEVKVLLEK	Met-loss+Acetyl@1	19	V20130429-05_FTMSms2hcd	72.399	1	19	20.6	4.6e-6	1.1e-8	1	26210.2	HUMAN	Calcyclin-binding protein
[215]		O60333	KIF1B_HUMAN	KIF1B	1	0.6	1.55	1.0e-7	727.2888	2	-10	LDLMREMYDR	LDLM(Oxidation)REM(Oxidation)Y(Phospho)DR	Oxidation@852;Oxidation@855;Phospho@856	10	V20130429-05_FTMSms2hcd	28.919	849	858	10.6	1.0e-7	2.6e-10	2	204478.0	HUMAN	Kinesin-like protein KIF1B
[215-1]	0	Q12756	KIF1A_HUMAN	KIF1A	1	0.6	1.55	1.0e-7	727.2888	2	-10	LDLMREMYDR	LDLM(Oxidation)REM(Oxidation)Y(Phospho)DR	Oxidation@812;Oxidation@815;Phospho@816	10	V20130429-05_FTMSms2hcd	28.919	809	818	10.6	1.0e-7	2.6e-10	2	191065.8	HUMAN	Kinesin-like protein KIF1A
[216]		A6NHP6	YR011_HUMAN		1	3.1	1.55	1.0e-7	727.2888	2	-9.0	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-05_FTMSms2hcd	28.919	173	182	10.6	1.0e-7	2.6e-10	2	37918.4	HUMAN	NPIP-like protein LOC729602
[216-1]	0	A8MZ50	NPIL4_HUMAN		1	3.0	1.55	1.0e-7	727.2888	2	-9.0	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-05_FTMSms2hcd	28.919	173	182	10.6	1.0e-7	2.6e-10	2	38380.9	HUMAN	Putative NPIP-like protein ENSP00000381263
[217]		P27708	PYR1_HUMAN	CAD	1	0.6	1.44	4.8e-6	642.8643	2	4.3	MAALVLEDGSVLR	M(Met-loss+Acetyl)AALVLEDGSVLR	Met-loss+Acetyl@1	13	V20130429-05_FTMSms2hcd	59.611	1	13	18.5	4.8e-6	1.2e-8	1	242985.9	HUMAN	CAD protein
[218]		Q02790	FKBP4_HUMAN	FKBP4	1	2.0	1.40	5.7e-5	544.8083	2	-0.50	VLQLYPNNK	VLQLYPNNK		9	V20130429-05_FTMSms2hcd	29.451	379	387	23.9	5.7e-5	1.0e-7	1	51805.0	HUMAN	Peptidyl-prolyl cis-trans isomerase FKBP4
[219]		Q15366	PCBP2_HUMAN	PCBP2	1	8.5	1.31	1.1e-5	846.6778	4	2.1	AFAMIIDKLEEDISSSMTNSTAASRPPVTLR	AFAM(Oxidation)IIDKLEEDISSSM(Oxidation)TNSTAASRPPVTLR	Oxidation@74;Oxidation@87	31	V20130429-05_FTMSms2hcd	63.328	71	101	19.2	1.1e-5	1.5e-8	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[220]		Q7Z2K8	GRIN1_HUMAN	GPRIN1	1	1.6	1.25	4.7e-5	807.4564	2	-3.3	VGSLPLEKGSPVTTTK	VGSLPLEKGSPVTTTK		16	V20130429-05_FTMSms2hcd	74.265	606	621	21.9	4.7e-5	1.3e-7	1	102400.1	HUMAN	G protein-regulated inducer of neurite outgrowth 1
[221]		P62829	RL23_HUMAN	RPL23	1	5.7	1.18	4.2e-5	475.2892	2	-0.60	NLYIISVK	NLYIISVK		8	V20130429-05_FTMSms2hcd	40.440	36	43	20.9	4.2e-5	3.0e-7	1	14865.6	HUMAN	60S ribosomal protein L23
[222]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.15	0.0040	435.2581	2	-0.20	LEPLLER	LEPLLER		7	V20130429-05_FTMSms2hcd	30.333	769	775	31.4	0.0040	1.8e-5	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[223]		Q12882	DPYD_HUMAN	DPYD	1	1.5	1.15	0.0013	920.4252	2	12	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-05_FTMSms2hcd	28.011	260	274	28.6	0.0013	1.4e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[224]		P55884	EIF3B_HUMAN	EIF3B	1	1.7	1.02	1.5e-6	680.8076	2	-0.62	AQAVSEDAGGNEGR	AQAVSEDAGGNEGR		14	V20130429-05_FTMSms2hcd	8.688	121	134	11.6	1.5e-6	2.2e-9	1	92482.4	HUMAN	Eukaryotic translation initiation factor 3 subunit B
[225]		P56537	IF6_HUMAN	EIF6	1	4.1	0.92	9.2e-4	571.8119	2	0.097	NSLPDTVQIR	NSLPDTVQIR		10	V20130429-05_FTMSms2hcd	30.920	86	95	25.6	9.2e-4	1.7e-6	1	26599.3	HUMAN	Eukaryotic translation initiation factor 6
[226]		Q86UQ4	ABCAD_HUMAN	ABCA13	1	0.1	0.73	9.7e-4	426.2713	2	0.48	HILDIIK	HILDIIK		7	V20130429-05_FTMSms2hcd	35.977	994	1000	23.8	9.7e-4	1.4e-5	1	576164.4	HUMAN	ATP-binding cassette sub-family A member 13
[227]		O95466	FMNL_HUMAN	FMNL1	1	0.9	0.69	7.6e-4	569.2679	2	-1.3	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-05_FTMSms2hcd	16.600	622	631	22.9	7.6e-4	1.4e-6	1	121854.6	HUMAN	Formin-like protein 1
[228]		Q9BXX3	AN30A_HUMAN	ANKRD30A	1	1.4	0.69	4.2e-6	806.9890	3	10	QEEDEEYSCDSRSLFESSAK	QEEDEEY(Phospho)SCDSRSLFESSAK	Phospho@480|481|484|486|490|491	20	V20130429-05_FTMSms2hcd	9.916	474	493	10.7	4.2e-6	7.4e-9	1	158836.6	HUMAN	Ankyrin repeat domain-containing protein 30A
[229]		Q6ZVZ8	ASB18_HUMAN	ASB18	1	4.9	0.66	3.4e-4	737.7061	3	11	GAHVDARNGRGETALSAACGAAR	GAHVDARNGRGETALSAACGAAR		23	V20130429-05_FTMSms2hcd	45.299	242	264	20.7	3.4e-4	3.8e-7	1	50803.8	HUMAN	Ankyrin repeat and SOCS box protein 18
[230]		Q01105	SET_HUMAN	SET	1	3.4	0.66	1.0e-4	604.8049	2	-1.6	VEVTEFEDIK	VEVTEFEDIK		10	V20130429-05_FTMSms2hcd	38.295	123	132	17.8	1.0e-4	1.4e-7	1	33489.1	HUMAN	Protein SET
[231]		P46781	RS9_HUMAN	RPS9	1	4.1	0.65	6.8e-4	460.7637	2	0.14	LIGEYGLR	LIGEYGLR		8	V20130429-05_FTMSms2hcd	31.762	31	38	22.2	6.8e-4	1.7e-6	1	22591.6	HUMAN	40S ribosomal protein S9
[232]		P62244	RS15A_HUMAN	RPS15A	1	6.2	0.65	2.3e-4	436.2718	2	0.40	IVVNLTGR	IVVNLTGR		8	V20130429-05_FTMSms2hcd	29.791	61	68	19.6	2.3e-4	5.6e-7	1	14839.6	HUMAN	40S ribosomal protein S15a
[233]		Q8NF50	DOCK8_HUMAN	DOCK8	1	0.6	0.63	4.9e-5	727.3219	2	13	LPPNYSMHSAEK	LPPNYS(Phospho)MHSAEK	Phospho@698|701	12	V20130429-05_FTMSms2hcd	15.888	693	704	15.8	4.9e-5	7.6e-8	1	238531.2	HUMAN	Dedicator of cytokinesis protein 8
[234]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.61	0.029	665.3597	2	-5.5	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-05_FTMSms2hcd	19.424	311	322	30.6	0.029	4.7e-5	1	37425.1	HUMAN	Transmembrane protein 68
[235]		Q9Y2V0	CO041_HUMAN	C15orf41	1	9.3	0.60	3.5e-4	771.3896	4	-3.2	MILTKAQYDEIAQCLVSVPPTRQSLR	Acetyl-MILTKAQYDEIAQCLVS(Phospho)VPPTRQSLR	Phospho@17|21|24	26	V20130429-05_FTMSms2hcd	54.570	1	26	20.1	3.5e-4	4.3e-7	1	32264.2	HUMAN	Uncharacterized protein C15orf41
[236]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	0.52	4.5e-4	695.3215	2	0.30	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-05_FTMSms2hcd	24.859	166	177	19.9	4.5e-4	6.0e-7	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[237]		Q8NG11	TSN14_HUMAN	TSPAN14	1	3.0	0.47	0.0069	416.7417	2	-1.6	GVLSDLTK	GVLSDLTK		8	V20130429-05_FTMSms2hcd	44.532	45	52	25.8	0.0069	1.3e-5	1	30691.1	HUMAN	Tetraspanin-14
[238]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.45	2.3e-4	668.3309	2	15	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-05_FTMSms2hcd	29.316	376	386	17.6	2.3e-4	3.2e-7	1	46099.6	HUMAN	Zinc finger protein 763
[239]		Q4G0M1	F132B_HUMAN	FAM132B	1	4.0	0.43	2.4e-4	750.3661	2	16	AGPAARPPEPTAER	AGPAARPPEPT(Phospho)AER	Phospho@69	14	V20130429-05_FTMSms2hcd	24.374	59	72	17.6	2.4e-4	3.0e-7	1	37279.2	HUMAN	Protein FAM132B
[240]		Q496Y0	LONF3_HUMAN	LONRF3	1	1.6	0.38	2.0e-4	735.8795	2	-1.4	AQLPFLAMRSLK	AQLPFLAM(Oxidation)RS(Phospho)LK	Oxidation@737;Phospho@739	12	V20130429-05_FTMSms2hcd	62.056	730	741	16.6	2.0e-4	2.7e-7	1	84490.4	HUMAN	LON peptidase N-terminal domain and RING finger protein 3
[241]		Q9UI30	TR112_HUMAN	TRMT112	1	11.2	0.27	1.2e-4	834.3749	2	-7.3	GPVEGYEENEEFLR	GPVEGYEENEEFLR		14	V20130429-05_FTMSms2hcd	37.773	69	82	14.3	1.2e-4	1.4e-7	1	14199.5	HUMAN	tRNA methyltransferase 112 homolog
[242]		Q96AX9	MIB2_HUMAN	MIB2	1	1.4	0.26	2.7e-5	824.8707	2	-2.0	AARPTMDPSAHRSR	AARPTM(Oxidation)DPSAHRS(Phospho)R	Oxidation@45;Phospho@52=24	14	V20130429-05_FTMSms2hcd	20.100	40	53	10.8	2.7e-5	3.7e-8	1	109939.8	HUMAN	E3 ubiquitin-protein ligase MIB2
[243]		Q9Y6I7	WSB1_HUMAN	WSB1	1	2.6	0.16	1.4e-4	646.3296	2	4.3	MASFPPRVNEK	M(Oxidation)ASFPPRVNEK	Oxidation@1	11	V20130429-05_FTMSms2hcd	54.783	1	11	13.6	1.4e-4	1.9e-7	1	47432.6	HUMAN	WD repeat and SOCS box-containing protein 1
[244]		Q9NXG0	CNTLN_HUMAN	CNTLN	1	0.7	0.14	0.0087	376.5479	3	1.0	RQVAEANALR	RQVAEANALR		10	V20130429-05_FTMSms2hcd	15.677	776	785	23.1	0.0087	2.7e-5	1	161604.6	HUMAN	Centlein
[245]		O14744	ANM5_HUMAN	PRMT5	1	3.3	0.13	6.5e-4	775.7775	3	8.5	AAILPTSIFLTNKKGFPVLSK	AAILPTSIFLT(Phospho)NKKGFPVLSK	Phospho@238|247	21	V20130429-05_FTMSms2hcd	59.737	228	248	16.9	6.5e-4	4.9e-6	1	72684.5	HUMAN	Protein arginine N-methyltransferase 5
[246]		Q08257	QOR_HUMAN	CRYZ	1	3.3	0.12	0.0033	407.8875	3	-2.8	VFEFGGPEVLK	VFEFGGPEVLK		11	V20130429-05_FTMSms2hcd	18.280	13	23	20.6	0.0033	5.7e-6	1	35206.9	HUMAN	Quinone oxidoreductase
[247]		Q8N3U4	STAG2_HUMAN	STAG2	1	0.8	0.11	0.0031	617.8661	2	-10	HLDALLRQIR	HLDALLRQIR		10	V20130429-05_FTMSms2hcd	46.766	608	617	20.3	0.0031	1.5e-5	1	141327.7	HUMAN	Cohesin subunit SA-2
[248]		Q8NF86	PRS33_HUMAN	PRSS33	1	5.0	0.03	0.0019	494.9594	3	-15	VRLGALRLGSTSPR	VRLGALRLGSTSPR		14	V20130429-05_FTMSms2hcd	37.734	90	103	18.4	0.0019	9.8e-6	1	29786.8	HUMAN	Serine protease 33
[249]		Q96MF6	CQ10A_HUMAN	COQ10A	1	5.3	0.02	8.0e-4	771.3932	2	13	QNVAAFERRAATK	QNVAAFERRAAT(Phospho)K	Phospho@227	13	V20130429-05_FTMSms2hcd	24.225	216	228	16.3	8.0e-4	1.1e-6	1	27686.5	HUMAN	Coenzyme Q-binding protein COQ10 homolog A, mitochondrial
[250]		P13569	CFTR_HUMAN	CFTR	1	0.7	0.01	0.0013	562.7905	2	-7.7	VGLLGRTGSGK	VGLLGRTGS(Phospho)GK	Phospho@1246|1248	11	V20130429-05_FTMSms2hcd	71.247	1240	1250	17.4	0.0013	1.9e-6	1	168143.1	HUMAN	Cystic fibrosis transmembrane conductance regulator
[251]		O94772	LY6H_HUMAN	LY6H	1	9.3	0.01	6.2e-4	728.7964	2	18	QCQPSDTVCASVR	Q(Gln->pyro-Glu)CQPSDTVCAS(Phospho)VR	Gln->pyro-Glu@44;Phospho@54=9	13	V20130429-05_FTMSms2hcd	10.669	44	56	15.6	6.2e-4	1.3e-6	1	14669.2	HUMAN	Lymphocyte antigen 6H
